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Attention-deficit/hyperactivity disorder (ADHD) is a highly heritable neurodevelopmental 
disorder associated with wide-ranging impairments in cognitive and brain functions. This thesis 
uses a multi-disciplinary approach to study cognitive and neurophysiological impairments in 
ADHD in adolescence and adulthood. The first part of this thesis examines the developmental 
and aetiological pathways of cognitive and electrophysiological (EEG) measures in a follow-up 
sample of adolescents and young adults with a childhood diagnosis of ADHD, their siblings and 
age-matched controls. The findings suggest that cognitive and event-related potential (ERP) 
indices of attention-vigilance and error processing are markers of ADHD remission, 
distinguishing between individuals with persistent and remitted ADHD at follow-up. Instead, 
cognitive and ERP measures mapping onto executive and conflict-monitoring processes, and 
indices of brain functional connectivity during cognitive performance are insensitive to ADHD 
outcome, as they do not differentiate the remitted and persistent ADHD groups. By examining 
the aetiological structure of a broad range of cognitive and ERP measures sensitive to differences 
between individuals with persistent ADHD and controls, this thesis further shows that 
impairments in these measures map onto three partially separable aetiological processes, which 
show moderate-to-large overlap with the aetiological influences on ADHD. The second part of 
this thesis examines how cognitive-neurophysiological profiles differ between women with 
ADHD, women with bipolar disorder (BD) and control women, to identify impairments that are 
specific to or shared between ADHD and BD. The findings provide evidence for multiple 
commonalities in cognitive and EEG measures of attentional processes and inhibitory control. A 
few impairments distinguishing between the disorders also emerged, which, if replicated, may 
represent candidate biomarkers to help dissociate ADHD from BD. Overall, by using a 
combination of cognitive, neurophysiological, developmental and sibling-modelling approaches, 
this thesis furthers our understanding of the developmental and aetiological pathways to ADHD, 
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In this introductory chapter, I will provide an overview of attention-deficit/hyperactivity disorder 
(ADHD), in relation to its diagnostic criteria, epidemiology, developmental presentations, co-
occurring symptoms and disorders, and aetiology. I will then review the methods used to 
investigate cognitive and neurophysiological impairments in ADHD, as well as the available 
literature on these impairments in children and adults with the disorder. This overview will then 
focus on bipolar disorder (BD), its similarities with ADHD, and review previous research 
investigating cognitive-neurophysiological biomarkers that could help identify overlapping and 
distinct characteristics of the two disorders. Finally, I will conclude with a summary of the 
specific aims of this thesis, and provide an overview of how the following chapters will address 





ADHD is a neurodevelopmental disorder characterised by developmentally inappropriate levels 
of inattentive and/or hyperactive-impulsive symptoms, which significantly interfere with 
individuals’ lives. The first reference in the medical literature to the syndrome that today is 
known as ADHD was recorded by the German physician Melchior Adam Weikard, in a book 
chapter published in 1775 describing children with attention disorders (Barkley and Peters, 
2012). Following the first documentations of case studies on children displaying inattentive and 
hyperactive-impulsive behaviours, the twentieth century has seen a rise of efforts to describe 
psychiatric conditions based on empirical evidence. The American Psychiatric Association (APA) 
included ADHD (referred to as “hyperactive child syndrome”) in the Diagnostic and Statistical 
Manual (DSM) of Mental Disorder for the first time in its second edition (DSM-II) (APA, 1968). 
This early description was updated in the third edition, DSM-III (APA, 1980), which replaced the 
aetiological formulations of mental health disorders (strongly influenced by psychoanalytic 
theories) with atheoretical descriptions of symptoms (Shorter, 2015). This version of the DSM 
placed equal emphasis on both inattentive and hyperactive-impulsive symptom dimensions of 
ADHD, and acknowledged the heterogeneity of symptom presentations that characterises the 
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disorder (APA, 1980). This recognition of the complexity and variability in presentation 
subsequently led to the first distinction between ADHD subtypes (inattentive, hyperactive-
impulsive and combined subtypes) in the DSM-IV and its revised version, DSM-IV-TR (APA, 1994, 
APA, 2000). Finally, the latest version of the DSM, DSM-5, has included further description of 
ADHD also in adulthood, and more explicitly acknowledged the possible comorbidity with 
commonly co-occurring disorders, such as autism spectrum disorder (ASD) (APA, 2013). This 
edition has also raised the age of onset of symptoms from 7 years to 12 years, to acknowledge 
the possible emergence of ADHD symptoms in pre-adolescence, and lowered the minimum 
number of symptoms needed for diagnosis in adults, from six to five symptoms of either 
inattention or hyperactivity-impulsivity. Finally, the three ADHD subtypes have been termed 
“presentations” in the DSM-5, in light of research showing that subtypes of ADHD diagnosis may 
not be as stable over time as previously thought (Willcutt et al., 2012).  
 
1.2.1 Diagnosis and symptoms of ADHD 
 
The diagnostic criteria for ADHD employed in this thesis are based on the DSM-IV-TR (APA, 
2000), which was the current DSM version at the time that the studies included in this thesis 
were planned and set up. The DSM-IV-TR includes 18 symptoms of ADHD: nine symptoms of 
inattention, six symptoms of hyperactivity and three symptoms of impulsivity (Table 1.1). The 
nine inattentive symptoms and the combination of the six hyperactive and three impulsive 
symptoms are grouped into inattentive and hyperactive-impulsive subscales, respectively. 
According to the DSM-IV-TR, a diagnosis of ADHD is met if an individual shows at least six 
symptoms of inattention and/or hyperactivity-impulsivity for at least 6 months, and if these 
symptoms are manifested before the age of 7 years. Additionally, these symptoms need to be 
associated with significant functional impairment across at least two settings (e.g., at home and 
at school), not to occur exclusively during the course of a pervasive developmental or psychotic 
disorder, or be better explained by another psychiatric condition. Three subtypes of ADHD 
diagnosis can also be made: predominately inattentive type (ADHD-IA), if at least six inattentive 
symptoms (but less than six hyperactive-impulsive symptoms) are present; predominately 
hyperactive-impulsive type (ADHD-HI), if at least six hyperactive-impulsive symptoms (but less 
than six inattentive symptoms) are present; and ADHD combined type (ADHD-C), if at least six 
symptoms are present on both symptom domains. An adult may be diagnosed according to 
DSM-IV-TR if they met diagnostic criteria in childhood, if symptoms were manifested before the 




Similar diagnostic criteria are included in the International Classification of Diseases (ICD-10), an 
alternative diagnostic system (not used in this thesis) by the World Health Organization (WHO) 
(WHO, 1992). In the ICD-10, ADHD is referred to as “hyperkinetic disorder” and defined by the 
presence of symptoms from all three symptom dimensions of inattention, hyperactivity and 
impulsivity. This diagnostic classification therefore identifies a more severe form of ADHD, and 
is considered more stringent than the DSM (Sorensen et al., 2005). 
 
 
Table 1.1. DSM-IV-TR diagnostic criteria for ADHD 
(A1) Inattention: six (or more) of the following symptoms persisting for at least 6 months to 
a degree that is maladaptive and inconsistent with developmental level:  
1 Often fails to give close attention to details or makes careless mistakes in schoolwork, at 
work, or during other activities 
2 Often has difficulty sustaining attention in tasks or play activities 
3 Often does not seem to listen when spoken to directly 
4 Often does not follow through on instructions and fails to finish schoolwork, chores, or 
duties in the workplace (not due to oppositional behaviour or failure of comprehension) 
5 Often has difficulty organising tasks and activities 
6 Often avoids, dislikes, or is reluctant to engage in tasks that require sustained mental effort 
(such as schoolwork or homework) 
7 Often loses things necessary for tasks or activities at school or at home 
8 Is often easily distracted by extraneous stimuli (may include unrelated thoughts) 
9 Is often forgetful in daily activities 
(A2) Hyperactivity-impulsivity: six (or more) of the following symptoms persisting for at 
least 6 months to a degree that is maladaptive and inconsistent with developmental level:  
Hyperactivity: 
10 Often fidgets with hands or feet or squirms in seat 
11 Often leaves seat in classroom or in other situations in which remaining seated is expected 
12 Often runs about or climbs excessively in situations in which it is inappropriate (in 
adolescents or adults, may be limited to feeling restless) 
13 Often has difficulty playing or engaging in leisure activities quietly 
14 Often talks excessively 




16 Often has difficulty awaiting turn in games or group situations 
17 Often blurts out answers to questions before they have been completed 
18 Often interrupts or intrudes on others, e.g., butts into other children's games 
Other criteria for diagnosis: 
a) Some hyperactive-impulsive or inattentive symptoms that caused impairment were 
present before age 7 years. 
b) Some impairment from the symptoms is present in two or more settings (e.g., at school [or 
work] and at home). 
c) There must be clear evidence of clinically significant impairment in social, academic, or 
occupational functioning. 
d) The symptoms do not occur exclusively during the course of a Pervasive Developmental 
Disorder, Schizophrenia, or other Psychotic Disorder and are not better accounted for by 
another mental disorder (e.g., Mood Disorder, Anxiety Disorder, Dissociative Disorder, or 
Personality Disorder). 
Note: Items replicated from the revised version of the DSM-IV (DSM-IV-TR; APA, 2000). 
 
 
1.2.1.1 Categorical and dimensional approaches 
The DSM criteria use a categorical classification of mental illnesses, including ADHD, with a 
binary definition of disorders (i.e., present/absent). This binary definition reflects the binary 
nature of treatment decisions in clinical practice, allows clear diagnostic decisions and has the 
advantage of allowing clear and effective communication between professionals in health care 
and research settings (Coghill and Sonuga-Barke, 2012, Barkley, 1998). Despite its practical 
advantages, this categorical approach is deemed not to take into account the notion that most 
psychiatric disorders may represent the impaired end of a distribution of traits that vary 
continuously throughout the general population, rather than qualitatively different entities 
(Larsson et al., 2012, Plomin et al., 2009). An alternative definition of ADHD, based on 
dimensional approaches to mental illnesses, builds on this notion, and posits that inattentive 
and hyperactive-impulsive behaviours reflect continuous traits rather than a categorical 
disorder, which may reach clinical levels only in individuals with the most severe and impairing 
presentations (Shah and Morton, 2013, Asherson et al., 2016, Faraone and Biederman, 2016). 
This dimensional approach may better reflect the continuous nature of ADHD psychopathology 
and associated cognitive and neurophysiological impairments, as well as of the involved 
neurobiological systems and the multifactorial aetiology that underlies the disorder (Shaw et al., 
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2011, Anokhin et al., 2008, de Geus, 2010, Polderman et al., 2006). The dimensional approach is 
supported by research studies showing that the aetiological contribution of genetic factors to 
ADHD (Chen et al., 2008, Larsson et al., 2012), as well as to the association between the disorder 
and cognitive impairments (Kuntsi et al., 2010, Kuntsi et al., 2014), is the same for the 
categorical/binary and dimensional/continuous definitions of ADHD symptoms. Recent 
initiatives, such as the Research Domain Criteria (RDoC) framework by the National Institute of 
Mental Health (NIMH) in the USA, have promoted a paradigm shift to develop a new 
classification of mental diseases based on a dimensional approach (Insel et al., 2010). Such a 
system, however, may be difficult to implement in clinical practice, as it may provide a less 
straightforward distinction between affected and unaffected individuals, and thus limited utility 
for diagnostic and treatment decisions (Brown and Barlow, 2005). Nonetheless, both categorical 
and dimensional approaches to ADHD present advantages and disadvantages, and may provide 
two valuable perspectives to describing and studying ADHD and its underlying pathophysiology. 
Both approaches are employed to study ADHD in this thesis. 
 
1.2.1.2 Parent-, teacher- and self-reports 
Depending on the age of an individual, different informants may provide reports of ADHD 
symptoms and functional impairments in clinical and research settings. In childhood and 
adolescence, clinical guidelines recommend collecting reports from parents and teachers (Taylor 
et al., 2004). Research shows that the agreement between reports of ADHD symptoms from 
different informants is typically only moderate (correlation estimates ranging between 0.30 and 
0.50) (Goodman, 2001, Achenbach and Rescorla, 2001). This low agreement likely reflects 
partially different information and point of views provided by each informant, who might report 
on child’s behaviour in different settings (e.g., parents at home, teachers at school). Since one 
of the requirements for diagnosis is that the symptoms are observed in at least two contexts 
(APA, 2013, WHO, 1992), accounts from multiple informants are valuable and should be 
integrated with the interviewer’s perspective both in clinical and research settings, to obtain a 
complete evaluation of behaviour of the individual concerned (Taylor et al., 2004).  
 
In adulthood, the difficulty of collecting multi-informant reports means that diagnoses often 
solely rely on self-report (Asherson, 2005). Although self-reports are recommended as the 
primary source of information for adult diagnosis in clinical settings (Kooij et al., 2010), empirical 
data show that young adults with ADHD may underestimate or lack insight into their problems, 
leading to concerns about the accuracy of their accounts (Knouse et al., 2005, Faraone and 
Biederman, 2016). The potentially lower reliability of self-ratings is considered the reason why 
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twin studies show higher heritability for parent- compared to self-rated ADHD symptoms (Chang 
et al., 2013, Larsson et al., 2013, Merwood et al., 2013): since low reliability leads to increased 
measurement error, which in the twin method is captured by factors that are not shared 
between twins, this in turn imposes a ceiling on heritability estimates (Merwood et al., 2013, 
Faraone and Biederman, 2016). In addition, while the DSM-5 has included more age-appropriate 
descriptions and examples of ADHD symptoms in adulthood (Asherson et al., 2016, APA, 2013), 
these still rely on behavioural descriptions of symptoms, which can be affected by rater effects. 
Considering the potential rater biases of subjective clinical accounts, research efforts have been 
conducted to assess the utility of objective measures (Groom et al., 2016, Hall et al., 2016, 
Lenartowicz and Loo, 2014), such as indices of cognitive and brain function, as possible aids in 





Meta-analytic evidence shows that ADHD affects 5-7% of children and adolescents, and 2-4% of 
adults worldwide (Polanczyk et al., 2007, Simon et al., 2009, Willcutt, 2012). Further evidence 
indicates that, over the last three decades, the prevalence of ADHD diagnoses in childhood has 
remained unchanged (Polanczyk et al., 2014, Collishaw, 2015), despite increases in prescriptions 
of medication for ADHD over time (Dalsgaard et al., 2015). While the disorder was originally 
believed to be a largely childhood-limited condition (Hill and Schoener, 1996), increasing 
recognition has been given to adult ADHD (Asherson et al., 2016, Faraone et al., 2006), as also 
reflected in the DSM-5 (APA, 2013).  
 
One main reason for the lower prevalence of ADHD in adulthood compared to childhood is that 
ADHD may remit with development (as discussed in detail in the next section). Another possible 
explanation is low recognition of ADHD in adulthood, leading to an under-diagnosis. Until the 
DSM-5, the symptoms of ADHD included in the DSM were based on behavioural descriptions 
developed for ADHD in children (APA, 2000, APA, 2013). However, symptoms of hyperactivity-
impulsivity in adulthood are often manifested with feelings of restlessness or inner tension 
(Asherson et al., 2014, Kooij et al., 2010, Haavik et al., 2010), which may not be fully captured 
by DSM symptoms, especially prior to the DSM-5. In addition, the relatively low recognition and 
experience of clinicians specialised in adult psychiatry with ADHD symptoms may result in adults 
with ADHD being misdiagnosed and assigned more typical adult psychiatric conditions (Asherson 
et al., 2014, Asherson, 2005).  
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1.2.2.2 Developmental presentations and trajectories of ADHD  
As mentioned above, the lower prevalence of ADHD in adulthood than in childhood or 
adolescence may reflect diagnostic remission with development. ADHD symptoms, especially 
hyperactivity-impulsivity (van Lieshout et al., 2016b, Pingault et al., 2015), tend to naturally 
decline with age (Faraone et al., 2006). Longitudinal studies have shown that ADHD may remit 
in adolescence or adulthood, although studies are inconsistent with regard to the 
persistence/remission rate of the disorder. A meta-analysis of longitudinal studies have shown 
that ADHD may persist in young adulthood in 15% of cases, with a further 50% of cases meeting 
criteria for partial remission (Faraone et al., 2006). More recent follow-up studies of children 
diagnosed with ADHD-C, however, have reported higher persistence rates (around 80%) into 
adolescence and young adulthood (Cheung et al., 2015, van Lieshout et al., 2016b). The 
persistence rates are significantly lower in recent population-based studies (1.5-10%) (Agnew-
Blais et al., 2016, Moffitt et al., 2015, Caye et al., 2016a, Riglin et al., 2016). 
 
One possible reason for the discrepancies between longitudinal studies on the persistence of 
ADHD may be found in the way remission and persistence are defined (Caye et al., 2016b). As 
described above (section 1.2.1.2), there is typically a change in the source of information used 
for ADHD diagnoses across development (parent- and teacher-reports in childhood and 
adolescence, self-reports alone in adulthood). A recent study has shown that ADHD persistence 
rates in early adulthood varied from 1.9% to 61.4% when using different combinations of 
information source (parent- vs self-report), method (rating scale vs interview) and symptom 
threshold (DSM vs norm-based) (Sibley et al., 2016). Follow-up studies of clinical samples in 
young adulthood based on self-report generally find lower rates of persistence of ADHD than 
studies using informant-report alone or in combination with self-report (Barkley et al., 2002, 
Wolraich et al., 2005, Biederman et al., 2009, Biederman et al., 2012, Du Rietz et al., 2016, van 
Lieshout et al., 2016b, Klein et al., 2012). On the one hand, the lower persistence and prevalence 
of adult ADHD based on self-report may represent an under-diagnosis due to false negatives 
(Ginsberg et al., 2014), given that individuals with ADHD may lack insight into their problems 
(Knouse et al., 2005, Faraone and Biederman, 2016). On the other hand, the higher persistence 
rate in clinical samples using informant-reports may result from informants (usually parents) 
over-estimating ADHD persistence due to not being aware of a decline in ADHD symptoms and 
impairments in their son/daughter after they leave the family environment. The use of self-
reports may explain the low persistence rates in the recent population-based studies (Agnew-
Blais et al., 2016, Moffitt et al., 2015, Caye et al., 2016a, Riglin et al., 2016). These studies are 
also based on non-clinically referred individuals for whom treatment was not sought for their 
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ADHD symptoms and impairment in childhood. As such, these population samples may not be 
fully representative of typical ADHD patient populations, but rather capture milder or transient 
forms of ADHD, which may be more likely to remit with development. Some of these studies 
have also ascertained ADHD in childhood and its persistence at follow-up only with reports on 
ADHD symptoms, rather than based on ADHD diagnosis (meeting criteria for both ADHD 
symptoms and impairment) (Riglin et al., 2016, Caye et al., 2016a), which may result in biased 
estimates.  
 
New evidence from recent population-based studies has raised the possibility that adults with 
ADHD may not always meet ADHD diagnoses in childhood (Agnew-Blais et al., 2016, Moffitt et 
al., 2015, Caye et al., 2016a), as required before the age of 12 years according to current DSM 
criteria (APA, 2013). These studies have proposed that ADHD may not always be the 
continuation of childhood ADHD, but instead emerge in late adolescence or adulthood, and 
potentially represent a distinct diagnostic entity from childhood ADHD (Agnew-Blais et al., 2016, 
Moffitt et al., 2015, Caye et al., 2016a). This is currently a topic of some controversy, with other 
authors suggesting that these studies may have overestimated the prevalence of adult-onset 
ADHD cases (Asherson et al., 2016, Faraone and Biederman, 2016). While childhood diagnoses 
were based on reports from parents and teachers, adult ADHD diagnoses relied on self-reports, 
which may have resulted in less reliable accounts of symptoms and impairments, and thus, 
potentially, led to false positives. In addition, it has been proposed that some children may 
manifest sub-threshold ADHD symptoms instead of the full-blown disorder thanks to the 
presence of positive external scaffolding or protective factors (e.g., high IQ, supportive family 
environment) (Faraone and Biederman, 2016). Since ADHD can be considered an extreme form 
of a dimensional trait, accumulation of risk factors across development may lead individuals with 
this positive scaffolding to exceed the diagnostic cut-offs only at later developmental stages, 
such as when they leave their family environment and face the new challenges of their adult 
lives (Faraone and Biederman, 2016). Further investigation into the characteristics of adult cases 
who do not meet ADHD criteria in childhood is needed, in order to clarify the nature of adult-
onset ADHD (Asherson et al., 2016). 
 
1.2.2.3 Gender differences 
A difference across development exists in the ratio of males and females affected by ADHD 
(Willcutt, 2012). The disorder is more prevalent in boys than in girls in childhood, with gender 
ratios ranging from 3:1 in population-based studies to 9:1 in clinical populations (Willcutt, 2012, 
Polanczyk et al., 2007, Gaub and Carlson, 1997, Staller and Faraone, 2006). In adults, however, 
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a more similar prevalence of ADHD has been reported in both genders, with gender distributions 
ranging from 1:1 to 1.6:1 (Faraone and Biederman, 2005, Kessler et al., 2006, Das et al., 2012).  
 
One possible reason for the lower rate of affected females in childhood is that ADHD in girls may 
represent a less severe version of the disorder in boys (Gaub and Carlson, 1997, Arnett et al., 
2015). However, evidence is inconsistent with regard to sex differences in symptom severity, 
with some studies reporting greater severity in boys with ADHD than in girls (Gaub and Carlson, 
1997, Arnett et al., 2015), but others finding no differences (Novik et al., 2006) or greater 
severities in girls (Elkins et al., 2011). It has further been proposed that the lower prevalence of 
ADHD in girls than boys may be the result of an underrepresentation of girls with ADHD, 
produced by gender-based referral bias (Biederman, 2005). Current ADHD criteria may better 
reflect the typical behavioural manifestations of ADHD in boys than in girls (Skogli et al., 2013, 
Ohan and Johnston, 2005, Staller and Faraone, 2006). ADHD in girls is less commonly manifested 
with hyperactive-impulsive symptoms or accompanied by disruptive behaviours (Biederman et 
al., 2002, Willcutt et al., 2012, Thorell and Rydell, 2008), which often are the reasons leading to 
clinical referral in childhood. Since adult ADHD cases are often self-referred, in contrast to 
childhood ADHD which is often brought to the attention of clinicians by parents and teachers, a 
more similar number of women and men may self-refer to mental health services (Biederman 
et al., 1994, Biederman et al., 2004a), leading to a more equal balance in gender ratios in 
adulthood. Yet, women may be more likely to self-refer than men (Arcia and Conners, 1998, 
Biederman et al., 1994), which may result in a more equal prevalence across the genders in 
adults due to possible under-diagnosis in adult men.  
 
An alternative explanation for the discrepancies in gender ratio in children but not in adults is 
the “female protective model” of neurodevelopmental disorders (Jacquemont et al., 2014), 
which proposes that, to be manifested in females, ADHD requires higher exposure to risk factors 
than in boys. This model is supported by recent empirical data from population-based twin 
samples, which found that co-twins of girls with ADHD had increased ADHD traits compared to 
co-twins of boys with ADHD (Taylor et al., 2016). These results suggest that girls with ADHD, 
compared to boys, may thus carry a greater burden of familial risk factors for ADHD, as indicated 
by greater ADHD symptoms in their co-twins. Due to the lower baseline levels of risk compared 
to boys, girls may require more time than boys to accumulate sufficient risk factors and manifest 
full-blown ADHD symptoms and impairment needed to exceed clinical cut-offs (Faraone and 
Biederman, 2016). As such, girls may have a later onset of ADHD than boys, as supported by one 
of the studies proposing the existence of late-onset ADHD (Agnew-Blais et al., 2016). A further 
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possible hypothesis is that more boys than girls may remit from childhood to adulthood, leading 
to a more similar gender distribution in adults. Most longitudinal studies, however, found similar 
persistence rates into early adulthood in males and females, thus not supporting this hypothesis 
(Agnew-Blais et al., 2016, Biederman et al., 2004a).  
 
Overall, although discrepancies exist between gender ratios in childhood and adulthood, clear 
empirical evidence on the reasons for these inconsistencies is still limited. More generally, the 
higher prevalence of ADHD in boys than girls has led several large-scale studies on ADHD to 
largely focus on male populations (Chen et al., 2008, Kuntsi et al., 2010, Doyle et al., 2000, Klein 
et al., 2012). Empirical evidence is more limited on girls and women with ADHD to date, 
especially in terms of impairments in cognitive and brain functions. 
 
1.2.2.4 Co-occurring symptoms and disorders 
ADHD is often associated with symptoms of other disorders, which in some cases may lead to 
additional diagnoses (Asherson et al., 2016). It has been shown that over half of children with 
ADHD have at least one psychiatric comorbidity (Kraut et al., 2013, Larson et al., 2011, Jensen 
and Steinhausen, 2015). These high rates of comorbid symptoms and disorders have been 
observed both in population samples (Michelini et al., 2015, Pinto et al., 2016, Kadesjo and 
Gillberg, 2001, Jensen and Steinhausen, 2015) and in clinical samples (Skirrow and Asherson, 
2013, Kitsune et al., 2016, Cooper et al., 2014).  
 
In children, ADHD is often comorbid with conduct disorder and oppositional defiant disorder. 
These disorders may occur in around 10-70% of children and adolescents with ADHD (Biederman 
et al., 1991, Larson et al., 2011, Jensen and Steinhausen, 2015), and are more strongly associated 
with the hyperactive-impulsive symptoms of ADHD rather than the inattentive symptoms 
(Willcutt, 2012). A significant proportion of children with ADHD, around 15-65%, also show 
specific disorders of language, learning or motor development (Jensen and Steinhausen, 2015, 
Biederman, 2005, Fliers et al., 2009, DuPaul et al., 2013). In particular, dyslexia, dyscalculia and 
writing disorders are estimated to occur in 24% to 65% of children with ADHD (DuPaul et al., 
2013). The comorbidity with ASD is also frequent, with studies showing that around 20-50% of 
those with ADHD also display ASD symptoms (Rommelse et al., 2011, Polderman et al., 2014). 
Anxiety disorders and internalising problems also co-occur in around 10-35% of ADHD cases, 
both in childhood and in adulthood (Biederman et al., 2013, Bowen et al., 2008), and may be 
more strongly related to the inattention symptom domain (Willcutt, 2012, Michelini et al., 2015). 
Comorbid symptoms of mood disorders and mood dysregulation are also common in individuals 
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with ADHD, especially in adulthood (Skirrow et al., 2012, Skirrow and Asherson, 2013). 
Depression and depressive symptoms co-occur in around 10-50% of adults with ADHD (Hesson 
and Fowler, 2015, Biederman et al., 2012, Goodman, 2009, Angold et al., 1999). Another 
common comorbid mood disorder in adulthood is bipolar disorder (BD), which has been shown 
to co-occur in 5% to 32% of adults with ADHD (Asherson et al., 2014, Halmoy et al., 2010). 
Moreover, ADHD and BD may present certain areas of symptomatic overlap, which in some 
cases may lead to difficulty in distinguishing ADHD from BD. The comparison between ADHD and 
BD is a major focus of this thesis (Chapters 5-6) and is discussed in detail in section 1.6. 
 
1.2.3 Aetiology of ADHD 
 
Similar to most quantitative traits and disorders (Plomin et al., 2009), ADHD is multifactorial 
disorder with a complex aetiological architecture, which arises from the interplay between 
genetic and environmental risk factors. Nearly three decades of quantitative genetic studies 
have established a large contribution of genetic factors on ADHD, but also a more limited role 
of individual-specific environmental influences (Burt, 2009, Burt et al., 2012). Building on this 
evidence, molecular genetic studies have set out to identify genetic variants associated with 
increased risk for ADHD (Faraone et al., 2005, Neale et al., 2010). Similarly, further research has 
tried to identify discrete environmental factors that may increase the risk of developing the 
disorder (Thapar and Rutter, 2009, Langley et al., 2005), and examined how these may interact 
with individuals’ genetic predispositions. 
 
1.2.3.1 Quantitative genetic studies 
Quantitative genetic methods use the difference in genetic relatedness between family 
members to estimate the contribution of genetic and environmental factors to the variation of 
a trait or the covariation between two or more traits within a population (Rijsdijk and Sham, 
2002). Specifically, quantitative genetic studies can quantify the role of additive genetic 
influences (A), non-additive (or dominant) genetic influences (D), environmental influences that 
make family members similar (shared environment, C; e.g., socio-economic status [SES]), and 
environmental influences that are individual-specific and make family members different (non-
shared environment, E). The most commonly used quantitative genetic approach is the twin 
design, which is able to estimate the contribution of genetic and environmental factors by 
comparing monozygotic (MZ) and dizygotic (DZ) twins that are raised in the same family. MZ 
twins are genetically identical, while DZ twins share on average 50% of their segregating genes. 
Both sets of twins are assumed to be perfectly correlated for their exposure to shared 
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environmental factors of relevance for a trait under study (Mitchell et al., 2007, Rijsdijk and 
Sham, 2002). Due to the difference in genetic similarity between MZ and DZ pairs, twin studies 
can disentangle the contribution of A from C (or D, when non-additive genetic effects are 
present), as well as estimate the role of E, which is derived as the variance that makes MZ twins 
in the same pair different from one another (including measurement error). Sibling studies, 
which represent a type of family study, use siblings raised in the same family to decompose the 
variance of a trait into familial and non-familial influences. Since full siblings share on average 
50% of their segregating genes and 100% of their shared environment, it is possible to 
decompose the variance/covariance of traits into contributions of familial influences (the 
combined effects of shared genetic and shared environmental effects) and non-familial 
influences (individual-specific effects and measurement error) (James et al., 2016, Kuntsi et al., 
2010). Although sibling studies cannot distinguish between A and C influences, they are a 
powerful alternative to twin studies to study clinically-diagnosed disorders, where recruiting 
sufficiently large samples of affected twins may prove difficult. Further details of the sibling 
design can be found in Chapter 4, which uses this approach. 
 
ADHD runs in families (Morrison and Stewart, 1971), as evident in the 2-to-8-fold increased risk 
for developing the disorder in first-degree relatives of individuals with ADHD (Biederman, 2005). 
Over the last three decades, many twin studies have explored the aetiological sources of 
individual differences in ADHD (Goodman and Stevenson, 1989, Kuntsi and Stevenson, 2001, 
McLoughlin et al., 2007, Nikolas and Burt, 2010). Heritability estimates across different studies 
of ADHD symptoms or diagnosis in childhood range between 0.60 and 0.90 (Burt, 2009, Nikolas 
and Burt, 2010, Faraone et al., 2005, Larsson et al., 2014), making ADHD one of the most highly 
heritable psychiatric disorders. Some studies suggested that dominance effects might also play 
a role (Rietveld et al., 2003, Wood et al., 2011). The familial co-segregation of ADHD traits may 
be largely due to genetic factors, as suggested by meta-analytic evidence indicating a negligible 
role of C influences (Burt, 2009, Nikolas and Burt, 2010). Environmental influences on ADHD are 
largely individual-specific and not shared between family members (Burt, 2009, Nikolas and 
Burt, 2010). Studies examining ADHD symptom domains separately have found similar 
heritability estimates for inattention and hyperactivity-impulsivity, and that the two dimensions 
are largely – but not perfectly – genetically correlated (r=0.55) (Greven et al., 2011, McLoughlin 
et al., 2007). Studies in late adolescence and adulthood using self-ratings of ADHD symptoms 
have reported lower heritability estimates (~0.30-0.50) (Michelini et al., 2015, Chang et al., 
2013). However, these lower estimates may be due to rater effects and inflation of 
measurement error in self-ratings (captured in E influences within the individual-specific 
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environment), rather than to a lower contribution of genetic effects beyond childhood, as 
indicated by studies examining multiple raters (Larsson et al., 2013, Merwood et al., 2013). 
While most twin studies of ADHD have examined continuous ADHD symptoms in population-
based samples (under the assumption that the risk for ADHD is normally distributed in the 
population), similar contributions of aetiological factors have been found for ADHD diagnosis 
measured as a present/absent category (Larsson et al., 2012). 
 
1.2.3.2 Molecular genetic studies 
A large number of molecular genetic studies have sought to pinpoint the common genetic 
variants (found in >5% of the population) contributing to the high heritability of ADHD (Thapar 
and Cooper, 2016). Prior to the development of genome-wide association (GWA) studies, 
molecular genetic research employed candidate genes and linkage approaches to examine the 
association between genetic variants associated with dopaminergic, noradrenergic and 
serotonergic systems implicated both in clinical response to drug treatment for ADHD (Faraone 
et al., 2005, Gizer et al., 2009). While replicated associations of several candidate genes have 
been reported (e.g., DRD4, DAT1, DRD5, 5HTT), a meta-analysis shows that effect sizes of each 
of these genes are very small, with odds ratios between 1.12 and 1.33 (Gizer et al., 2009). In 
addition, given the thousands of genetic variants in the genome, hypothesis-driven candidate 
gene and linkage approaches are prone to false positives (Kendler, 2013). An increased rate of 
large rare chromosomal mutations (frequent in <1% of the population), such as rare duplications 
and deletions termed copy number variants, have also been associated with ADHD, with larger 
effects (Williams et al., 2010). 
 
More recent molecular genetic approaches have used hypothesis-free GWA approaches, testing 
for the association between ADHD and genetic markers across the whole genome (Neale et al., 
2010). Until recently, GWA studies on ADHD in childhood had failed to detect single nucleotide 
polymorphisms (SNPs) below the stringent genome-wide significant threshold (p-value<5×10-8) 
(Neale et al., 2010, Hinney et al., 2011, Lasky-Su et al., 2010, Middeldorp et al., 2016, Neale et 
al., 2008, Mick et al., 2010). This failure highlights the need for collaborative efforts and larger 
samples including tens of thousands of cases and controls to accumulate sufficient power to 
detect significant associations. A new effort carried out by the Psychiatric Genetic Consortium 
(PGC), including over 20,000 cases and 35,000 controls, however, has recently identified the first 
16 genome-wide significant loci for ADHD (Demontis et al., 2017). Given the complex genetic 
architecture of the disorder, with single genetic variants having very small effects, recent studies 
have also employed polygenic approaches and set out to aggregate the contribution of several 
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risk variants from GWA studies. These studies may be promising in guiding future research into 
the mechanisms underlying ADHD, and potentially the early prediction of individuals at greater 
genetic risk (Stergiakouli et al., 2016, Martin et al., 2015, Mooney et al., 2016). 
 
1.2.3.3 Environmental risk  
Several environmental risk factors have been associated with an increased risk for ADHD. The 
factors include maternal smoking, preterm birth, low birth weight, dietary factors, psychosocial 
factors and family adversity (Thapar et al., 2013). Most studies examining such environmental 
effects, however, have not controlled for unmeasured confounding familial risk factors shared 
between individuals living in the same family (Thapar and Rutter, 2009). As such, these 
associations do not necessarily reflect a role of the environmental factor per se, consistent with 
a causal effect, but could instead reflect effects of other background environmental or genetic 
risk factors that characterise families with ADHD. Quasi-experimental sibling-comparison studies 
have been employed to disentangle the effects of the environment and unmeasured confounds. 
The sibling-comparison approach compares siblings in the same pair to estimate environmental 
effects, while controlling for unmeasured confounding factors (i.e., genetic and environmental 
factors that make siblings similar, including risk factors associated with the investigated 
environmental factor). Studies using this approach have shown, for example, that the 
association of increased ADHD risk with maternal smoking during pregnancy, low SES, family 
adversity, and negative parenting may be due to unmeasured familial confounding, rather than 
a causal role of these environmental factors (Skoglund et al., 2014, Thapar and Cooper, 2016). 
The effect of other environmental factors, such as preterm birth, may instead be independent 
of familial confounding factors, and potentially causal (D'Onofrio et al., 2014).  
 
1.2.3.4 Gene-environment interplay 
Further research has examined the way that genetic and environmental factors may interact 
(Nigg et al., 2010, Thapar et al., 2013). Environmental risk factors, for example, may have an 
effect on a trait due to an interaction with an individual’s genetic predisposition (gene-
environment interaction), which makes an individual more susceptible to the effects of 
environmental influences (Nigg et al., 2010). Alternatively, an individual’s genetic predisposition 
may increase the risk of exposure to certain environmental risks (gene-environment correlation) 
(Plomin, 2014). The interaction between genes and environmental factors has further been 
proposed as a possible reason for inconsistencies in candidate gene studies, as candidate genes 
may appear associated to the disorder only in the presence of certain environmental factors 
with which they interact (Buitelaar, 2005). A relatively limited amount of studies have examined 
33 
 
gene-environment interplay in ADHD, mostly focusing on dopaminergic and serotonergic 
neurotransmission genes (Stevens et al., 2009, Morgan et al., 2016, van der Meer et al., 2014), 
and effects have proven difficult to replicate (Nigg et al., 2010, Thapar et al., 2013, Gould et al., 
2017). The environment may dynamically interact with an individual’s genetic architecture via 
epigenetic processes, occurring when environmental or stochastic factors alter the expression 
of genes, without altering the DNA sequence (Mill and Petronis, 2008). Although research into 
the epigenetic mechanisms in ADHD is still in its infancy, initial data suggest a potential role of 
DNA methylation (an epigenetic mechanism commonly studied in psychiatric disorders) in genes 
related to neurodevelopmental processes in ADHD (Walton et al., 2017, van Mil et al., 2014).  
 
1.2.4 Treatments for ADHD 
 
The impairing nature of ADHD requires continued efforts to find efficient therapies and improve 
clinical outcomes for affected individuals. The National Institute for Health and Care Excellence 
(NICE) guidelines recommend pharmacotherapy as the first-line treatment for adults with ADHD 
and severe cases of ADHD in children and adolescents (Retz et al., 2011, Kendall et al., 2011, 
NICE, 2013). In milder childhood and adolescent cases, behavioural interventions (e.g., parental 
education, optimised classroom strategies, behavioural managed techniques) are preferred as 
first line of intervention (NICE, 2013).  
 
Drug treatments for ADHD include stimulants (the most commonly prescribed medication 
treatment), such as methylphenidate and dexamphetamine, and non-stimulant drug treatments 
with atomoxetine, a noradrenaline reuptake inhibitor (NICE, 2013, Retz et al., 2011). Moderate-
to-large effects of these medication treatments on ADHD symptoms and outcomes have been 
reported in a large body of research and meta-analyses in children (Prasad et al., 2013, Gayleard 
and Mychailyszyn, 2017, Chan et al., 2016, Maneeton et al., 2015) and adults (Maneeton et al., 
2014, Faraone and Glatt, 2010, Meszaros et al., 2009). A recent meta-analysis, however, raised 
doubts on the efficacy and safety of stimulant medication for children with ADHD (Storebo et 
al., 2015), and led to an extensive debate amongst clinicians, with several authors considering 
the results of this study flawed (Mulder et al., 2016, Romanos et al., 2016, Banaschewski et al., 
2016a, Banaschewski et al., 2016b).  
 
Nevertheless, it is recognised that, in around one third of affected individuals with ADHD, 
medication may be ineffective, intolerable due to side effects, or unsuitable due to comorbid 
conditions (Biederman et al., 2004b). Among non-pharmacological treatments proposed as 
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alternatives to pharmacotherapy, the only interventions currently recommended by clinical 
guidelines are behavioural interventions (NICE, 2013). Yet, meta-analyses of randomised control 
studies indicate that, when outcome is rated by blinded reviewers, there are small-to-medium 
effects of behavioural interventions on childhood conduct problems and parenting (SMD=0.21-
0.63), but non-significant effects on core symptoms of ADHD (Sonuga-Barke et al., 2013, Daley 
et al., 2014). A variety of other non-pharmacological interventions have been developed, such 
as neurofeedback, mindfulness training and cognitive training (Cortese et al., 2015, Cortese et 
al., 2016). Dietary interventions, such as free fatty acid supplementation, restricted elimination 
diets and artificial food colour exclusions, have also been investigated (Cooper et al., 2015, Nigg 
and Holton, 2014, Bloch and Mulqueen, 2014). Exercise interventions have also been recently 
proposed as alternative non-pharmacological options for ADHD, because of their potential for 
long-term, patient-led symptom management and reduction (Rommel et al., 2013, Halperin et 
al., 2014). However, strong evidence from blinded studies on the efficacy of available non-
pharmacological treatments is still limited, and meta-analysis indicates significant, yet modest, 
effects only for free fatty acid supplementation and artificial food colour exclusion (Sonuga-




This section has provided an overview of ADHD as a clinical disorder, covering its epidemiology, 
aetiology and treatment options. Although the disorder was initially considered largely limited 
to childhood, decades of research have made it clear that ADHD can continue into adulthood, 
requiring further research applying a follow-up approach. High rates of comorbidities in adults, 
and the similar prevalence of ADHD in men and women, further highlight the need of more 
research into ADHD in adulthood in both genders. A focus on associated conditions may further 
help delineate adult ADHD from other common adult psychiatric conditions. Overall, ADHD is a 
highly complex disorder, with substantial heterogeneity among affected individuals in clinical 
symptoms, functional impairments and associated characteristics, which may, in turn, be 





Cognitive and neurophysiological studies in ADHD seek to elucidate what are the mechanisms 
and processes that are associated with the symptoms and impairments of the disorder. The 
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identification of objective measures of alterations at the cognitive, neurophysiological and 
anatomical levels associated with the behavioural manifestations of ADHD may further our 
understanding of the pathways leading to the clinical features of the disorder. Investigating the 
impairments in cognitive and neural processes may further inform future research and clinical 
applications, and provide new targets for the development of new strategies of interventions, 
prevention and early identification of the disorder. Objective measures of cognitive and neural 
processes may be considered putative “biomarkers”, defined as characteristics that are 
objectively measured and evaluated as indicators of normal biological processes, pathogenic 
processes, or pharmacologic responses to a therapeutic intervention (Biomarkers Definition 
Working Group, 2001). In this section, I will provide an overview of the cognitive and 
neurophysiological methods used in this thesis, as well as review the previous studies on the 
cognitive and neurophysiological impairments associated with ADHD that are of particular 
relevance to this thesis. 
 
1.3.1 Cognitive assessments and methods 
 
Cognitive processes can be assessed with standardised cognitive instruments, such as IQ tests 
(Wechsler, 1991, Wechsler et al., 2008) and computerised cognitive tasks (Tamm et al., 2012, 
Nichols and Waschbusch, 2004). Performance on these assessments can provide information on 
an individual’s cognitive abilities and impairments in the assessed cognitive domains. Cognitive 
tasks are largely based on measuring reaction time performance and accuracy. Mean reaction 
time (MRT) is assessed by averaging the latencies between stimulus appearance and 
participants’ response (generally button click) over trials, and is often used as an index of 
processing speed. The standard deviation of response times can be captured by an index called 
reaction time variability (RTV), which gives an indication of the consistency of response times 
throughout a task. Task accuracy is generally examined by measuring the number of response 
omissions (omission errors [OE]) and incorrect responses (commission errors [CE]) to targets. OE 
are generally used as an index of ability to maintain attention over a period of time (sustained 
attention) and vigilance. CE are used to measure cognitive processes such as inhibitory control 
(ability to inhibit a prepotent response) and interference control (ability to control the 
interference due to competition of relevant and irrelevant stimuli).  
 
A variety of cognitive and neuropsychological tasks have been employed to measure cognitive 
performance in ADHD. Several studies have focused on the continuous performance test (CPT), 
which requires participants to respond to a certain type of stimuli (target or “Go” stimuli) and 
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ignore distracting stimuli (non-target or “NoGo” stimuli) (Beck et al., 1956). CPT tasks are 
characterised by a low target probability, and probe sustained attention and vigilance. A similar 
cognitive task often used in ADHD research, the Go/NoGo task, includes Go and NoGo stimuli, 
but is characterised by a higher target probability compared to the CPT. Go/NoGo tasks are thus 
better at probing inhibitory control processes than standard CPT paradigms (Berwid et al., 2005). 
Another task often employed to study ADHD is the Eriksen flanker task (and its variants), 
measuring inhibitory control, performance monitoring and interference control processes, 
where targets are presented with congruent or incongruent flanking stimuli (Zhang, 1997). The 
cognitive-performance tasks used in this thesis are a CPT variant with cues preceding targets 
(Chapters 4 and 5), an arrow flanker task (Chapters 2, 3 and 4), and a simple four-choice reaction 
time task under slow-unrewarded baseline and faster-rewarded conditions (Chapters 4 and 6). 
More details on each task can be found in the respective chapters.  
 
1.3.2 Cognitive impairments in ADHD 
 
The study of cognitive impairments in ADHD is valuable to obtain a better understanding of the 
impairments in core processes associated with the disorder. Over the last few decades, it has 
become clear that ADHD is associated with several cognitive impairments compared with 
typically developing individuals, both in childhood and in adulthood. Cognitive deficits in ADHD 
encompass both executive, effortful cognitive functions (e.g., inhibitory control, working 
memory and sustained attention) and non-executive, more automatic cognitive processes (e.g., 
temporal information processing and timing, vigilance, intra-individual variability, choice 
impulsivity and reward processing) (Willcutt et al., 2005, Karalunas et al., 2014, van Lieshout et 
al., 2013, Mowinckel et al., 2015, Coghill et al., 2014, Mostert et al., 2015, Sonuga-Barke et al., 
2010, Marco et al., 2009). 
 
Executive dysfunction has been proposed to play a key role in ADHD since the earliest theoretical 
models of the disorder (Barkley, 1997, Barkley et al., 1992). Meta-analyses of cognitive studies 
in children with ADHD indicate moderate effects sizes (Cohen’s d=0.43-0.69) for poorer 
performance on tasks measuring inhibition, short-term memory, working memory, sustained 
attention and planning (Willcutt et al., 2005, Huang-Pollock et al., 2012, Martinussen et al., 
2005). Studies of adults reveal overall similar patterns of cognitive impairments (Hervey et al., 
2004, Mowinckel et al., 2015, Lijffijt et al., 2005). Adults with ADHD have been found to show 
poorer performance compared to controls in Go/NoGo and CPT paradigms, with significantly 
more CE and OE, indicating impaired response inhibition and sustained attention, respectively 
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(McLoughlin et al., 2010, Woltering et al., 2013, Advokat et al., 2007, Boonstra et al., 2005). 
These group differences have been quantified in a meta-analysis of neuropsychological studies 
in adults with ADHD, indicating that significantly increased CE and OE have been reported in 
around 80% of studies, with medium effect sizes (Cohen’s d=0.50-0.75) (Hervey et al., 2004). 
 
ADHD is also strongly associated with increased RTV, capturing short-term fluctuations in 
response times thought to index lapses in attention (Karalunas et al., 2014, Kuntsi et al., 2010, 
Frazier-Wood et al., 2012). Evidence from meta-analyses and large studies consistently indicates 
moderate-to-large effect sizes for RTV impairments in children and adolescents with ADHD 
(Hedge’s g and Cohen’s d effect sizes between 0.72 and 0.85) (Kofler et al., 2013, Klein et al., 
2006, Metin et al., 2012, Huang-Pollock et al., 2012) and a moderate effect size in adults 
(Hedge’s g=0.46) (Kofler et al., 2013, Huang-Pollock et al., 2012). In ADHD, RTV has been 
identified as one of the best cognitive variables to distinguish between cases and controls (Klein 
et al., 2006), and showed the highest phenotypic and familial correlations with ADHD amongst 
several cognitive measures (Kuntsi et al., 2010). Meta-analytic evidence indicates more modest 
effects for increased MRT (d=0.37), measuring slower response speed (Huang-Pollock et al., 
2012).  
 
Lower IQ scores have further been consistently associated with ADHD, with meta-analytic 
estimates indicating an average difference between children with ADHD and controls of 7-11 
points (Frazier et al., 2004). This finding is also supported by data from population samples, 
indicating moderate negative correlations of IQ with ADHD symptoms between -0.20 and -0.40 
(Kuntsi et al., 2004, Rommel et al., 2015).  
 
A potentially challenging aspect for cognitive studies in ADHD is whether to control for the 
effects of IQ when investigation the association between the disorder and other cognitive 
impairments (e.g., RTV). On the one hand, since IQ is associated with ADHD (Frazier et al., 2004), 
accounting for the effects of IQ could potentially remove part of the effects of interest (Miller 
and Chapman, 2001, Dennis et al., 2009). On the other hand, controlling for IQ allows to capture 
the association between ADHD and other variables beyond the association of ADHD with IQ 
(Dennis et al., 2009). An empirical approach, in the presence of differences between ADHD and 
control groups on IQ, is to conduct analyses both with and without including IQ as a covariate 
(Kuntsi et al., 2009, Rommelse et al., 2008a), or include IQ and other variables into multivariate 
analyses (Frazier-Wood et al., 2012). Both approaches are used in the studies included in the 
first part of this thesis (but not in the second part, as groups were matched on IQ). Previous 
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studies in children have shown that the relationship between ADHD and other cognitive 
impairments is largely not affected by covarying for IQ (Kuntsi et al., 2009, Rommelse et al., 
2008a). Evidence from one of the largest cognitive-neurophysiological studies of ADHD in 
adolescence and young adults (also used for this thesis, Chapters 2-4), however, indicates that 
group differences may be reduced or disappear when controlling for IQ (Cheung et al., 2016, 
Kitsune et al., 2015). It has been further proposed that IQ may have a moderating effect on 
ADHD (Cheung et al., 2015, Cheung et al., 2016), as higher IQ has been associated with improved 
ADHD outcome (Gao et al., 2015, Agnew-Blais et al., 2016, Cheung et al., 2015, Cheung et al., 
2016) and better ADHD medication response (Handen et al., 1997, Owens et al., 2003); although 
the former results has not been replicated in all available studies (Francx et al., 2015b, Breyer et 
al., 2014). Further evidence is needed to better understand the relationship between ADHD, IQ 
and other cognitive impairments in adolescents and young adults.  
 
Overall, three decades of cognitive and neuropsychological research have shown that ADHD is 
associated with impairments in multiple cognitive domains. This evidence has contributed to a 
shift in the theoretical understanding of the disorder: from models that proposed one single 
deficit, for example in inhibition (Barkley, 1997, Barkley et al., 1992), underlying the multiple 
cognitive impairments, to more recent models that argue for multiple factors and pathways 
responsible for cognitive dysfunction in ADHD (Halperin and Schulz, 2006, Sonuga-Barke et al., 
2010, Sergeant, 2005, Castellanos et al., 2006). Further research has aimed to clarify whether 
these impairments may reflect multiple underlying factors or a single core factor, as discussed 
more in detail in section 1.5.1.  
 
1.3.3 Electrophysiological methods 
 
While cognitive-performance measures can provide information on response times and 
accuracy during cognitive tasks, the measurement of brain activity during task performance 
enables a more direct investigation of overt and covert neurophysiological processes and brain 
functions underlying cognitive processes (Tye et al., 2011, Banaschewski and Brandeis, 2007, 
Luck et al., 2011). Among measures of brain function, neurophysiological measures of electrical 
activity derived from electroencephalography (EEG) enable a direct investigation of neural 
processes with millisecond temporal resolution (Banaschewski and Brandeis, 2007, Tye et al., 
2011, McLoughlin et al., 2014a). EEG recordings are measured with electrodes placed on the 
scalp, which capture the electrical activity generated by groups of neurons synchronously firing 
to produce brain impulses (Buzsaki and Draguhn, 2004). Synchronised activity generates brain 
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rhythms (or oscillations), which are thought to represent the fundamental mechanism enabling 
the coordination of activity during brain functioning (Uhlhaas and Singer, 2006, Buzsaki and 
Draguhn, 2004). EEG data can measure spontaneous brain activity during resting state, indexing 
background processes such as arousal or activation, or brain responses evoked by particular 
stimuli during cognitive tasks, indexing a variety of cognitive processes such as attentional 
allocation and inhibition (Loo et al., 2015).  
 
1.3.3.1 Traditional EEG approaches: quantitative EEG and event-related potentials 
Raw EEG data consist of overlapping brain rhythms at different frequencies across power 
spectra, which represent the magnitude of power of brain activity. Through spectral 
decompositions, such as the Fast Fourier Transform (FFT), EEG activity can be divided into its 
constituent frequency bands (Figure 1.1), measured in cycles per second, i.e., hertz (Hz): delta 
(0.1–4 Hz), theta (4–8 Hz), alpha (8–12 Hz), beta (12–30 Hz), and gamma (>30 Hz) (Schwilden, 
2006, Loo and Makeig, 2012). The boundaries of these frequency bands are somewhat arbitrary 
and vary between studies. Yet the existence of different frequency bands is functionally 
meaningful, as different EEG rhythms have been shown to contribute to different aspects of 
neural processes: delta oscillations are predominantly associated with sleep and drowsiness; 
theta oscillations with arousal but also control and conflict cognitive processes; alpha 
oscillations with relaxation and attentive processes; beta oscillations with concentration and 
motor responses (Uhlhaas and Singer, 2006, Klimesch, 1999, Klimesch, 2012). Quantitative EEG 
(QEEG) analyses quantify the amount of power in each of these frequencies (Loo et al., 2015). 
These quantitative methods have been used to characterise changes in brain activity across 
development and alterations in psychiatric disorders (in contrast to earlier “qualitative” visual 
EEG inspections, still used in neurology). Although EEG can measure sub-second fluctuations, 
the temporal precision of EEG is not preserved in QEEG analyses, as these average the power 
within each frequency band over a continuous recording period (lasting at least a few minutes). 
As such, QEEG analyses are most useful for measuring brain processes in conditions where brain 
signals can be assumed to remain stable (i.e., stationary) over the measured recording period, 






Figure 1.1. Typical EEG frequency bands. Adapted from Tye et al. (2011).  
 
 
While QEEG analyses do not capitalise on the excellent temporal resolution of EEG recordings, 
event-related potential (ERP) approaches measure sub-second increases in voltage that are 
time-locked to an event. An individual’s ERP responses to the same stimulus in a task are 
typically averaged over a number of trials to produce an averaged ERP response. Averaging 
removes the background EEG oscillations unrelated to the stimulus (considered “noise”, in 
traditional ERP approaches), and allows the emergence of the characteristic ERP waveform with 
alternating positive and negative peaks, termed ERP components (Figure 1.2) (Luck, 2014). ERP 
components are quantified by measuring their amplitude and latency, reflecting the magnitude 
and the timing of the allocated brain activity contributing to each component. Using cognitive 
paradigms such as Go/NoGo and CPT tasks, it is possible to elicit several ERP components and 
measure several overt and covert cognitive processes. A particular adaptation of the CPT, the 
cued CPT with flankers (or CPT-OX), has been used to characterise additional aspects of cognitive 
processes in ERP studies, allowing for the investigation of covert processes such as attentional 
orienting, response preparation and inhibition of a prepotent response (Banaschewski et al., 
2003, van Leeuwen et al., 1998). In this adapted CPT, Cue stimuli precede both Go and NoGo 
stimuli, and participants are required to respond only when a Go follows the Cue, but to 
41 
 
withhold the response if the Cue is followed by a NoGo. Depending on the stimulus being 
presented, ERP components can reflect different processes. For example, the P3, a late positive 
enhancement observed after stimulus presentation (Polich and Kok, 1995, Polich, 2007), can 
index response inhibition when evoked by NoGo stimuli, response executions when evoked by 
Go stimuli, or attentional orienting when evoked by Cue stimuli.  
 
 
Figure 1.2. A typical ERP waveform showing characteristic positive and negative ERP 
components. Adapted from Odom et al. (2010).  
 
 
While ERPs preserve the information in the time domain, the averaged ERP responses do not 
provide information on the frequency bands underlying the measured brain potentials. Of note, 
ERP averages capture brain activity that is both time-locked and phase-locked to an event (i.e., 
evoked), but not activity that is time-locked but not phase-locked (i.e., induced) (Mazaheri and 
Picton, 2005, Schurmann and Basar, 2001). This means that the phase (e.g., positive or negative 
inclination) of an evoked response needs to align over trials for it to be reflected in the average 
ERP, while inconsistent phases across trials tend to be averaged out, producing attenuated or 
absent ERP peaks (Bickel et al., 2012). The averaged ERP amplitude may thus reflect a 
combination of power increases of the evoked response and of its phase consistency across trials 
(Basar-Eroglu et al., 1992, Spencer and Polich, 1999, Mazaheri and Picton, 2005). 
 
1.3.3.2 Advanced EEG analyses: time-frequency and connectivity approaches 
Although QEEG and ERP techniques are the most frequent approaches to analyse EEG activity in 
psychiatric conditions, they cannot fully capture the modulations of brain activity over time, with 
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combined characterisation of brain activity both in the frequency and time domain. More recent 
advances in signal processing, called time-frequency analyses, are able to combine the strengths 
of QEEG and ERP approaches, by allowing event-related time resolution of the EEG signal across 
the full power spectrum (Loo et al., 2015, Makeig et al., 2004a). These techniques measure 
changes of spectral power and phase that are time-locked to an event, and allow examination 
of sub-second modulations of brain oscillations at different frequency bands and at different 
temporal stages of stimulus processing (Makeig et al., 2004a, Pfurtscheller, 1981). Using similar 
cognitive paradigms as used in ERP studies, time-frequency analyses can quantify an event-
related increase or decrease in power at each frequency over time, generally termed, 
respectively, event-related synchronisation (ERS) and event-related desynchronisation (ERD) or 
suppression (Bickel et al., 2012, Mazaheri and Picton, 2005). Additionally, indices of consistency 
of the phase of brain oscillations over trials can be extracted, to examine whether the processing 
of a stimulus repeated over time reflects stable or variable neural mechanisms (Makeig et al., 
2004a, Papenberg et al., 2013). Greater phase consistency over trials is generally thought to 
reflect an adaptive mechanism to maintain stable neural processing of a stimulus (Makeig et al., 
2004a, Papenberg et al., 2013). These approaches thus enable fine-grained modelling of EEG 
dynamics that cannot be captured by more traditional QEEG and ERP approaches.  
 
Furthermore, advances in EEG analytic techniques have focused on ways to characterise the 
connectivity between brain signals at different brain regions, rather than the activity at single 
regions. Brain functional connectivity refers to the phenomenon of interdependence and 
communication between brain oscillations from different brain regions, measured with EEG or 
other neuroimaging techniques, such as functional magnetic resonance imaging (fMRI) (Friston, 
2011, Rubinov and Sporns, 2010). FMRI is an indirect measure of brain activity, as it measures 
magnetic changes associated with fluctuations in blood oxygen levels in areas of the brain (i.e., 
hemodynamic response). Although fMRI provides precise spatial resolution, it can only measure 
slow brain activity below 0.5 Hz (Lewis et al., 2016). As a consequence, fMRI connectivity 
methods are powerful in localising the patterns of connectivity between regions, but may only 
capture connectivity between slower brain oscillations. Instead, investigating brain connectivity 
using the excellent temporal resolution provided by EEG may allow to further capture transient 
changes in functional connectivity which underlie fast-changing cognitive processes (Coben et 
al., 2014, McLoughlin et al., 2014a, Silberstein et al., 2016).  
 
A commonly used metric to characterise EEG connectivity is coherence, which measures the 
degree of cross-correlation in the time domain between oscillations at a given frequency 
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between pairs of EEG channels from different scalp regions (Barry et al., 2002, Nunez et al., 
1997). However, since EEG activity measured at the scalp arises from the instantaneous 
projection, spreading and mixing of several underlying brain sources (i.e., volume conduction) 
(Onton and Makeig, 2006, Lopes da Silva, 2004, Nunez et al., 1997), EEG coherence between 
scalp channels may reflect inflated connectivity estimates. One effective way to measure 
connectivity between brain regions using scalp-level signals is to employ measures of functional 
association that capture interactions between brain signals not arising from artefacts of volume 
conduction with a certain phase lag, such as the imaginary part of the coherence (Nolte et al., 
2004, Palva and Palva, 2012). Furthermore, recently-developed network approaches, such as 
those based on graph theory, may further be applied to better capture brain connectivity 
between several large-scale brain networks and identify connectivity alteration (Bullmore and 
Sporns, 2009, Rubinov and Sporns, 2010, Castellanos and Aoki, 2016).  
 
Recent advances in EEG analyses further use statistical and computational approaches to 
measure the activity of brain sources, and their localisation and connectivity in the brain. Despite 
the excellent temporal resolution, EEG scalp distributions of traditional EEG methods result from 
several overlapping brain sources. As such, these traditional methods do not allow precise 
localisation of neural processes in the brain (McLoughlin et al., 2014a, Loo and Makeig, 2012, 
Makeig et al., 2004a). Advances in EEG approaches allow more precisely to investigate the 
patterns of cortical activation with enhanced spatial resolution (Makeig et al., 1997, McLoughlin 
et al., 2014a). Recently developed analysis techniques, such as independent-component analysis 
(ICA), are able to isolate individual sources of EEG activity, thus providing improved spatial 
resolution compared to standard EEG techniques. Performing connectivity analyses on these 
source-activities, rather than scalp-based measures, may thus enable the investigation of 
connectivity between more localised functional networks, and tracking of the dynamic 
formation of functional networks during cognitive processes (Loo et al., 2015). 
 
1.3.4 EEG impairments in ADHD 
 
1.3.4.1 QEEG studies 
Using EEG methods, several studies have shown atypical brain activity during resting states and 
task performance in ADHD (Tye et al., 2011, Loo and Makeig, 2012). QEEG abnormalities have 
been found both in children and adults with the disorder (Tye et al., 2012, Loo et al., 2009, Loo 
et al., 2010, Kitsune et al., 2015). In particular, individuals with ADHD show increased power in 
the lower frequency bands (delta and theta) and decreased power in the faster frequency bands 
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(alpha and beta), during resting state (Tye et al., 2012, Loo et al., 2009, Loo et al., 2010, Kitsune 
et al., 2015, Dupuy et al., 2013, Snyder and Hall, 2006). Further evidence indicates that very low 
frequency activity (<0.5 Hz), thought to represent a marker of the default-mode network (DMN), 
may be decreased in children and adults with ADHD at rest (Helps et al., 2008, Helps et al., 2010). 
Additionally, previous evidence has shown an imbalance in slow and fast EEG rhythms (indicated 
by increased theta/beta ratio) in individuals with ADHD, with an effect size of 3.08 and sensitivity 
and specificity of 94% in a meta-analysis of QEEG studies in ADHD (Snyder and Hall, 2006). These 
large effects led to the approval by the Federal Drug Administration (FDA) in the USA of the 
theta/beta ratio as an aid in ADHD diagnosis in combination with standard diagnostic tools 
(Snyder et al., 2015, Stein et al., 2016). Several more recent studies, however, have not reported 
alterations in theta/beta ratio in ADHD (Rommel et al., 2016, Arns et al., 2016, Loo et al., 2013, 
Skirrow et al., 2015), indicating inconsistent evidence for the use of the theta/beta ratio as a 
putative biomarker for the disorder (Arns et al., 2013, Arns et al., 2016, Loo et al., 2013, Saad et 
al., 2015). Further studies have examined QEEG profiles in individuals with ADHD during simple 
cognitive tasks, such as the CPT, but several inconsistencies across studies have emerged. For 
example, increased, decreased and intact alpha power have each been reported in different 
studies (Loo et al., 2009, Nazari et al., 2011, Skirrow et al., 2015, Rommel et al., 2016). Overall, 
despite early reports of certain QEEG indices (theta/beta ratio) as promising biomarkers for the 
disorder, these results may indicate a need for better EEG biomarkers for ADHD. 
 
1.3.4.2 ERP studies 
Previous studies have shown patterns of atypical ERP activity underlying multiple cognitive 
processes, such as attentional allocation, inhibition, motor response preparation and 
performance monitoring, in individuals with ADHD (Albrecht et al., 2013, Geburek et al., 2013, 
Cheung et al., 2016). Evidence of impaired attentional and inhibitory processing in ADHD is 
supported by ERP studies reporting attenuations of ERP components differentiating ADHD 
probands from controls. Several studies of children, adolescents and adults with ADHD have 
found, using CPT and Go/NoGo tasks, a reduced fronto-central P3 component in response to 
NoGo stimuli (NoGo-P3), reflecting atypical response inhibition (Albrecht et al., 2013, 
Banaschewski et al., 2003, Doehnert et al., 2013, McLoughlin et al., 2010, McLoughlin et al., 
2011, Groom et al., 2010b). In addition, attenuations in the parietal P3 (Cue-P3) and central 
contingent-negative variation (CNV) in response to Cue stimuli have been reported in individuals 
with ADHD using the CPT-OX paradigm, indicating deficits in attentional orienting and response 
preparation, respectively (McLoughlin et al., 2010, Banaschewski et al., 2004, Doehnert et al., 
2013). Attenuated P3s to target stimuli, reflecting allocation of attentional resources for 
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response execution, have also been reported in children, adolescents and adults with ADHD 
(Banaschewski et al., 2004, Groom et al., 2010b, Cheung et al., 2017, Grane et al., 2016), as 
confirmed by a meta-analysis (Szuromi et al., 2011). Yet, intact target P3s in ADHD have also 
been found (Groom et al., 2008, McLoughlin et al., 2010, Barry et al., 2009, Albrecht et al., 2013), 
which may indicate potentially context-dependent impairments in the target P3 measured with 
different cognitive tasks.  
 
Alterations in ERPs of performance monitoring, indicating the cognitive ability in goal-directed 
behaviour to monitor ongoing performance and to adjust response selection, have also been 
found in individuals with ADHD. Reduced frontal N2 components, reflecting conflict monitoring 
processes arising from two competing responses and evaluation of the correct response, have 
been found during flanker tasks in children and adults with ADHD (McLoughlin et al., 2009, 
Albrecht et al., 2008, Wild-Wall et al., 2009), although not in all studies (Johnstone and Galletta, 
2013, Jonkman et al., 2007). N2 attenuations have further been reported in ADHD using the Stop 
Signal Task and Go/NoGo tasks (Woltering et al., 2013, Pliszka et al., 2000), but generally not in 
CPT-OX tasks (McLoughlin et al., 2010, Doehnert et al., 2013, McLoughlin et al., 2011, Albrecht 
et al., 2013), indicating that impairments may be limited to paradigms inducing higher conflict 
monitoring demands (McLoughlin et al., 2009, Barry et al., 2009, McLoughlin et al., 2014b). 
Further impairments in performance-monitoring ERPs in individuals with ADHD have been 
reported in components underlying error processing when an incorrect behavioural response is 
made (Geburek et al., 2013). In particular, the fronto-central error-related negativity (ERN), 
reflecting automatic error processing, has been found reduced in children and adults with ADHD 
during flanker tasks (Albrecht et al., 2008, McLoughlin et al., 2009) and Go/NoGo tasks (Groom 
et al., 2013), as also indicated by a meta-analysis showing medium effect sizes (Cohen’s d=0.50) 
(Geburek et al., 2013). ERN reductions, however, have not been found in all studies, for example 
using Go/NoGo tasks (Wiersema et al., 2009, Groom et al., 2010a, O'Connell et al., 2009). 
Similarly, mixed evidence exists on reductions in the error-related positivity (Pe), reflecting more 
conscious error processing, which have been found in some studies (O'Connell et al., 2009, 
Wiersema et al., 2009, Groom et al., 2013), but not in others (Albrecht et al., 2008, McLoughlin 
et al., 2009). Some of the inconsistencies across studies on ERPs of performance monitoring may 
be partly attributed to variability across studies in the way these components are measured 
(e.g., with peak amplitude or area amplitude approaches), and most studies have used modest 
sample sizes. Larger-scale investigations remain rare to date, but are needed to help clarify the 




1.3.4.3 Time-frequency studies 
More recent studies have also examined the synchronisation/desynchronisation of power and 
variability of phase of EEG oscillations during cognitive tasks with time-frequency approaches. 
Available evidence indicates that children and adolescents with ADHD show reductions in phase 
consistency of target- (McLoughlin et al., 2014b) and response-locked theta activity (Groom et 
al., 2010a), and in alpha ERD following targets (Lenartowicz et al., 2014) and cue stimuli 
preceding targets (Mazaheri et al., 2014). Evidence in adults further suggests reductions in cue- 
and target-related alpha and beta ERDs (Hasler et al., 2016). These results indicate that 
individuals with ADHD may be characterised by suboptimal ability to maintain a consistent 
pattern in the timing of evoked theta response over trials (theta phase variability) (McLoughlin 
et al., 2014b, Groom et al., 2010a), as well as in attentional mechanisms related to attentional 
selection (target-related alpha ERD), sensory gating (cue-related alpha ERD) and motor 
preparation and execution (cue- and target-related beta ERD). A recent time-frequency study 
on EEG oscillations during a working memory task found reduced alpha ERD during encoding, 
and increased theta ERS and alpha ERS during maintenance of the stimulus in children with 
ADHD compared to controls (Lenartowicz et al., 2014). Increased power in the latter two 
measures in individuals with ADHD may reflect mechanisms aimed at compensating for the 
deficits in alpha ERD in the earlier encoding stage of the task. Combined, these three indices 
predicted ADHD status with 70% accuracy (Lenartowicz et al., 2014). Taken together, available 
time-frequency studies in ADHD indicate impairments in measures that can capture fine-grained 
modulations in brain activity. The investigation of brain-oscillatory indices underlying various 
stages of cognitive processes with time-frequency analyses may help a deeper investigation into 
the alterations in neural processes implicated in ADHD (Loo et al., 2015). Yet, compared with 
ERP studies, considerably fewer studies have examined brain activity during cognitive 
performance in ADHD with time-frequency approaches. 
 
1.3.4.4 EEG connectivity studies 
Further evidence on neurophysiological alterations in ADHD comes from studies investigating 
impairments in functional connectivity. During resting state, EEG studies examining coherence 
values between EEG channels have shown mixed evidence of hypo- and hyper-connectivity in 
slower and faster brain oscillations between different cortical regions. Several studies have 
reported increased intra- and inter-hemispheric coherence in children with ADHD (Clarke et al., 
2007, Dupuy et al., 2008, Barry et al., 2005), especially in slow frequency bands (delta, theta) 
(Barry et al., 2002, Clarke et al., 2005, Clarke et al., 2007). Reduced coherence values, however, 
have also been reported, in particular in the alpha and beta bands (Barry et al., 2002, Barry et 
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al., 2005, Clarke et al., 2005). Fewer studies have examined adults with ADHD during resting 
states. Available evidence suggests increased connectivity in delta coherence (Barttfeld et al., 
2014), no differences in theta coherence, but lower coherences in the alpha band (Clarke et al., 
2008) in adults with ADHD compared to controls. 
 
Studies examining brain connectivity in ADHD during task performance, which may allow a more 
direct examination of alterations underlying impairments in cognition and behaviour (Ernst et 
al., 2015, Finn et al., 2017), have similarly reported inconsistent results. For example, previous 
studies have indicated that connectivity may be reduced in children with ADHD (Mazaheri et al., 
2010, Mazaheri et al., 2014), while other studies have found increased connectivity in the alpha 
(Murias et al., 2007) and beta (Silberstein et al., 2016) bands. No study to date has examined 
EEG connectivity during task performance in adults.  
 
Overall, available studies to date indicate several connectivity alterations in individuals with 
ADHD. This evidence is in keeping with atypical functional connectivity profiles reported with 
other neuroimaging techniques, in particular fMRI. Yet, although both increased and decreased 
connectivity have been reported with EEG, a large number of fMRI studies reported decreased 
connectivity during resting states, especially within the DMN and between the DMN and 
networks that become more active during a task performance (e.g., the executive control 
network) in children and adults with ADHD (Fair et al., 2010, Sripada et al., 2014, Sun et al., 2012, 
Castellanos et al., 2008, Uddin et al., 2008). Patterns of increased resting-state connectivity 
between or within these networks, however, have also been reported (Barbera et al., 2015, 
Hoekzema et al., 2014, McCarthy et al., 2013, Tian et al., 2006, Sidlauskaite et al., 2016). Task-
based fMRI studies have shown hypo-connectivity in fronto-striato-cerebellar networks during 
sustained attention (Rubia et al., 2009) and inhibition (van Rooij et al., 2015a, Cubillo et al., 2010, 
Vloet et al., 2010), and hyper-connectivity within the DMN (van Rooij et al., 2015a) and between 
networks of reward/cognitive control integration. The inconsistencies in results from EEG and 
fMRI studies may be due to the different methodological strengths of these techniques (outlined 
above in section 1.3.3). EEG methods are particularly indicated for studying transient and fast-
changing neural processes underlying the cognitive impairments implicated in ADHD, as they 
allow a more precise characterisation of deficits at multiple sensory and cognitive processing 
stages with sub-second temporal resolution (Makeig et al., 2004a, McLoughlin et al., 2014a). In 
addition, the majority of EEG connectivity studies conducted to date in ADHD present 
methodological limitations, such as the use of connectivity metrics contaminated by volume-




1.3.5 Summary  
 
Overall, the studies reviewed in this section indicate that ADHD is associated with several 
alterations in cognitive processes and brain activity measured by EEG, both during resting state 
and during task performance. While other neuroimaging modalities are not the focus of this 
thesis and are not reviewed in detail, studies on cognitive functions and EEG activity are largely 
consistent with impairments in wide-spread neural processes in ADHD reported with other 
neuroimaging techniques. For example, fMRI studies indicate that individuals with ADHD show 
alterations across partially separate neural networks, which include the frontal-parietal 
network, the DMN and the ventral-attentional network, involved in executive but also non-
executive cognitive processes (Cortese et al., 2012, Castellanos and Proal, 2012). Although 
several studies have investigated abnormalities in cognitive function and brain activity in 
children, adolescents and adults, fewer studies have investigated the developmental and 





1.4.1 Continuity of impairments from childhood to adulthood 
 
While cross-sectional studies are suggestive of similar impairments in cognitive and brain 
functions across development, prospective longitudinal studies with repeated assessments of 
ADHD and cognitive measures are needed to establish developmental patterns. Longitudinal 
research to date has mostly focused on higher-level cognitive functions (e.g., working memory, 
organisation, response inhibition), with several studies showing that impairments tend to persist 
from childhood to adolescence and adulthood in ADHD persisters (Cheung et al., 2016, 
Biederman et al., 2009, Hinshaw et al., 2007). This pattern is also observed for IQ (Cheung et al., 
2016, Biederman et al., 2009). Fewer prospective longitudinal studies have investigated the 
developmental association between ADHD and lower-level cognitive impairments, such as intra-
individual variability measured with RTV. The three largest studies conducted to date on RTV 
have shown persisting impairments both from middle to late childhood (Vaughn et al., 2011), 
and from childhood to adolescence/early adulthood in ADHD persisters compared to 
neurotypical individuals (Thissen et al., 2014, Cheung et al., 2016); although in one of these 
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studies the impairment did not persist in their oldest group of adults aged 22 or above (Thissen 
et al., 2014). Further studies have investigated the continuity of cognitive impairments in ADHD, 
but comparability to the above findings is less clear due to reliance on small samples or not 
making a distinction between individuals with persistent ADHD and remitted ADHD at follow-up 
(Doehnert et al., 2013, Moffitt et al., 2015). Studies not differentiating between remitters and 
persisters have found that deficits in visual processing, vigilance, inhibition and IQ may continue 
in adult age (Moffitt et al., 2015). For RTV, measured with different tasks, continuity of 
impairments was observed from childhood to adulthood in a smaller-scale study (Doehnert et 
al., 2013), but ADHD-control differences were less clear in adolescence (Doehnert et al., 2010). 
In another longitudinal study, some cognitive impairments (response inhibition) persisted in 
adolescence in ADHD persisters, while others did not (RTV, working memory) (McAuley et al., 
2014); yet comparability of the latter study to other studies is not clear, as different control 
groups were used in childhood and adolescence.  
 
Overall, studies to date converge in indicating that most cognitive impairments persist when 
ADHD persists from childhood to later assessments. Yet, most studies in adulthood have used 
samples of young adults, and studies with assessments of older age groups are needed to fully 
characterise the developmental trajectories of ADHD-related impairments across the lifespan. 
With regard to studies examining impairments in brain function in ADHD, little data exist as yet, 
but an initial prospective longitudinal EEG study reported that, among impairments in Cue-P3, 
NoGo-P3 and CNV observed in childhood, only deficits in the CNV were associated with ADHD in 
adults (n=11) (Doehnert et al., 2013). However, within this small-scale study, it was not possible 
to differentiate between persistent and remitted ADHD at follow-up. Further longitudinal EEG 
studies are needed to better understand the developmental continuity of such deficits. 
 
1.4.2 Predictors of ADHD outcome 
 
The prediction of later ADHD outcome (persistence/remission), within ADHD samples, based on 
early (childhood) impairments in cognition and brain function may be important for early 
identification of those at risk for worse long-term outcomes (van Lieshout et al., 2013). Studies 
examining such longitudinal prediction within childhood only, when ADHD symptoms have 
persisted in all individuals, indicate that impairments in early childhood in executive functions, 
especially inhibition and working memory, and in IQ predicted ADHD symptoms in later 
childhood (Berlin et al., 2003, Campbell and von Stauffenberg, 2009, Kalff et al., 2002, Brocki et 
al., 2007), whereas RTV was not predictive (Vaughn et al., 2011). Studies investigating clinical 
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outcomes of ADHD persistence/remittance, with follow-up assessments in adolescence and 
adulthood, have obtained inconsistent results. Recent studies suggest that RTV and working 
memory in childhood may predict ADHD symptoms and/or functional impairment in adolescents 
and young adults (van Lieshout et al., 2016a, Sjowall et al., 2015), even when controlling for 
childhood ADHD symptoms (Sjowall et al., 2015). This is inconsistent with results of studies 
examining later outcome as persistence/remission, which found no evidence for association of 
aggregated measures of executive functions, sustained attention, inhibition, working memory 
and RTV in childhood and ADHD remission/persistence in adolescence and adulthood 
(Biederman et al., 2009, Mick et al., 2011, Cheung et al., 2015). In a recent follow-up study, IQ 
was the only cognitive measure in childhood which predicted later ADHD remission/persistence, 
while measures of attention, inhibition, working memory and RTV did not predict future ADHD 
status (Cheung et al., 2015). The predictive value of IQ has been replicated in two other samples 
of young adults (Agnew-Blais et al., 2016, Gao et al., 2015), but not in other studies (Francx et 
al., 2015b, Breyer et al., 2014). The only study to date to examine the predictive value of brain 
activity in childhood on ADHD adult outcome indicate that resting-state EEG measures in the 
theta and beta bands in childhood predict adult ADHD remission/persistence (Clarke et al., 
2011), especially in frontal regions which are implicated in ADHD.  
 
Overall, these studies suggest that, while some cognitive impairments in children with ADHD 
may predict levels of ADHD symptoms at short term (within childhood and when symptoms of 
ADHD persist in all individuals), results are more mixed for predictions into adolescence and 
adulthood. Further research, also including measures of brain activity along with cognitive 
measures, is needed to elucidate what neurocognitive impairments are the most predictive in 
terms of ADHD persistence. 
 
1.4.3 Markers of remission and enduring deficits 
 
The identification of cognitive and neural processes underlying the trajectories of persistence 
and recovery from childhood-onset ADHD during the transition to adulthood may further 
contribute to the prevention of negative long-term outcomes. It has been hypothesised that the 
persistence of ADHD from childhood to adulthood would be predicted by the degree of 
maturation and improvement over time in higher-level cognitive function (Halperin and Schulz, 
2006). Contrary to this compensatory mechanism, lower-level cognitive functions would be 
linked to the presence of ADHD in childhood irrespective of later clinical status (Halperin and 
Schulz, 2006). In a follow-up study of almost 100 individuals with childhood ADHD assessed with 
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both cognitive function and EEG activity, ADHD remitters did not differ from controls in higher-
level cognitive functions (e.g., working memory and inhibition), but were still impaired in 
measures associated with lower-level cognitive processes (e.g., RTV) and movement level 
(Halperin et al., 2008). These results were supported by a second study on the same sample, 
where RTV did not distinguish ADHD remitters from persisters, both of whom were impaired 
compared to controls (Bedard et al., 2010).  
 
Other studies, however, have not found an association between ADHD remission and 
improvements in higher-level cognitive functions. Three studies reported that ADHD remitters 
and persisters in adolescence and adulthood did not differ from one another, and were both 
impaired compared to neurotypical individuals, in an aggregate index of executive functions 
(Biederman et al., 2009), interference control (Pazvantoglu et al., 2012), and response inhibition 
(McAuley et al., 2014). Working memory impairments in young adults diagnosed with ADHD in 
adolescence compared to controls were also observed regardless of whether they still met an 
ADHD diagnosis (Roman-Urrestarazu et al., 2016). Two recent studies (on one of the samples 
used for this thesis; Chapters 2-4) further found, across different cognitive tasks, that cognitive-
EEG measures of preparation, intra-individual variability and vigilance (mostly reflecting lower-
level cognitive functions) differentiated ADHD remitters from persisters assessed in adolescence 
and young adulthood (James et al., 2017, Cheung et al., 2016). Instead, cognitive and brain 
activity measures of executive control of inhibition and working memory (reflecting higher-level 
cognitive functions) were not sensitive to persistence/remission of the disorder (Cheung et al., 
2016). As such, these studies may suggest that cognitive processes and brain activity of 
preparation-vigilance (“lower-level”) processes – instead of higher-lever functions – may be 
markers of ADHD remission, following the symptom level at follow-up.  
 
Only three studies have examined the developmental pathways of brain connectivity in 
individuals with a diagnosis of ADHD in childhood, using fMRI. Two of these studies suggest that 
lower functional correlation between posterior cingulate and medial prefrontal cortices (major 
components of the DMN) during rest (Mattfeld et al., 2014) and lower connectivity between the 
thalamus and prefrontal regions during response preparation (Clerkin et al., 2013) may 
distinguish ADHD persisters from remitters and controls. Resting-state medial-dorsolateral 
functional associations in the prefrontal cortex, implicated in cognitive control, may instead be 
reduced in both ADHD remitters and persisters, compared to controls (Mattfeld et al., 2014), 
potentially indexing an enduring deficit. A recent larger-scale study further reported increased 
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resting-state fMRI connectivity in ADHD remitters compared to controls in the executive control 
network, with intermediate connectivity profiles in persisters (Francx et al., 2015a).  
 
Overall, despite some inconsistencies between studies, initial convergence across cognitive and 
neurophysiological markers of ADHD persistence and remittance is starting to emerge. For 
example, ADHD remitters show both reduced RTV and increased DMN activity compared to 
persisters (James et al., 2017, Cheung et al., 2016, Mattfeld et al., 2014). This corresponds to the 
hypothesis of an association between intra-individual variability and the DMN in ADHD (Sonuga-
Barke and Castellanos, 2007), which may both represent markers of remission. In addition, most 
studies to date show that impairments in executive functions do not distinguish ADHD remitters 
and persisters (Biederman et al., 2009, McAuley et al., 2014, Roman-Urrestarazu et al., 2016, 
Pazvantoglu et al., 2012, Cheung et al., 2016). Future studies should aim to address the 
inconsistencies across studies using methodologically robust procedures. One possible reason 
for some of the discrepancies across studies may be found in the way the persistence and 
remission are defined. While ADHD diagnosis in childhood is commonly based on parent-report 
assessments, studies differ in the use of parent- or self-reports at later assessments. However, 
there is a relatively low agreement between self- and parent-reports of ADHD in adolescents 
and young adults, and recent evidence shows that objective cognitive and neurophysiological 
data show lower agreement with ADHD outcome based on self-reports than on parent-reports 
(Du Rietz et al., 2016). Future studies should also consider more explicitly how the follow-up 





The studies reviewed in this section show that cognitive and neurophysiological impairments 
tend to persist into adulthood in individuals with persistent ADHD. Instead, when ADHD remits 
in the transition to adulthood, there appears to be a separation between measures that may 
represent markers of remission, distinguishing persisters from remitters at follow-up, and 
measures that are not sensitive to ADHD outcome. Most studies, however, have used cognitive-
performance measures, and studies examining the association between measures of brain 
activity and ADHD outcomes remain limited. It also remains unclear how aetiological factors 
related to ADHD map onto the trajectories of neurocognitive and brain function alterations. 







One possible explanation for the phenotypic association between cognitive-neurophysiological 
impairments and ADHD is that the same genes contributing to ADHD may also account for 
impairments in the cognitive and neural processes. Genes associated with ADHD may be non-
specific, but pleiotropic, meaning that each gene may influence more than one trait or disorder, 
either co-occurring at the same time or manifest at different times across development (Kovas 
and Plomin, 2006, Thapar and Cooper, 2016).  
 
It has been proposed that alterations in cognitive and neural processes in psychiatric disorders 
may lay on the causal pathway between the genetic susceptibility and the phenotypic expression 
of the disorder (Doyle et al., 2005, Castellanos and Tannock, 2002). From this perspective, 
cognitive and neural indices have been employed in psychiatric genetic research with an 
“endophenotype” approach, as possible targets (alternative to more heterogeneous 
behavioural presentations to which the endophenotypes are associated) to facilitate the 
discovery of genetic variants for psychiatric diagnoses (Almasy and Blangero, 2001, Castellanos 
and Tannock, 2002, Gottesman and Gould, 2003, Doyle et al., 2005, Waldman, 2005). The 
construct of endophenotype (also commonly known as “intermediate phenotype”) refers to a 
measurable trait, mediating between the genetic susceptibility to a certain disease and its 
phenotypic expression (Gottesman and Shields, 1973, Gottesman and Gould, 2003). Limited 
evidence, however, has emerged that the aetiology of intermediate phenotypes may be 
considerably simpler than that of psychiatric diseases (Flint and Munafo, 2007). Early 
endophenotype models may thus have been based on overly simplistic models of gene action, 
also ignoring the role of environmental influences and the interplay with gene expression (Loo 
et al., 2015). In addition, most endophenotype studies do not clearly discriminate between a 
“liability-index” (or “risk indicator”) model and a “mediational” model (Kendler and Neale, 
2010). The liability-index model specifies that a common set of genes increases the risk for both 
the putative intermediate phenotype and the disorder, implying pleiotropy. The mediational 
model makes the stronger assumption that the causal pathway from a set of genetic variants to 
a psychiatric disorder would pass exclusively through the associated marker. Kendler and Neale 
(2010) have proposed that the term endophenotype should be applied only to variables 
satisfying the mediational model, whilst variables fitting the liability-index model should be 




Nevertheless, the study of the overlap in aetiological factors between ADHD and cognitive-
neurophysiological impairments can help improve our understanding of the mechanisms 
underlying the disorder. This section will provide an overview of quantitative genetic studies of 
the association between cognitive-neurophysiological impairments and ADHD.  
 
1.5.1 Quantitative genetic studies of cognitive impairments in ADHD  
 
Cognitive impairments in ADHD have been investigated in several family studies, showing that 
unaffected first-degree family members (e.g., siblings) of children with ADHD may show the 
same cognitive impairments found in affected probands in their family (Rommelse et al., 2008b, 
Andreou et al., 2007, Sonuga-Barke et al., 2010, Loo et al., 2008, van Rooij et al., 2015b, von 
Rhein et al., 2015). This similarity in cognitive impairments is attributable to familial factors 
(genetic and environmental influences shared between ADHD probands and their affected and 
unaffected family members).  
 
In the presence of a phenotypic association between ADHD and a cognitive or 
neurophysiological measure, sibling and twin model-fitting studies are able to decompose this 
association into contribution of aetiological factors (familial and non-familial factors in sibling 
studies; genetic, shared environmental and non-shared environmental factors in twin studies) 
(see section 1.2.3.1 above). The overlap in the aetiological influences between two traits is 
further estimated with correlational indices. For example, genetic and familial correlations 
estimate the degree of overlap in genetic and familial influences, respectively, between two 
given traits (Kuntsi et al., 2010, Rijsdijk and Sham, 2002). Sibling and twin model-fitting studies 
in childhood have found substantial overlap between familial/genetic influences on ADHD and 
on several cognitive impairments, including IQ, working memory, inhibition, RTV, timing and 
delay aversion (Andreou et al., 2007, Frazier-Wood et al., 2012, Kuntsi et al., 2010, Wood et al., 
2010, Wood et al., 2011). Several twin studies have sought to quantify the degree of genetic 
overlap underlying the phenotypic association between ADHD symptoms and IQ. One study in 
children aged 5 years old found a genetic correlation (rA) of -0.45 between IQ and ADHD 
symptoms (on a continuum), and of -0.59 with ADHD diagnosis (present/absent) (Kuntsi et al., 
2004). The shared genetic influences accounted for 86% and 100% of the phenotypic association 
of low IQ with, respectively, ADHD symptoms and diagnosed ADHD (r=-0.28/-0.34, respectively) 
(Kuntsi et al., 2004). Similar estimates have been reported in more recent twin studies on 
general populations (Wood et al., 2010, Greven et al., 2014, Polderman et al., 2006). Using a 
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longitudinal twin model, another study has further shown that the genetic factors underlying 
the developmental association between ADHD and IQ at age 12, 14 and 16 are largely stable 
over time, yet some time-specific genetic influences also emerge on ADHD, IQ and their 
association at 14 and 16 years (Rommel et al., 2015). Similarly, twin studies have estimated that 
the phenotypic association between RTV and ADHD symptoms is moderately-to-largely 
explained by genetic factors, with estimates of genetic correlation between 0.31 and 0.64 
(Kuntsi et al., 2014, Cheung et al., 2014, McLoughlin et al., 2014b). Less consistent evidence 
exists for a genetic overlap between ADHD symptoms and measures of inhibition and working 
memory. Using a composite of ratings of ADHD symptoms from parents and teachers, a study 
found low, non-significant genetic correlations between CE and both ADHD symptom domains 
(rA=0.11 with inattention and rA=0.17 with hyperactivity-impulsivity) (Kuntsi et al., 2014). 
 
Quantitative genetic research has further focused on whether the multiple impairments 
associated with ADHD may reflect a multifactorial structure or a single core impairment. Using 
a multivariate familial factor analysis approach, one study found two separable familial factors 
accounting for cognitive impairment in a large sample of children and adolescents with ADHD, 
unaffected siblings and control sibling pairs (Kuntsi et al., 2010). The first, larger factor, 
accounting for 85% of the familial variance of ADHD, captured 98% and 100% of the familial 
variance of MRT and RTV, respectively. The second, smaller factor, accounting for 13% of the 
familial variance of ADHD, captured 62% and 82% of the familial variance of CE and OE, 
respectively (Kuntsi et al., 2010). These results have been interpreted as reflecting a dissociation 
between the aetiological influences underlying largely bottom-up (RTV) and top-down (response 
accuracy) processes in ADHD (Kuntsi et al., 2010). A subsequent study, using a similar approach 
in ADHD and control sibling pairs assessed with a different large neuropsychological battery, 
found a similar two-factor structure (Frazier-Wood et al., 2012). The first factor explained 100% 
of the familial influences on an aggregated measure of intra-individual variability and 50% of the 
familial influences of ADHD. The second factor captured 100% of the variance of digit-span 
backwards (measuring working memory) and a small proportion of the variance of ADHD (15%), 
Stop Signal RT (speed of the inhibition process) (20%), and IQ (33%) (Frazier-Wood et al., 2012). 
The majority of the familial influences on Stop Signal RT and IQ remained unaccounted for by 
the model, suggesting a partial separation from the other two factors. Taken together, these 
studies suggest the presence of two partially independent familial processes, one capturing 
increased intra-individual variability, and the other factor capturing impairments in executive 
function, such as response accuracy and working memory (Frazier-Wood et al., 2012, Kuntsi et 
al., 2010). The aetiological separation of RTV from response accuracy was also confirmed in a 
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more recent twin study on a population sample, where RTV showed a substantial genetic 
overlap with inattentive symptoms (rA=0.64) but no significant genetic overlap with CE (rA=-0.10) 
(Kuntsi et al., 2014). IQ may further potentially represent a third factor, as also indicated by 
three other twin and sibling studies showing that the genetic/familial influences shared between 
IQ and ADHD are largely separate from those shared between other cognitive impairments and 
the disorder (Wood et al., 2010, Wood et al., 2011, Rommelse et al., 2008c). The evidence of 
multiple aetiological factors is reflected in more recent theoretical models, which propose 
multiple processes and pathways underlying neurocognitive dysfunctions in ADHD (Halperin and 
Schulz, 2006, Sonuga-Barke et al., 2010, Sergeant, 2005, Castellanos et al., 2006, Johnson, 2012). 
Yet, results differ between studies on the number of factors that may underlie ADHD, likely 
owing to different tasks and varying (and often limited) number of measures included. In 
addition, limited evidence exists on the aetiological factor structure of cognitive impairments in 
ADHD in adolescence and adulthood, which is the focus on one of the studies included in this 
thesis (Chapter 4). 
 
1.5.2 Quantitative genetic studies of neurophysiological impairments in ADHD 
 
Electrophysiological alterations are moderately-to-highly heritable. A meta-analysis of twin 
studies of electrophysiological measures (Van Beijsterveldt and Van Baal, 2002) and a more 
recent systematic review (de Geus, 2010) indicate that genetic factors account for 60-90% and 
for 40-80%, respectively, of the variance of QEEG and ERP measures. Environmental factors also 
seem to play a role via the non-shared route (Zietsch et al., 2007, Stroganova et al., 2009, 
Gilmore et al., 2010).  
 
Family studies on samples including individuals with ADHD have shown that unaffected first-
degree family members of ADHD probands show some degree of impairment (scores typically 
between affected probands and controls) in ERP measures of inhibitory control (NoGo-P3), 
attentional allocation and orienting (Cue-P3), response preparation (CNV), conflict monitoring 
(N2) and error processing (ERN), both in children and adolescents (Albrecht et al., 2008, Albrecht 
et al., 2010, Albrecht et al., 2013) and in adults (McLoughlin et al., 2009, McLoughlin et al., 2011). 
Although this evidence suggests shared familial effects, less than a handful of quantitative 
genetic studies have quantified the contribution of genetic factors underlying the observed 
association between EEG measures and ADHD. The three available studies, using a modest 
sample of adolescent twins from the general population selected for having high and low ADHD 
symptoms (n=134; 30 MZ or DZ pairs concordant or discordant for high ADHD symptom scores, 
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and 37 MZ or DZ pairs concordant for low ADHD symptom scores), found moderate-to-large 
genetic overlap of ADHD symptoms with elevated theta power during rest (rA=0.35) (Tye et al., 
2014), reduced very-low frequency power during the CPT-OX (rA=0.80) (Tye et al., 2012) and 
increased source (ICA)-based frontal midline theta phase variability during an arrow flanker task 
(rA=0.51) (McLoughlin et al., 2014b). In the latter study, theta phase variability further showed 
a substantial genetic overlap with RTV. Yet, these studies focused more on the significance of 
the association between measures and ADHD (measured with t and p-value statistics on the 
difference between high- and low-ADHD symptom groups on the EEG measures), rather than on 
the size of these associations with standardised statistics. As such, limited conclusions can be 
derived from the evidence of genetic overlap between ADHD and the investigated EEG markers 




Investigating cognitive impairments and EEG alterations in individuals with ADHD can provide 
an important tool to gain a better understanding of the mechanisms that are impaired in the 
disorder. By further exploring the aetiological architecture of the observed associations between 
ADHD and cognitive-EEG impairments, available studies further indicate that familial/genetic 
influences largely underlie such associations, although studies remain limited and more research 
is warranted, especially on EEG indices. The use of multivariate approaches may be particularly 
valuable in this regard, both to clarify the aetiological overlap between ADHD and cognitive-
neurophysiological impairments, but also to investigate the shared aetiology between 
impairments in cognitive functions and in brain activity. Ultimately, a better understanding of 
the aetiology and pathophysiology of ADHD will lead to improved causal modes of the disorder, 





Bipolar disorder (BD) denotes a severe psychiatric condition generally occurring in adulthood. 
Although diagnostic classifications consider it distinct from ADHD (APA, 2013), the two disorders 
present certain areas of symptomatic overlap. In some cases, this overlap can lead to 
uncertainties regarding diagnostic boundaries between these two disorders, which can have 




1.6.1 Clinical symptoms and epidemiology of BD 
 
BD has been classified under the DSM category of mood disorders until the DSM-IV-TR edition 
(APA, 2000). In the DSM-5, BD has been classified separately from depressive disorders, to 
recognise the commonalities in terms of aetiology, family history and symptomatology with 
depressive disorders but also schizophrenia (APA, 2013). Individuals with BD may experience 
unusually intense emotional states that occur for distinct periods of time in episodes of mania 
and depression. A manic episode is a period lasting at least one week (or any duration if 
hospitalisation is necessary) of abnormally elated, expansive or irritable mood, increased 
talkativeness, impulsiveness, distractibility, activity, grandiose ideation and decreased need for 
sleep. A depressive episode is a period of at least two weeks of persistent and pervasive low 
mood and/or a loss of interest, pleasure or energy, along with difficulty concentrating, 
psychomotor retardation, increased need for sleep and suicidal ideation (APA, 2013, APA, 2000). 
Psychotic symptoms may also occur during manic and depressive states, such as hallucinations 
and delusional beliefs. Between episodes, individuals return to periods of relatively normal 
mood (euthymia), although full functioning may not be reached (Muller-Oerlinghausen et al., 
2002, Henry et al., 2013). The DSM-IV-TR and DSM-5 include different types of BD (APA, 2013, 
APA, 2000), which may be considered on a “bipolar spectrum” (Alloy and Abramson, 2010). BD 
type I (BD-I) is defined by the presence of one or more manic episodes or mixed episodes of 
mania and depression which may be alternated with depressive episodes. BD type II (BD-II) is 
characterised by at least one depressive episode and at least one hypomanic episode (similar to 
a manic episode, but less severe and impairing) lasting at least four days, but no full-blown manic 
or mixed episodes. Finally, cyclothymia is considered a milder but more chronic form of BD, 
defined by hypomanic episodes alternated to episodes of mild or moderate depression, less 
severe than full-blown depressive episodes (APA, 2013, APA, 2000). 
 
BD is conceptualised as a disorder of adult age, with onset in late adolescence or early 
adulthood. The lifetime prevalence of BD is estimated at around 1-3.9% (Merikangas et al., 2011, 
Fajutrao et al., 2009, Kessler et al., 2005, Merikangas et al., 2007). BD-I is the most common 
form of BD, with prevalence ranging between 0.6% and 2.2%. Equal proportions of men and 
women are affected by BD. In a large study on adults from 11 countries, higher lifetime 
prevalence of BD-I was found in males that females, while greater prevalence of BD-II was found 
in females (Merikangas et al., 2011). Around three-quarters of individuals with BD present with 
a co-occurring or lifetime psychiatric disorder, such as anxiety (60% of BD cases), substance use 
disorder (40%), ADHD (20%) or conduct disorder (20%) (Merikangas et al., 2011). Comorbidities 
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may be more frequent in men than in women (Hendrick et al., 2000). BD is highly heritable, with 
heritability estimates ranging between 0.58 and 0.77 (Song et al., 2015, Edvardsen et al., 2008, 
Barnett and Smoller, 2009, Smoller and Finn, 2003); since the aetiology of BD is not a specific 
focus of this thesis, relevant literature will not be discussed in detail. 
 
1.6.2 Cognitive and neurophysiological impairments in BD 
 
BD is associated with impairments in multiple cognitive domains. Meta-analytic evidence 
indicates that several executive functions, such as sustained attention, working memory and 
inhibition, are impaired in BD, with medium-to-large effect sizes during depressive and manic 
episodes (Cohen’s d=0.55-1.43) (Kurtz and Gerraty, 2009). Of note, these impairments tend to 
persist during euthymia (Robinson et al., 2006), with medium-to-large effect sizes (d=0.61-0.83) 
(Kurtz and Gerraty, 2009). For example, impairments in response inhibition and sustained 
attention have been found in individuals with BD during Go/NoGo and CPT paradigms, as 
indicated by higher numbers of CE and OE (Clark et al., 2002, Torres et al., 2007, Robinson et al., 
2013). Increased RTV has further been reported during CPT tasks (Brotman et al., 2009, Bora et 
al., 2006, Moss et al., 2016). Impairments in executive functions have also been found in 
individuals before BD onset in longitudinal studies, suggesting that such impairments in BD are 
state-independent (Meyer et al., 2004, Ratheesh et al., 2013). Atypical profiles in executive 
functions and in RTV have also been reported in first-degree family members of individuals with 
BD (Adleman et al., 2014, Brotman et al., 2009, Erol et al., 2014, Kulkarni et al., 2010). This 
evidence suggests that familial influences may underlie the association of such impairments with 
BD. 
 
EEG studies of BD have shown alterations in QEEG profiles and ERP components. Resting-state 
theta and delta power may be increased in individuals with BD, while alpha power may be 
decreased (Basar and Guntekin, 2013, Outhred et al., 2014). Individuals with BD may show a 
pre-attentive dysfunction, indexed by abnormalities in early sensory and attentional ERP 
components, such as reduced mismatch negativity (MMN) and P50, in auditory tasks (Hall et al., 
2007, Cabranes et al., 2013, Jahshan et al., 2012). P3 components have been studied in BD 
individuals mostly in comparison to individuals with schizophrenia using oddball paradigms, to 
examine target discrimination and stimulus context updating (Chun et al., 2013, Maekawa et al., 
2013, Thaker, 2008, Polich, 2007). Reduced target P3 amplitudes in individuals with BD 
compared to controls have been shown during auditory oddball paradigms (Ethridge et al., 2015, 
Bersani et al., 2015, Kaur et al., 2011) and using a task with standard, deviant and target 
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conditions (Maekawa et al., 2013). P3 attenuations have further been reported in first-degree 
unaffected relatives of individuals with BD (Pierson et al., 2000), indicating familial influences on 
this ERP component. Normal enhancements of the P3 component to target stimuli, however, 
have also been found using a visual three-stimulus oddball paradigm (Bestelmeyer, 2012), an 
auditory oddball paradigm (Schulze et al., 2008) and a Go/NoGo task (Chun et al., 2013). 
Previous studies also suggest impairments in BD in P2 and fronto-central P3 component (also 
called P3a), thought to reflect stimulus classification and covert attentional orienting, 
respectively (Ethridge et al., 2015, Jahshan et al., 2012). Reduced CNV amplitudes have further 
been reported in BD, indicating attentional deficits of response preparation (Li et al., 2015). 
Studies examining ERPs of performance monitoring have found conflicting results. Two studies 
on participants with BD found reduced N2 amplitude in response to target stimuli with an 
auditory oddball paradigm (Ethridge et al., 2012, Ethridge et al., 2015). Another study, however, 
found no N2 reductions in individuals with the disorder (Morsel et al., 2014). Two recent studies 
examining ERPs of error processing found evidence of significantly reduced ERN (Morsel et al., 
2014), suggestive evidence of increased ERN and significantly reduced Pe (Kopf et al., 2015). The 
use of small samples in most ERP studies of BD may explain some of the inconsistencies in 
results, and warrants further empirical data. Initial evidence from studies using time-frequency 
approaches further suggests that individuals with BD show increased event-related beta and 
delta power (Ozerdem et al., 2008b, Ozerdem et al., 2008a, Tan et al., 2016, Ethridge et al., 2012, 
Ethridge et al., 2015), and decreased theta and alpha power (Atagun et al., 2013, Basar et al., 
2012, Ethridge et al., 2012, Ethridge et al., 2015) during visual and auditory oddball tasks 
compared to controls. Yet, these studies used time-frequency methods applied on averaged ERP 
(evoked) responses, rather than more sophisticated time-frequency decompositions capturing 
both evoked and induced increases and decreases in brain oscillations. Further research is 
needed to provide full characterisation of event-related oscillatory responses in BD. 
 
1.6.3 Comparison between BD and ADHD 
 
1.6.3.1 Similarities and differences in clinical characteristics 
Diagnostic formulations for ADHD and BD present certain areas of symptomatic overlap. Adult 
ADHD may present with some symptoms common to manic episodes, such as distractibility, 
psychomotor restlessness and talkativeness (Kent and Craddock, 2003, Skirrow et al., 2012, 
Asherson et al., 2014). The ceaseless distractible and uncontrolled thought processes and 
wandering mind (everyday thoughts flitting from one topic to another) seen in many adults with 
ADHD may be similar to racing thoughts or flight of ideas typical of mania (Asherson, 2005, 
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Asherson et al., 2014). Additionally, both disorders may be characterised by features of mood 
dysregulation, such as irritability and emotional lability (Skirrow and Asherson, 2013, Skirrow et 
al., 2012). However, although mood dysregulation is commonly seen in patients with ADHD and 
patients with BD, it is not disorder-specific, but instead typical also of other psychiatric 
conditions often co-occurring with ADHD and BD, such as major depressive disorder and anxiety 
disorders (Cumyn et al., 2009, Skirrow and Asherson, 2013). These symptomatic similarities may 
result in uncertainty regarding the boundaries of the two disorders, and difficulties in 
distinguishing between the two disorders when patients are referred for first clinical 
assessments (Skirrow et al., 2012, Asherson et al., 2014). Diagnosis influences treatment 
decisions, which differ for the two disorders (typically stimulants or atomoxetine for ADHD, and 
mood stabilisers or antipsychotics for BD), making the correct distinction between ADHD and BD 
critically important (Skirrow et al., 2012, Asherson et al., 2014). Under the DSM-5, the 
delineation between the two disorders may be further complicated by the inclusion of mood 
dysregulation as an associated feature of ADHD, and of persistently increased goal-directed 
energy and activity as a symptom of BD (APA, 2013). 
 
In addition, ADHD and BD often co-occur (Merikangas et al., 2011, Hensch et al., 2011, Klassen 
et al., 2010). This co-occurrence may be partly explained by shared familial/genetic factors. 
Meta-analytic evidence summarising results of family studies has shown that there is an 
increased prevalence of ADHD among family members of individuals with BD (relative risk 
[RR]=2.6) and an increased prevalence of BD among relatives of individuals with ADHD (RR=1.8) 
(Faraone et al., 2012). Genetic studies using GWA approaches have further confirmed this 
aetiological overlap between ADHD and BD, showing that shared common genetic variants are 
associated with a range of psychiatric disorders, including ADHD and BD (Lee et al., 2013). A 
recent meta-analytic GWA study also found a substantial SNP-based genetic correlation 
between ADHD and BD (rA=0.64) (van Hulzen et al., 2016).  
 
Despite wide areas of overlap between ADHD and BD, there are clinical characteristics that are 
not common between the two disorders. For example, the elated mood and grandiosity 
observed during manic episodes, and the psychomotor retardation, loss of energy and suicidal 
ideation typical of depressive episodes, are not part of ADHD symptoms (Asherson et al., 2014). 
Another important difference in clinical presentations between ADHD and BD is that, while 
ADHD symptoms are chronic, trait-like and represent differences from developmental norms, 
BD symptoms tend to occur for a distinct period and refer to changes from an individual's usual 
euthymic state (APA, 2000, APA, 2013). Yet, although BD diagnosis requires episodicity of 
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symptoms, it has been shown that individuals with BD between episodes still show residual 
symptoms of distractibility and mood dysregulation (overlapping with ADHD) and impairments 
in functional performance (Henry et al., 2013). In addition, while relatively clear alterations of 
episodes is seen in BD-I and BD-II, these are less distinct in cyclothymia, which represents a more 
chronic form of BD (Skirrow et al., 2012). 
 
Only few small-scale studies have directly examined the suitability of standard diagnostic tools 
to distinguish between ADHD and BD. One study found that individuals with ADHD (n=16) and 
individuals with BD (n=15) showed increased scores on a depression scale relative to controls 
(Torralva et al., 2011). In another study, scores on an ADHD rating scale were able to discriminate 
between ADHD and BD, but individuals with BD during euthymia showed lower levels of 
depressive and manic symptoms than individuals with ADHD (Ibanez et al., 2012). In a more 
recent study from one of the samples used for this thesis (Chapters 5 and 6), ADHD interview 
measures and self-ratings of ADHD symptoms best discriminated between women with ADHD 
and women with BD, while measures of emotional lability and depressive symptoms were 
increased in both groups relative to control women (Kitsune et al., 2016).  
 
1.6.3.2 Similarities and differences in cognitive and neurophysiological impairments 
Comparative studies across ADHD and BD, using cognitive and EEG measures, may aid in the 
distinction of impairments that are shared and may potentially underlie the overlap in symptoms 
between ADHD and BD, from impairments that may be distinct between the two disorders. The 
latter group of measures has the potential to help identify objective measures which could serve 
as biomarkers to aid in distinguishing between the two conditions.  
 
Although previous research has shown evidence of similar cognitive impairments in attentional 
and inhibitory processing in ADHD and BD separately, only a few cognitive studies have directly 
compared these processes in adults with ADHD or BD, concluding that subtle differences in 
executive function impairments may aid in distinguishing between the disorders (Levent et al., 
2014, Torralva et al., 2011). One study used an extensive neuropsychological battery measuring 
multiple cognitive domains (short-term, verbal, non-verbal, logical and working memory, 
attention, various other executive functions including motor inhibitory control). This study 
found that ADHD and BD groups could not be distinguished based on their performance on 
attention, inhibition, short-term and working memory, but that individuals with ADHD 
performed better in verbal and non-verbal memory tests (Torralva et al., 2011). Another study 
assessed ADHD and BD groups on a digit span test, a verbal memory test, the Wisconsin Card 
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Sorting Test and Stroop Test, and found that individuals with BD showed poorer performance 
than individuals with ADHD in all tests except for inhibitory control measured with the Stroop 
Test (Levent et al., 2014). Yet, participants with ADHD only showed differences from controls on 
the Stroop Test, but not in other tasks, suggesting that the ADHD group may have been less 
impaired than samples used in other studies.  
 
Similarly, only a few small-scale studies have examined the similarities and differences between 
ADHD and BD on neurophysiological impairments. One study on 12 adults with ADHD and 13 
adults with BD investigating ERP measures of reward processing using a gambling task found 
significant impairments in the amplitude of a reward-sensitive P3 in both clinical groups 
compared to controls (n=25) (Ibanez et al., 2012). Yet, similar to controls, individuals in the BD 
groups displayed an increase in P3 amplitude with increasing reward magnitude, while 
individuals with ADHD showed no modulation of the P3 with reward magnitude changes. In a 
recent QEEG study from one of the samples used for this thesis (Chapters 5 and 6), both women 
with ADHD (n=20) and women with BD (n=20) showed increased theta power during rest 
compared to controls (n=20) (Rommel et al., 2016). Both groups further lacked an increase in 
theta power (observed in controls) in switching from rest to the CPT-OX task, but no differences 
emerged between clinical and control groups during the task. Another study assessed resting-
state brain functional connectivity and temporal variability in connectivity in the delta band in a 
small sample of adults with euthymic BD (n=11) and with ADHD (n=9) relative to healthy controls 
(n=15) (Barttfeld et al., 2014). Results suggest that delta connectivity was increased in both 
clinical groups, while connectivity variability was increased in ADHD but reduced in BD compared 
to controls. Finally, two studies, of which only one included a control sample (Nazhvani et al., 
2013), used a machine learning approach to classify individuals with ADHD or BD based on their 
resting-state EEG power and early visual ERP (P1) (Nazhvani et al., 2013, Sadatnezhad et al., 
2010). Both resting-state EEG power data, and P1 amplitude and latency data combined, yielded 
a high classification accuracy, of 72-87% and 93%, respectively. Overall, empirical data from 
cross-disorder cognitive-neurophysiological studies of ADHD and BD are limited to date. In 
particular, little is known on the differences or similarities in cognitive and brain processes that 
are relevant to the behavioural symptoms that overlap between ADHD and BD, such as 
distractibility or impulsivity. No published study prior to this thesis has compared impairments 
in attentional and inhibitory processes in ADHD and BD in adulthood using ERP or time-
frequency EEG measures. In addition, most EEG studies, especially on ADHD, have been 
performed on male samples, and very little is known about these processes in females. Further 
studies are needed, to compare cognitive-neurophysiological markers between ADHD and BD 
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and gain further insights into distinct and overlapping impairments. The identification of 
disorder-specific objective measures would further our understanding of impairments 





This section has introduced the clinical, cognitive and neurophysiological features of BD, and 
provided an overview of similarities and differences from ADHD. The clinical manifestations of 
BD present certain areas of overlap with that of ADHD. The two disorders may also often co-
occur. The overlap between BD and ADHD may be challenging in clinical settings when an 
individual presents with symptoms such as distractibility, emotional lability, restlessness, which 
characterise both disorders. Assigning a correct diagnosis is necessary to make correct 
treatment decisions, as different treatments are indicated for the two disorders. Careful clinical 
considerations are required to delineate between ADHD and BD, and may benefit from the 
development of biomarkers to aid in diagnostic decisions and treatment monitoring. Cross-
disorder comparisons between ADHD and BD on measures of neurocognitive and brain function 
may point to measures that could represent such candidate biomarkers. Studies examining 
ADHD and BD separately suggest that similar but also distinct cognitive-neurophysiological 
impairments may characterise the two disorders. However, very few direct cross-disorder 
comparison studies have been carried out to date, and more research is warranted to confirm 
the extent to which cognitive and neurophysiological profiles may help differentiate between 





This thesis uses a multi-disciplinary approach to study cognitive and neurophysiological 
impairments underlying ADHD in adolescence and adulthood. The first part (Chapters 2, 3 and 
4) aims to further our understanding of the developmental pathways and aetiological structure 
of these impairments in adolescents and young adults with a childhood diagnosis of ADHD-C, 
their unaffected siblings and age-matched neurotypical participants. The second part of this 
thesis (Chapters 5 and 6) aims to compare cognitive-neurophysiological profiles between 
women with ADHD, women with BD and control women, in order to identify impairments that 
are specific to, or shared between, ADHD and BD. Overall, by using a combination of cognitive, 
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neurophysiological, developmental and sibling-modelling approaches, this work aims to further 
our understanding of the developmental pathways, aetiology and specificity of cognitive 
impairments and brain activity alterations in adolescents and adults with ADHD.  
 
1.7.1 Part 1: developmental and aetiological pathways to ADHD (Chapters 2, 3 and 4) 
 
ADHD persists into adolescence and adulthood, either in full or in partial remission, in the 
majority of children clinically diagnosed in childhood (Faraone et al., 2006). Yet, the mechanisms 
underlying persistence and remission are poorly understood.  
 
Chapters 2 and 3 aim to extend previous research into the cognitive and EEG markers of ADHD 
remission and enduring deficits (reviewed in section 1.4.3), by examining, for the first time, the 
association of ADHD outcomes with ERPs of performance monitoring (Chapter 2) and EEG 
functional connectivity measures (Chapter 3) in a follow-up study of individuals with ADHD-C in 
childhood. Chapter 2 examines profiles of cognitive and ERP impairments of performance 
monitoring (N2, ERN, Pe components) in ADHD persisters, remitters and controls, as well as the 
continuous association between these cognitive-ERP measures and ADHD severity within the 
childhood ADHD group. Chapter 3 represents a further investigation into the neurophysiological 
impairments of ADHD with advanced EEG connectivity methods, to extend our understanding 
into functional connectivity in adolescents and adults with ADHD during a cognitive control task, 
as well as to examine the association of the identified connectivity markers with persistent and 
remitted ADHD. 
 
Chapter 4 investigates the aetiological mechanisms underlying persistent ADHD, by examining 
the aetiological factor structure of cognitive and ERP impairments associated with persistent 
ADHD in adolescence and young adulthood in Chapter 2 and previous studies (Cheung et al., 
2016, Cheung et al., 2017). Specifically, this chapter aims to estimate the extent to which the 
impairments in cognitive-ERP measures in ADHD cluster into one or more familial and non-
familial factors. 
 
1.7.2 Part 2: comparison between ADHD and BD (Chapters 5 and 6) 
 
ADHD and BD in adults present certain areas of symptom overlap, which in some cases may lead 
to incorrect clinical decisions. Direct cognitive-neurophysiological comparisons between ADHD 




Chapter 5 compares cognitive-performance and ERP measures of attentional and inhibitory 
processes from the CPT-OX task in a sample of women with ADHD, women with BD and control 
women. Chapter 6 further examines RTV and alterations in brain activity of attentional processes 
in the three groups, extracted with ERP and time-frequency analyses, during the Fast task, a 
four-choice RT task with baseline and fast-incentive conditions. Both studies use an all-female 
sample, in order to match the groups on gender but also to explore the neglected area of EEG 
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CHAPTER 3 - Atypical functional connectivity in 






Background: We previously provided initial evidence for cognitive and event-related potential 
markers of persistence/remission of attention-deficit/hyperactivity disorder (ADHD) from 
childhood to adolescence and adulthood. In this follow-up study, using a novel brain-network 
connectivity approach, we aimed to examine whether functional connectivity reflects a marker 
of ADHD remission, or an enduring deficit unrelated to ADHD outcome. Methods: High-density 
EEG was recorded in 110 adolescents and young adults with childhood ADHD (87 persisters, 23 
remitters) and 169 typically-developing individuals during an arrow-flanker task, eliciting 
cognitive control. Functional connectivity was quantified with network-based graph theory 
metrics before target onset (pre-stimulus), during target processing (post-stimulus) and in the 
degree of change between pre-stimulus/post-stimulus. ADHD outcome was examined with 
parent-reported symptoms and impairment using both a categorical (DSM-IV) and a dimensional 
approach. Results: Graph-theory measures converged in indicating that, compared to controls, 
ADHD persisters showed increased connectivity in pre-stimulus theta, alpha and beta and in 
post-stimulus beta (all p<.01), and reduced pre-stimulus/post-stimulus change in theta 
connectivity (p<.01). In the majority of indices showing ADHD persister-control differences, 
ADHD remitters differed from controls (all p<.05), but not from persisters. Similarly, connectivity 
measures were not associated with continuous outcome measures of ADHD symptoms and 
impairment in participants with childhood ADHD. Conclusions: Adolescents and young adults 
with persistent and remitted ADHD share atypical over-connectivity profiles and reduced ability 
to modulate connectivity patterns with task demands, compared to controls. Brain connectivity 
impairments may represent enduring deficits in individuals with childhood ADHD irrespective of 





A coherent communication between different brain regions, or brain functional connectivity, is 
thought to have a key role in cognition and behaviour (Deco and Kringelbach, 2016, Bullmore 
and Sporns, 2009, Coben et al., 2017). Accumulating evidence suggests that atypical connectivity 
may be implicated in neurodevelopmental disorders (Castellanos and Aoki, 2016, Kitzbichler et 
al., 2015, Xing et al., 2017), such as attention-deficit/hyperactivity disorder (ADHD). Most studies 
to date have investigated brain connectivity in ADHD using functional magnetic-resonance 
imaging (fMRI), with reduced connectivity within and between brain regions/sub-networks 
during resting (e.g., within the default-mode network (DMN) and between DMN and executive 
networks) observed in individuals with ADHD (Fair et al., 2010, Sripada et al., 2014, Sun et al., 
2012, Castellanos et al., 2008, Uddin et al., 2008). Evidence of increased resting-state 
connectivity within and between these regions, however, has also been reported in ADHD 
(Barbera et al., 2015, Hoekzema et al., 2014, McCarthy et al., 2013, Tian et al., 2006, Sidlauskaite 
et al., 2016, Castellanos and Aoki, 2016). Examining brain connectivity during task performance 
further allows a more direct characterisation of connectivity alterations underlying the 
impairments in cognition and behaviour associated with ADHD (Ernst et al., 2015, Finn et al., 
2017). Task-based fMRI studies of ADHD show hypo-connectivity in fronto-striato-cerebellar 
networks during sustained attention (Rubia et al., 2009) and inhibition (van Rooij et al., 2015a, 
Cubillo et al., 2010, Vloet et al., 2010), and hyper-connectivity within the DMN (van Rooij et al., 
2015a) and between networks of reward/cognitive control integration (Ma et al., 2016). Using 
the sub-second temporal resolution of electroencephalography (EEG), previous studies have 
further shown hypo- and hyper-connectivity in slower and faster brain oscillations from different 
cortical regions during rest (Clarke et al., 2007, Dupuy et al., 2008, Barry et al., 2005) and 
cognitive performance in individuals with ADHD (Murias et al., 2007, Mazaheri et al., 2014, 
Silberstein et al., 2016). Available task-based studies in children and adolescents with ADHD 
indicate reduced fronto-parietal theta-alpha connectivity (Mazaheri et al., 2010, Mazaheri et al., 
2014), but also increased connectivity in alpha (Murias et al., 2007) and beta (Silberstein et al., 
2016). No study to date has examined task-based EEG connectivity in adults with ADHD. Overall, 
despite inconsistencies regarding which brain networks may be hypo- and hyper-connected, 
available evidence points to atypical brain connectivity in ADHD.  
 
While atypical functional connectivity has been documented both in children (Fair et al., 2010, 
Sripada et al., 2014, Sun et al., 2012) and adults (Mattfeld et al., 2014, Uddin et al., 2008, 
Castellanos et al., 2008) with ADHD, little is known on how these alterations map onto ADHD 
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developmental outcomes. ADHD persists, in full or in partial remission, in the majority of 
adolescents and adults clinically diagnosed in childhood (Faraone et al., 2006, Sibley et al., 2016). 
Yet, the evidence that some individuals remit across development may suggest the presence of 
(1) neural processes that are markers of remission, improving concurrently with clinical profiles 
and distinguishing individuals with persistent and remitted ADHD (ADHD “persisters” and 
“remitters”, respectively); and of (2) enduring deficits that are unrelated to the clinical outcome, 
remaining impaired in both remitters and persisters (Halperin and Schulz, 2006). The 
identification of such measures may help elucidate the mechanisms underlying 
remission/persistence, and point to candidate biomarkers for the development of new 
interventions for ADHD. Most studies to date, using cognitive-performance indices, found that 
executive functioning measures do not distinguish between ADHD persisters and remitters, and 
are thus insensitive to ADHD outcomes (Pazvantoglu et al., 2012, Biederman et al., 2009, 
McAuley et al., 2014, Cheung et al., 2016, Michelini et al., 2016a). Fewer studies have 
investigated the neural underpinnings of remission/persistence. In a recent follow-up of 
adolescents and young adults with childhood ADHD, we found that cognitive and event-related 
potential (ERP) markers of executive control (inhibition, working memory, conflict monitoring) 
were insensitive to ADHD outcome (Cheung et al., 2016, Michelini et al., 2016a, James et al., 
2017). Instead, cognitive, ERP and EEG power measures of preparation-vigilance and error 
detection were markers of remission, distinguishing ADHD remitters from persisters.  
 
Considering the important role of brain connectivity in behaviour and cognition (Deco and 
Kringelbach, 2016, Bullmore and Sporns, 2009, Coben et al., 2017), the investigation of this 
brain-wide neural mechanism may provide new insight into the neural pathways of persistence 
and remission of ADHD. Only three studies to date have investigated functional connectivity in 
remitted and persistent ADHD, using fMRI (Clerkin et al., 2013, Mattfeld et al., 2014, Francx et 
al., 2015a). Two of these studies, using small samples, suggest that ADHD persisters may show 
lower functional connectivity than remitters and controls between the DMN and executive 
network during rest (Mattfeld et al., 2014) and between the thalamus and frontal areas during 
response preparation (Clerkin et al., 2013). Resting-state medial-dorsolateral functional 
associations in the prefrontal cortex, implicated in cognitive control, may instead be unrelated 
to ADHD outcome, and reduced in both ADHD remitters and persisters, compared to controls 
(Mattfeld et al., 2014). A larger-scale study, however, found higher connectivity in ADHD 
remitters than controls, with persisters showing intermediate profiles between remitters and 
controls (Francx et al., 2015a). Investigating brain connectivity using the excellent temporal 
resolution of EEG may provide further information in relation to ADHD remission/persistence by 
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capturing fast and transient changes in functional connectivity (not captured by fMRI) during 
cognitive processes (Coben et al., 2014, McLoughlin et al., 2014a). Yet, most EEG connectivity 
studies in ADHD to date present methodological limitations, such as the use of connectivity 
metrics contaminated by volume-conduction artefacts (i.e., the spreading and mixing of multiple 
brain sources at the scalp), which may produce inflated connectivity estimates (Nolte et al., 
2004, Nunez et al., 1997). Recently developed network approaches, such as graph theory, may 
be further applied to characterise brain connectivity between large-scale brain networks and 
identify connectivity alteration (Bullmore and Sporns, 2009, Rubinov and Sporns, 2010, 
Castellanos and Aoki, 2016). Initial graph-theoretic evidence from two task-based studies shows 
atypical functional connectivity in children with ADHD (Xia et al., 2014, Liu et al., 2015). No study 
to date has examined measures of EEG connectivity in relation to longitudinal ADHD outcome. 
 
In the present EEG study, we aimed to investigate brain functional connectivity during a 
cognitive control task in a follow-up of adolescents and adults with and without childhood 
ADHD. In previous analyses on these data we have shown that attention-vigilance cognitive 
processes and ERPs of error detection were markers of remission, while cognitive-ERP measures 
of executive and conflict processes were insensitive to ADHD outcome (Michelini et al., 2016a). 
Here, we aimed to test whether functional connectivity patterns, measured with graph-theory 
and connectivity metrics not contaminated by volume conduction, represent markers of ADHD 
remission or enduring deficits. We hypothesised that both ADHD remitters and persisters would 
display functional connectivity alterations during this task evoking high levels of cognitive 
control, consistent with most studies examining cognitive and EEG markers of executive 
processes (Pazvantoglu et al., 2012, Biederman et al., 2009, McAuley et al., 2014, Cheung et al., 





3.3.1 Sample  
 
The sample consisted of 279 participants who were followed up on average 5.8 years (SD=1.1) 
after assessments in childhood (Kuntsi et al., 2010), including 110 adolescents and young adults 
who met DSM-IV criteria for combined-type ADHD in childhood (10 sibling pairs and 90 
singletons) and 169 control participants (76 sibling pairs and 17 singletons) (Cheung et al., 2016). 
Participants with ADHD were initially recruited from specialised ADHD clinics, and controls from 
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schools in the UK (Kuntsi et al., 2010). Exclusion criteria at both assessments were: IQ<70, 
autism, epilepsy, brain disorders, and any genetic/medical disorder associated with externalising 
behaviours that might mimic ADHD. Among those with childhood ADHD, at follow-up 87 (79%) 
continued to meet clinical (DSM-IV) levels of ADHD symptoms and impairment (ADHD 
persisters), while 23 (21%) were below the clinical cut-off (ADHD remitters) (Cheung et al., 
2015). Among ADHD remitters, 14 displayed ≥5 symptoms of inattention or hyperactivity-
impulsivity, but did not show functional impairment. Participants attended a single research 
session for clinical, IQ and cognitive-EEG assessments. An estimate of IQ was derived with the 
vocabulary and block design subtests of the Wechsler Abbreviated Scale of Intelligence (WASI) 
(Wechsler, 1999). ADHD persisters, remitters and controls did not differ in age, but there were 
significantly more males in the remitted group than in the other two groups, with no females 
among ADHD remitters (Table 3.1) (Cheung et al., 2016, Michelini et al., 2016a). ADHD persisters 
showed lower IQ compared to remitters and controls (Cheung et al., 2015, Cheung et al., 2016). 
47% of participants with childhood ADHD were on drug treatment at follow-up, but the 
proportion of participants on medication did not differ between ADHD persisters and remitters 
(χ2=1.95, p=0.16) (Cheung et al., 2016). A 48-hour ADHD medication-free period was required 
before assessments. Parents of all participants gave informed consent following procedures 
approved by the London-Surrey Borders Research Ethics Committee (09/H0806/58). 
 
3.3.2 ADHD diagnosis 
 
The Diagnostic Interview for ADHD in Adults (DIVA) (Ramos-Quiroga et al., 2016) was conducted 
by trained researchers with parents of the ADHD probands, to assess DSM-IV-defined ADHD 
presence and persistence of the 18 ADHD symptoms. Evidence of impairment commonly 
associated with ADHD was assessed with the Barkley’s functional impairment scale (BFIS) 
(Barkley and Murphy, 2006). Parent-report DIVA and impairments were used to determine 
ADHD status, as these were validated against objective markers (cognitive-performance and EEG 
measures) in this sample, whereas the same objective markers showed limited agreement with 
self-reported ADHD (Du Rietz et al., 2016). Participants were classified as “affected” at follow-
up if they showed at least 6 items in either the inattention or hyperactivity-impulsivity domains 
on the DIVA, and two or more areas of impairments on the BFIS. We defined ADHD outcome 
using a categorical definition of persistence based on diagnoses, as well as a dimensional 
approach based on continuous levels of symptoms of ADHD and impairments.  
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 Table 3.1. Sample demographics divided by group, with tests for differences between ADHD 
persisters, remitters and controls 
Abbreviations: ADHD-P = ADHD persisters; ADHD-R = ADHD remitters; Ctrl = Control group; F = 
number of females; M = number of males.  
Notes: Group differences on gender were tested via Chi-square test; group differences on age 
and IQ were tested with linear regressions. Group differences in gender, age and IQ were 
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The task was an adaptation of the Eriksen Flanker paradigm designed to increase cognitive load 
(Albrecht et al., 2008, McLoughlin et al., 2014b). In each trial a central black fixation mark was 
replaced by a target arrow (a black 18 mm equilateral triangle). Participants had to indicate 
whether this arrow pointed towards the left or right by pressing corresponding response buttons 
with their left or right index fingers. Two flanker arrows identical in shape and size to the target 
appeared 22 mm above and below the centre of the target arrow 100 ms before each target 
arrow. Both flankers either pointed in the same (congruent) or opposite (incongruent) direction 
to the target. As such, cognitive control and conflict monitoring are maximal during incongruent 
trials. When the target appeared, both target and flankers remained on the screen for 150 ms, 
with a new trial being presented every 1650 ms. Two-hundred congruent and 200 incongruent 
trials were arranged in 10 blocks of 40 trials. Only incongruent trials, known to elicit greater 
ADHD-control differences (McLoughlin et al., 2014b, Michelini et al., 2016a), were considered in 
the present analysis. For further details on the task, see Appendix B.  
 
3.3.4 EEG recording and processing  
 
The EEG was recorded from a 62-channel extended 10–20 system montage (Brain Products, 
GmbH, Munich, Germany), using a 500 Hz sampling-rate, impedances under 10 kΩ, and 
recording reference at FCz. The electro-oculograms (EOGs) were recorded from electrodes 
above and below the left eye and at the outer canthi. Raw EEG recordings were down-sampled 
to 256 Hz, re-referenced to the average of all electrodes (turning FCz into an active channel), 
and filtered using Butterworth band-pass filters (0.10-30 Hz, 24 dB/oct). All trials were visually 
inspected and sections of data containing electrical or movement artefacts were removed 
manually. Ocular artefacts were identified using Independent Component Analysis (ICA) (Jung 
et al., 2000). Sections of data containing artefacts exceeding ±100 μV or with a voltage step 
greater than 50 μV were automatically rejected. The artefact-free data were segmented in 
epochs between -650–1000 ms stimulus-locked to incongruent stimuli. Both trials with correct 
and incorrect responses were examined (Michelini et al., 2016a). Only data containing ≥20 clean 
segments for condition were included in analyses, leaving 271 participants (83 ADHD persisters, 
22 remitters, 166 controls) for correctly-responded trials and 240 (75 ADHD persisters, 20 




3.3.5 Connectivity analysis 
 
3.3.5.1 Calculation of functional connectivity and graph-theory metrics 
We examined functional brain connectivity with the imaginary part of coherence (iCoh), a 
functional association index able to detect interactions between EEG signals occurring with a 
certain time delay, thus ignoring instantaneous interaction between neighbouring electrodes 
likely produced by volume conduction (Hinkley et al., 2010, Nolte et al., 2004, Palva and Palva, 
2012) (for further explanation see Appendix B). Values of iCoh for all possible electrode pairs 
(62x62) were computed in the theta (4-8 Hz), alpha (8-12 Hz) and beta (12-20 Hz) bands (Figure 
3.1), which have previously been implicated in cognitive processes engaging top-down control 
networks requiring coherent activity between brain areas (Buzsaki and Draguhn, 2004, Uhlhaas 
and Singer, 2006, Wang, 2010), such as the fronto-parietal network (Klimesch et al., 2010, 
Klimesch et al., 2007, Halgren et al., 2002, Capotosto et al., 2009). 
 
The high multi-dimensionality of the iCoh measures was disentangled with a graph-theory 
approach. Unthresholded weighted iCoh matrices were used, in line with previous studies (Xing 
et al., 2017, Hardmeier et al., 2014, Boersma et al., 2013, van den Heuvel et al., 2010), where 
each connection is equivalent to the measured iCoh of two electrodes. Graph theory metrics 
measure the degree of network segregation (i.e., the tendency of brain regions to form local 
clusters with dense functional interconnections), and network integration and efficiency (i.e., 
the capacity of the network to become interconnected and efficiently exchange information 
between brain regions) (Bullmore and Sporns, 2009, Sporns, 2014). The following commonly-
used graph measures were calculated (Ahmadlou et al., 2012, Boersma et al., 2013, Liu et al., 
2015, Xing et al., 2017, Fraga Gonzalez et al., 2016): average clustering coefficient (the 
probability of neighbouring nodes of being inter-connected, reflecting local connectedness); 
global efficiency (how efficient the network is in transferring information); characteristic path 
length and diameter (respectively, the average number of edges along the shortest paths, and 
the largest possible distance, between all possible pairs of nodes). Values of iCoh and graph-
theory metrics were computed with the BioNeCT toolbox 
(https://sites.google.com/site/bionectweb/home; Coben et al., 2017) and Matlab custom 
scripts separately for correctly- and incorrectly-responded trials in stimulus-locked windows, 





3.3.6 Statistical analyses 
 
3.3.6.1 Categorical analysis based on diagnostic status 
Connectivity metrics were examined with random intercept linear models (i.e., multilevel 
regression models) in Stata 14 (StataCorp, College Station, TX), testing for effects of group 
(ADHD persisters vs remitters vs controls), time window (pre-stimulus vs post-stimulus), 
response (correct vs incorrect) and their interaction (group-by-window-by-response). When the 
three-way interaction was not statistically significant, only statistically significant main effects 
and two-way interactions were included. For all measures, the within-group degree of change 
from pre-stimulus to post-stimulus was compared across groups using difference scores. All 
models controlled for age and took into account the degree of clustering due to family status. 
Cohen’s d effect sizes are presented along with test statistics, where d≥0.20 is a small effect, 
d≥0.50 a medium effect and d≥0.80 a large effect (Cohen, 1988). Given the large number of 
hypotheses tested, sensitivity analyses applied multiple-testing corrections with false discovery 
rate (FDR) on post-hoc tests with the “multproc” package (Simes, 1986). 
 
Since 80% of our sample consisted of males, but groups were not fully matched on sex (Table 
3.1), analyses were performed on the whole sample and then repeated with females (15 ADHD 
persisters, 41 controls) removed. As in this sample ADHD persisters had a lower IQ than 
remitters (Cheung et al., 2016), and childhood IQ predicted ADHD outcome at follow-up (Cheung 
et al., 2015), all analyses were also re-run controlling for IQ to examine whether IQ contributes 
to the results. Finally, to examine brain connectivity within and between cortical regions, 
analyses were repeated using iCoh values within and between clusters of electrodes in different 
scalp regions (anterior/central/posterior) and between the two hemispheres (left/right) (for 
further details, see Appendix B). 
 
3.3.6.2 Dimensional analysis with ADHD symptoms/impairment 
The association between connectivity and the continua of ADHD symptoms and impairment 
within individuals with childhood ADHD were examined with random intercept linear models 
using DIVA ADHD symptom and impairment scores as independent variables, controlling for age 
and sex and clustering for family status. All analyses were re-run, firstly, correcting for multiple 




Figure 3.1. Connectivity matrices showing values of imaginary part of coherence (iCoh) in the 







3.4.1 Differences between ADHD persisters, remitters and controls 
 
Post-hoc analyses revealed that, in correctly-responded trials, ADHD persisters showed greater 
clustering coefficient, global efficiency and mean iCoh, and lower path length and diameter 
compared to controls at all frequency bands in the pre-stimulus window, and only in beta in the 
post-stimulus windows (Table 3.2, Figure 3.2). ADHD remitters showed lower pre-stimulus 
diameter in theta and beta, lower pre-stimulus path length in alpha and beta, and lower post-
stimulus diameter in beta, compared to controls. ADHD remitters did not differ from persisters 
in any connectivity measure in correctly-responded trials, except diameter in beta (where 
remitters were intermediate between controls and persisters, and significantly differed from 
both groups) (Table 3.2). These findings indicate increased functional connectivity in both ADHD 
persisters and remitters compared to controls during correct trials. In error trials, group 
differences only emerged for clustering coefficient, global efficiency and mean iCoh in post-
stimulus theta: both ADHD persisters and remitters showed reduced values in these measures 
(indicating lower connectivity) compared to controls, but did not differ from each other (Table 
3.2). All three groups showed increased connectivity (greater clustering coefficient, global 
efficiency and mean iCoh; decreased path length and diameter) in incorrect compared to correct 
trials, in both pre-stimulus and post-stimulus windows (Table S3.1-S3.2, Appendix B). All main 
and interaction effects are shown in Table S3.2, Appendix B. 
 
Among measures showing significant group-by-window interactions (all in theta, all except 
diameter in alpha, none in beta; Table S3.2, Appendix B), significant within-group differences in 
changing from pre-stimulus to post-stimulus windows emerged in all groups for all theta 
connectivity measures, in controls only for clustering coefficient, path length and mean iCoh in 
the alpha band, and in both ADHD groups for global efficiency in alpha (Table 3.3). ADHD 
persisters and remitters exhibited a significantly lower degree of change than controls in all 
measures of theta connectivity, but no differences emerged between the two ADHD groups 
(Table 3.3).  
 
Multiple-testing corrections (controlling the FDR at 15%) on post-hoc group comparisons 
(separately for ADHD persisters vs controls, ADHD remitters vs controls, ADHD persisters vs 
remitters) showed that all significant group differences that were statistically significant 
remained significant, except for the difference between ADHD persisters and remitters in beta 
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diameter. All significant group differences on measures of pre-stimulus/post-stimulus change 
remained statistically significant.  
 
All results remained unchanged when rerunning analyses on the male-only sample (Table S3.3-
S3.4, Appendix B), except that the p-values of certain tests that were statistically significant in 
the full sample became trend-level effects (p=0.05-0.10) (see Appendix B). All effect sizes were 
similar to those on the full sample, suggesting that these non-significant results may be due to 
lower power in this smaller sample.  
 
Results of group comparisons on connectivity measures in pre- and post-stimulus were largely 
unchanged when IQ was included as a covariate in categorical analyses (Table S3.5, Appendix B), 
while few differences between persisters and controls on measures of pre-stimulus/post-
stimulus change in theta and alpha connectivity during error trials were no longer significant 
(Table S3.6, Appendix B).  
 
Results of analyses on group differences in local connectivity within cortical regions (within 
anterior/central/posterior regions and within left/right hemispheres) and these three cortical 
regions and two hemispheres, were consistent with those on whole-brain connectivity (see 




Figure 3.2. Results of the categorical analyses comparing ADHD persisters, remitters and controls 
on measures of graph theory and imaginary part of the coherence (iCoh) in the theta, alpha and 






Table 3.2.  Group comparisons on graph-theory and imaginary coherence measures 
    Group comparison 
THETA   
Overall Group Ctrl vs ADHD-P Ctrl vs ADHD-R ADHD-R vs ADHD-P 
p p d p d p d 
Average clustering 
coefficient    
Pre, Corr 0.016* 0.004** 0.63 0.880 0.29 0.139 0.35 
Pre, Err 0.544 - - - - - - 
Post, Corr 0.401 - - - - - - 
Post, Err <0.001*** <0.001*** 0.35 0.017* 0.30 0.955 0.05 
Global efficiency 
Pre, Corr 0.053 0.019* 0.51 0.901 0.16 0.145 0.37 
Pre, Err 0.568 - - - - - - 
Post, Corr 0.189 - - - - - - 
Post, Err <0.001*** <0.001*** 0.35 0.019* 0.30 0.916 0.05 
Path length 
Pre, Corr 0.012* <0.001*** 0.58 0.095 0.30 0.130 0.30 
Pre, Err 0.434 - - - - - - 
Post, Corr 0.338 - - - - - - 
Post, Err 0.122 - - - - - - 
Diameter 
Pre, Corr <0.001*** <0.001*** 0.64 0.012* 0.49 0.352 0.17 
Pre, Err 0.646 - - - - - - 
Post, Corr 0.976 - - - - - - 
Post, Err 0.279 - - - - - - 
Mean imaginary 
coherence 
Pre, Corr 0.024* 0.007** 0.60 0.952 -0.25 0.140 0.35 
Pre, Err 0.562 - - - - - - 
Post, Corr 0.319 - - - - - - 
Post, Err <0.001*** <0.001*** 0.35 0.019* 0.30 0.955 0.06 






p p d p d p d 
Average clustering 
coefficient    
Pre, Corr 0.001** <0.001*** 0.44 0.097 0.42 0.636 0.06 
Pre, Err 0.415 - - - - - - 
Post, Corr 0.328 - - - - - - 
Post, Err 0.084 - - - - - - 
Global efficiency 
Pre, Corr 0.003** 0.002** 0.32 0.054 0.39 0.976 0.04 
Pre, Err 0.325 - - - - - - 
Post, Corr 0.816 - - - - - - 
Post, Err 0.152 - - - - - - 
Path length 
Pre, Corr <0.001*** <0.001*** 0.32 0.005** 0.47 0.539 0.13 
Pre, Err 0.709 - - - - - - 
Post, Corr 0.201 - - - - - - 
Post, Err 0.235 - - - - - - 
Diameter 
Corr <0.001*** <0.001*** 0.41 0.054 0.30 0.610 0.13 
Err 0.444 - - - - - - 
Mean imaginary 
coherence 
Pre, Corr 0.001** <0.001*** 0.40 0.073 0.39 0.684 0.04 
Pre, Err 0.341 - - - - - - 
Post, Corr 0.501 - - - - - - 
Post, Err 0.064 - - - - - - 
BETA   
Overall Group Ctrl vs ADHD-P Ctrl vs ADHD-R ADHD-R vs ADHD-P 
p p d p d p d 
Average clustering 
coefficient    
Corr <0.001*** <0.001*** 0.79 0.097 0.51 0.101 0.31 
Err 0.135 - - - - - - 
Global efficiency 
Corr <0.001*** <0.001*** 0.73 0.137 0.44 0.098 0.31 
Err 0.154 - - - - - - 






Err 0.343 - - - - - - 
Diameter 
Corr <0.001*** <0.001*** 0.83 0.003** 0.53 0.044* 0.31 
Err 0.221 - - - - - - 
Mean imaginary 
coherence 
Corr <0.001*** <0.001*** 0.77 0.097 0.49 0.101 0.31 
Err 0.135 - - - - - - 
Abbreviations: ADHD-P = ADHD persisters; ADHD-R = ADHD remitters; Corr = trials with correct responses; Ctrl = Control group; d = Cohen’s d effect size; Err = 
trials with incorrect responses; p = random intercept linear model significance testing; Pre = pre-stimulus time window; Post = post-stimulus time window. 
Notes: Random intercept linear models tested for main effects of group (ADHD remitters vs ADHD persisters vs controls), time window (pre-stimulus vs post-
stimulus) ad response (correctly- vs incorrectly-responded trials), two-way interactions (group-by-window, group-by-response, time window-by-response), and 
three-way interactions (group-by-window-by-response) on connectivity measures. Full results are presented in Table S3.2, Appendix B. Since neither diameter in 
the alpha band, nor any measures in the beta band showed a significant group-by-window interaction, post-hoc effects of group were tested for with correctly- 
and incorrectly-responded trials collapsed across pre-stimulus and post-stimulus time windows. Post-hoc comparisons between groups were run only on measures 
showing a significant overall group effect. Age was also included as a covariate of no interest in all analyses. Data in correctly-responded trials were available for 
83 ADHD persisters, 22 remitters, 166 controls; and in incorrectly-responded trials for 75 ADHD persisters, 20 remitters, 145 controls. 






Table 3.3.  Within- and between-group effects on measures of change between pre-stimulus and post-stimulus windows in graph-theory and imaginary coherence 
measures 
  Within-Group Change  Between-Group Change 
THETA  
Ctrl ADHD-P ADHD-R Ctrl vs ADHD-P Ctrl vs ADHD-R ADHD-R vs ADHD-P 
p p p p d p d p d 
Average clustering 
coefficient 
Corr <0.001*** <0.001*** <0.001*** 0.001** 0.42 0.010* 0.41 0.981 0.05 
Err <0.001*** <0.001*** <0.001*** 0.011* 0.33 0.618 0.06 0.370 0.26 
Global efficiency 
Corr <0.001*** <0.001*** <0.001*** 0.002** 0.40 0.014* 0.38 0.997 0.04 
Err <0.001*** <0.001*** <0.001*** 0.017* 0.31 0.643 0.06 0.400 0.25 
Path length 
Corr <0.001*** <0.001*** <0.001*** <0.001*** 0.61 0.014* 0.44 0.506 0.19 
Err <0.001*** <0.001*** <0.001*** 0.058 0.27 0.776 0.11 0.209 0.36 
Diameter 
Corr <0.001*** <0.001*** <0.001*** <0.001*** 0.61 0.016* 0.43 0.499 0.19 
Err <0.001*** <0.001*** <0.001*** 0.058 0.20 0.776 0.14 0.209 0.33 
Mean imaginary 
coherence 
Corr <0.001*** <0.001*** <0.001*** 0.001** 0.42 0.011* 0.40 0.995 0.05 
Err <0.001*** <0.001*** <0.001*** 0.013* 0.33 0.632 0.06 0.378 0.26 
ALPHA  
Ctrl ADHD-P ADHD-R Ctrl vs ADHD-P Ctrl vs ADHD-R ADHD-R vs ADHD-P 
p p p p d p d p d 
Average clustering 
coefficient 
Corr 0.002** 0.910 0.767 0.055 0.27 0.091 0.38 0.704 0.09 
Err 0.001** 0.981 0.599 0.069 0.28 0.267 0.16 0.468 0.13 
Global efficiency 
Corr 0.728 0.004** 0.045* 0.071 0.27 0.147 0.40 0.705 0.11 
Err 0.155 0.029* 0.683 0.019* 0.38 0.140 0.25 0.389 0.15 
Path length 
Corr 0.002** 0.856 0.319 0.124 0.20 0.049* 0.42 0.349 0.23 
Err 0.011* 0.831 0.931 0.023* 0.37 0.094 0.33 0.743 0.07 
Mean imaginary 
coherence 
Corr 0.020* 0.491 0.472 0.064 0.27 0.111 0.37 0.735 0.08 






Abbreviations: ADHD-P = ADHD persisters; ADHD-R = ADHD remitters; Corr = trials with correct responses; Ctrl = Control group; d = Cohen’s d effect size; Err = 
trials with incorrect responses; p = random intercept linear model significance testing. 
Notes: Random intercept linear models tested for main effects of group (ADHD remitters vs ADHD persisters vs controls), time window (pre-stimulus vs post-
stimulus) ad response (correctly- vs incorrectly-responded trials), two-way interactions (group-by-window, group-by-response, time window-by-response), and 
three-way interactions (group-by-window-by-response) on connectivity measures. Full results are presented in Table S3.2, Appendix B. Post-hoc tests on within- 
and between-group effects of change were run only on measures showing a significant group-by-window interaction. Since this interaction was not significant in 
diameter in the alpha band or in any measures in the beta band, post-hoc within- and between-groups effects of change were not tested. Age was also included 
as a covariate of no interest in all analyses. Data in correctly-responded trials were available for 83 ADHD persisters, 22 remitters, 166 controls; and in incorrectly-
responded trials for 75 ADHD persisters, 20 remitters, 145 controls. 




3.4.2 Association with ADHD symptoms and impairment 
 
In dimensional analyses on participants with childhood ADHD, no association emerged between 
ADHD symptoms and any of the measures of connectivity in theta, alpha or beta frequencies in 
correct or error trials (Table 3.4). Functional impairment was not associated with any 
connectivity measure in the theta band, but showed associations with a subgroup of measures 
in alpha and beta in correct and error trials (Table 3.4). Results remained largely unchanged 
when controlling for IQ (Table S3.7, Appendix B). Statistically significant associations were no 







Table 3.4. Dimensional associations between graph-theory and imaginary coherence measures 
and interview-based DIVA ADHD symptom counts and clinical impairment within the ADHD 
group only, controlling for age and gender 
THETA   
ADHD symptoms Impairment 
β (95% CIs) p β (95% CIs) p 
Average 
clustering 
coefficient    
Pre, Corr <0.001 (-0.001;0.001) 0.964 <0.001 (-0.001;0.001) 0.163 
Pre, Err <0.001 (-0.001;0.001) 0.844 <0.001 (-0.000;0.001) 0.110 
Post, Corr <0.001 (-0.001;0.001) 0.827 <0.001 (-0.001;0.001) 0.111 
Post, Err -0.001 (-0.002;0.001) 0.315 <0.001 (-0.001;0.001) 0.494 
Global 
efficiency 
Pre, Corr <0.001 (-0.001;0.001) 0.685 <0.001 (-0.001;0.001) 0.393 
Pre, Err <0.001 (-0.001;0.001) 0.969 <0.001 (-0.000;0.001) 0.110 
Post, Corr <0.001 (-0.001;0.001) 0.667 0.001 (-0.001;0.001) 0.194 
Post, Err -0.001 (-0.002;0.001) 0.196 -0.001 (-0.001;0.001) 0.120 
Path 
length 
Pre, Corr 0.029 (-0.127;0.185) 0.716 -0.052 (-0.135;0.032) 0.226 
Pre, Err -0.017 (-0.148;0.114) 0.797 -0.053 (-0.123;0.016) 0.132 
Post, Corr 0.041 (-0.086;0.169) 0.528 -0.030 (-0.098;0.039) 0.395 
Post, Err 0.053 (-0.045;0.151) 0.290 0.013 (-0.040;0.066) 0.630 
Diameter 
Pre, Corr 0.067 (-0.185;0.320) 0.601 -0.072 (-0.211;0.067) 0.310 
Pre, Err -0.044 (-0.259;0.170) 0.685 -0.083 (-0.196;0.031) 0.153 
Post, Corr 0.032 (-0.171;0.236) 0.756 -0.059 (-0.167;0.049) 0.287 




Pre, Corr <0.001 (-0.001;0.001) 0.898 <0.001 (-0.001;0.001) 0.204 
Pre, Err <0.001 (-0.001;0.001) 0.878 <0.001 (-0.000;0.001) 0.110 
Post, Corr <0.001 (-0.001;0.001) 0.778 0.001 (-0.001;0.001) 0.134 
Post, Err -0.001 (-0.002;0.001) 0.268 <0.001 (-0.001;0.000) 0.306 
ALPHA   
ADHD symptoms  Impairment 
β (95% CIs) p β (95% CIs) p 
Average 
clustering 
coefficient    
Pre, Corr <0.001 (-0.001;0.001) 0.894 <0.001 (-0.001;0.001) 0.708 
Pre, Err <0.001 (-0.001;0.002) 0.578 0.001 (-0.000;0.001) 0.135 
Post, Corr <0.001 (-0.001;0.001) 0.500 <0.001 (-0.001;0.001) 0.012* 
Post, Err 0.001 (-0.001;0.001) 0.204 0.001 (0.000;0.001) 0.034* 
Global 
efficiency 
Pre, Corr <0.001 (-0.002;0.002) 0.794 <0.001 (-0.001;0.001) 0.450 
Pre, Err <0.001 (-0.001;0.002) 0.738 0.001 (-0.000;0.001) 0.245 
Post, Corr <0.001 (-0.001;0.001) 0.563 <0.001 (0.000;0.001) 0.046* 
Post, Err 0.001 (-0.001;0.002) 0.216 0.001 (0.001;0.001) 0.031* 
Path 
length 
Pre, Corr <0.001 (-0.205;0.205) 0.998 0.043 (-0.069;0.154) 0.452 
Pre, Err -0.018 (-0.154;0.118) 0.793 -0.044 (-0.117;0.001) 0.229 
Post, Corr -0.036 (-0.163;0.091) 0.580 -0.066 (-0.133;0.000) 0.050 
Post, Err -0.062 (-0.152;0.027) 0.172 -0.050 (-0.099;-0.002) 0.042* 
Diameter 
Pre, Corr -0.042 (-0.344;0.259) 0.784 -0.037 (-0.204;0.129) 0.659 
Pre, Err -0.085 (-0.290;0.120) 0.417 -0.090 (-0.202;0.022) 0.114 
Post, Corr -0.058 (-0.270;0.153) 0.588 -0.122 (-0.233;-0.012) 0.030* 







Pre, Corr <0.001 (-0.001;0.001) 0.973 <0.001 (-0.001;0.001) 0.981 
Pre, Err <0.001 (-0.001;0.002) 0.631 0.001 (-0.000;0.001) 0.156 
Post, Corr <0.001 (-0.001;0.001) 0.505 <0.001 (0.000;0.001) 0.016* 
Post, Err 0.001 (-0.001;0.001) 0.204 0.001 (0.000;0.001) 0.033* 
BETA   
ADHD symptoms Impairment 
β (95% CIs) p β (95% CIs) p 
Average 
clustering 
coefficient    
Pre, Corr <0.001 (-0.001;0.001) 0.278 <0.001 (-0.000;0.001) 0.014* 
Pre, Err <0.001 (-0.001;0.001) 0.613 <0.001 (-0.001;0.001) 0.077 
Post, Corr <0.001 (-0.001;0.001) 0.435 <0.001 (0.000;0.001) 0.049* 
Post, Err <0.001 (-0.001;0.001) 0.666 <0.001 (-0.001;0.001) 0.153 
Global 
efficiency 
Pre, Corr <0.001 (-0.001;0.001) 0.372 <0.001 (-0.001;0.001) 0.014* 
Pre, Err <0.001 (-0.001;0.001) 0.650 <0.001 (-0.000;0.001) 0.069 
Post, Corr <0.001 (-0.001;0.001) 0.572 <0.001 (-0.001;0.001) 0.065 
Post, Err <0.001 (-0.001;0.001) 0.688 <0.001 (-0.000;0.001) 0.152 
Path 
length 
Pre, Corr -0.071 (-0.114;0.081) 0.361 -0.086 (-0.166;-0.006) 0.035* 
Pre, Err -0.038 (-0.152;0.075) 0.508 -0.054 (-0.115;0.006) 0.080 
Post, Corr -0.052 (-0.201;0.097) 0.490 -0.066 (-0.146;0.015) 0.110 
Post, Err -0.046 (-0.164;0.072) 0.444 -0.045 (-0.107;0.017) 0.153 
Diameter 
Pre, Corr -0.144 (-0.390;0.102) 0.251 -0.148 (-0.277;0.019) 0.024* 
Pre, Err -0.091 (-0.292;0.109) 0.372 -0.077 (-0.183;0.029) 0.157 
Post, Corr -0.125 (-0.372;0.121) 0.320 -0.108 (-0.241;0.026) 0.114 




Pre, Corr <0.001 (-0.001;0.001) 0.301 <0.001 (-0.001;0.001) 0.013* 
Pre, Err <0.001 (-0.001;0.001) 0.620 <0.001 (-0.000;0.001) 0.072 
Post, Corr <0.001 (-0.001;0.001) 0.478 <0.001 (-0.000;0.001) 0.054 
Post, Err <0.001 (-0.001;0.001) 0.676 <0.001 (-0.000;0.001) 0.153 
Abbreviations: β = regression coefficient; CIs = confidence intervals; Corr = trials with correct 
responses; Err = trials with incorrect responses; p = random intercept linear model significance 
testing; Pre = pre-stimulus time window; Post = post-stimulus time window. Data in correctly-
responded trials were available for 105 childhood ADHD participants (83 ADHD persisters, 22 
remitters); and in incorrectly-responded trials for 95 childhood ADHD participants (75 ADHD 
persisters, 20 remitters). 
Notes: Random intercept linear models tested for the effect of ADHD symptom 










Using a network-based EEG functional connectivity approach, our results indicate that ADHD 
persisters show widespread over-connectivity underlying cognitive-control processes compared 
to controls, as well as reduced adjustments of connectivity with changed task demands. ADHD 
remitters showed similar impairments as persisters, and differed from controls in most 
measures of connectivity and connectivity adjustments. These findings indicate that hyper-
connectivity and reduced ability to modulate connectivity patterns with task demands 
characterise adolescents and young adults with both persistent and remitted ADHD. Atypical 
functional connectivity during cognitive-control processes may thus represent an enduring 
deficit in adolescents and adults with childhood ADHD, irrespective of their current diagnostic 
status.  
 
Two main connectivity impairments emerged in individuals with persistent ADHD compared to 
controls. Firstly, ADHD persisters showed increased global connectivity (higher iCoh), network 
segregation (higher clustering coefficient), efficiency (higher global efficiency) and integration 
(lower path length and diameter) at all frequency bands prior to target onset in trials with 
correct behavioural responses, as well as during target processing in beta oscillations. The 
increases in functional connectivity are consistent with a previous EEG study reporting pre-
target over-connectivity in children with ADHD (Silberstein et al., 2016), and more generally 
supports evidence indicating hyper-connectivity in ADHD (van Rooij et al., 2015a, Ma et al., 2016, 
Murias et al., 2007, Mazaheri et al., 2014). Connectivity in theta, alpha and beta oscillations 
during cognitive tasks is associated with cognitive processes engaging control networks and 
requiring coordination of activity between distributed brain areas (Buzsaki and Draguhn, 2004, 
Uhlhaas and Singer, 2006, Wang, 2010). Here, over-connectivity in these frequency ranges in 
persistent ADHD may reflect exaggerated interactions between brain regions, both during the 
inactive pre-stimulus period and during cognitive target processing. Considering the high 
cognitive demands induced by incongruent stimuli in this highly effortful task, which requires a 
response at every trial, increased connectivity (especially in the beta band) may reflect hyper-
connectivity in executive control networks. Secondly, while all groups showed increased theta 
connectivity in changing from pre-stimulus to post-stimulus windows, this change was reduced 
in ADHD persisters compared to controls. This result in individuals with ADHD may point to a 
reduced ability to modulate brain connectivity patterns in slow oscillations from a relatively 
inactive context to a condition requiring cognitive engagement. This finding is in line with 




cognitive states (Rommel et al., 2016, Skirrow et al., 2015, Cheung et al., 2017). Overall, these 
findings show widespread connectivity impairments underlying cognitive-control processes in 
ADHD persisters, and advance our understanding of the neural underpinnings of persistent 
ADHD in adolescence and early adulthood. 
 
Our study represents the first investigation into EEG connectivity in adolescents and adults with 
remitted ADHD. In several connectivity measures sensitive to impairments in persisters, ADHD 
remitters were impaired compared to controls and indistinguishable from persisters, consistent 
with our hypotheses. ADHD remitters also showed the same reduction in all measures of pre-
stimulus/post-stimulus change in theta connectivity displayed by persisters. As such, brain 
connectivity impairments were insensitive to ADHD outcome (remission/persistence) in 
adolescence and early adulthood, and may represent enduring deficits irrespective of current 
diagnostic status. Findings from dimensional analyses supported these results, as most 
connectivity measures were unrelated to continuous levels of ADHD symptoms and impairments 
in participants with childhood ADHD. Of note, while results of categorical analyses were largely 
unchanged after correcting for multiple testing, the few significant associations between 
connectivity and functional impairment did not survive multiple-testing corrections. Overall, 
these connectivity findings in remitters are consistent with previous cognitive-EEG studies, 
including our previous analyses on this sample (Cheung et al., 2016, Michelini et al., 2016a), 
reporting that executive-functioning measures were insensitive to ADHD outcomes in 
adolescence and adulthood (Pazvantoglu et al., 2012, Biederman et al., 2009, McAuley et al., 
2014, Cheung et al., 2016, Michelini et al., 2016a). They also partially align with results from a 
previous resting-state connectivity fMRI study, which found over-connectivity in remitters 
compared to controls and no differences between remitters and persisters (Francx et al., 2015a). 
A clinical implication is that connectivity impairments in executive-control processes may not be 
suitable targets for interventions for ADHD, consistent with previous evidence of no effects of 
stimulants on EEG connectivity in ADHD (Clarke et al., 2005, Dupuy et al., 2008). Future EEG 
studies should examine whether connectivity during less effortful activities, such as rest or non-
executive processes, represent markers of remission, similar to cognitive-EEG measures of non-
executive processes in our previous studies (Cheung et al., 2016, James et al., 2017, Michelini et 
al., 2016a). 
 
Of note, while widespread group differences emerged in correctly-responded trials, group 
differences in error trials, likely representing a failure of cognitive control, emerged only in three 




responses may suggest that a failure in brain connectivity may attenuate the differences in 
brain-network profiles of neurotypical individuals from individuals with ADHD, who are prone 
to making more incorrect responses (Michelini et al., 2016a). In addition, all groups showed 
greater connectivity before and during incorrect responses than correct responses. A 
suboptimal pattern of pre-stimulus and post-stimulus over-connectivity underlying cognitive 
control processes may thus lead to a dysfunctional behavioural response, both in neurotypical 
individuals and in individuals with childhood ADHD. Future family model-fitting analyses (James 
et al., 2016) will investigate the phenotypic and aetiological associations between brain 
connectivity and cognitive-performance impairments in ADHD, which will provide new insights 
into the inter-relationships between these impairments. 
 
A limitation of this study is that, despite the large sample, the low ADHD remission rate at follow-
up resulted in a relatively small group of remitters. Therefore, we could not exclude the 
possibility that some non-significant group differences could be due to low power. However, the 
moderate effect sizes (d=0.38-0.53) between ADHD remitters and controls, but negligible or 
small (d=0.02-0.36) between remitters and persisters, in measures showing ADHD persister-
control differences suggest that we had sufficient power to detect, with the current sample 
sizes, differences in connectivity with at least moderate effect sizes. In addition, our sample 
included young adults as well as adolescents, who are still undergoing rapid cortical maturation. 
While analyses controlled for age, future follow-up assessments with participants having 
reached adulthood could provide further insight into developmental patterns. Finally, while the 
current EEG connectivity analyses allowed precise temporal resolution and connectivity 
estimates unaffected by volume-conduction artefacts, the relatively poor spatial resolution of 
scalp-EEG did not allow precise localisation of the brain networks. Yet, results of local 
connectivity within and between cortical regions were consistent with those of whole-brain 
analyses, indicating comparable effects in more localised networks. 
 
In conclusion, we report new evidence of shared atypical connectivity profiles in adolescents 
and young adults with persistent and remitted ADHD. These connectivity alterations may 
represent enduring deficits and neural signatures associated with having a history of childhood 
ADHD, but unrelated to current diagnostic status. Connectivity impairments underlying 
executive processes may represent associated characteristics or risk factors in ADHD (Johnson, 
2012), which do not follow the developmental pathways of clinical profiles. Future studies 
should explore the presence of potential compensatory mechanisms in individuals with remitted 




processes (Cheung et al., 2016, James et al., 2017, Michelini et al., 2016a), despite persistence 





CHAPTER 4 - The aetiological structure of cognitive-
neurophysiological impairments in ADHD in adolescence 





Background: Adolescents and adults with attention-deficit/hyperactivity disorder (ADHD) show 
multiple cognitive-neurophysiological impairments. Previous studies in children with ADHD have 
identified two partially-separable familial factors underlying cognitive dysfunction, but evidence 
in adolescents and adults is lacking. Here, we investigate the aetiological structure of cognitive-
neurophysiological impairments in ADHD in adolescence and young adulthood. Methods: In a 
sample of 356 participants from ADHD and control sibling pairs (mean age: 18 years, range: 11-
27 years), factor analyses and multivariate familial models were run on data on IQ, digit span 
forward (DSF), digit span backward (DSB), and cognitive-performance and event-related 
potential (ERP) measures from a cued continuous performance task, an arrow-flanker task and 
a four-choice reaction time task. Results: Three familial factors (cF1-3) were identified, which 
captured the familial covariation of ADHD with nine cognitive-ERP measures. cF1 loaded on IQ, 
mean reaction time (MRT) and reaction time variability (RTV); cF2 on DSF and DSB; and cF3 on 
number of errors and ERPs of inhibition and error processing. All three factors showed significant 
familial overlap with ADHD (rcF1-ADHD=.50; rcF2-ADHD=-.36; rcF3-ADHD=-.66). Non-familial influences 
showed the same factor structure, except for IQ that clustered with digit span measures. Non-
familial influences on MRT and RTV largely overlapped with those on ADHD, while other non-
familial effects were largely measure-specific. Conclusions: Three partially separable familial 
factors substantially accounted for the phenotypic association between cognitive-
neurophysiological measures and ADHD in adolescence and adulthood. These results identify 








The majority of children clinically diagnosed with ADHD continue to meet ADHD diagnostic 
criteria in full or in partial remission in adolescence and adulthood (Biederman et al., 2009, 
Cheung et al., 2015, van Lieshout et al., 2016b, Karam et al., 2015, Faraone et al., 2006). In 
addition to symptoms of inattention and hyperactivity-impulsivity, adolescents and adults with 
ADHD typically show the same wide range of impairments in multiple cognitive functions that 
also characterise children with this disorder (Cheung et al., 2016, Kuntsi et al., 2010, Uebel et 
al., 2010, Hervey et al., 2004). For example, deficits in executive processes, such as inhibition 
and working memory, and in non-executive processes, such as preparation-vigilance 
impairments, have been found in individuals with ADHD in adolescence and adulthood (Hervey 
et al., 2004, Mostert et al., 2015, Cheung et al., 2016). The investigation of brain activity during 
cognitive tasks has further revealed widespread neurophysiological impairments, such as 
atypical brain activity during error processing, attentional allocation and response inhibition, in 
adolescents and adults with ADHD (Michelini et al., 2016b, Cheung et al., 2016, McLoughlin et 
al., 2009, Woltering et al., 2013, Groom et al., 2010a). The evidence of multiple cognitive and 
brain abnormalities in ADHD has contributed to a shift in the theoretical understanding of the 
disorder: from models that propose the existence of a single deficit, for example in inhibition 
(Barkley, 1997), as responsible for the multiple cognitive impairments, to models that argue for 
multiple underlying factors and pathways to ADHD (Castellanos and Proal, 2012, Halperin and 
Schulz, 2006, Johnson, 2012). 
 
Twin and family studies have consistently reported high genetic/familial influences and limited-
to-no role of the shared environment on ADHD (Faraone et al., 2005, Burt et al., 2012). In 
childhood, the genetic/familial influences on ADHD also show strong overlap with those on 
cognitive impairments (Andreou et al., 2007, Frazier-Wood et al., 2012, Kuntsi et al., 2010, Wood 
et al., 2010, Wood et al., 2011). Sibling studies have revealed two partially separable familial 
factors underlying the structure of cognitive impairments in ADHD in children, one capturing 
reaction time variability (RTV) and another capturing executive function, such as response 
accuracy (Kuntsi et al., 2010) and working memory (Frazier-Wood et al., 2012). IQ may also 
represent a separate process, as the genetic/familial effects that ADHD shares with IQ are largely 
separate from those that ADHD shares with other cognitive impairments (Wood et al., 2010, 
Wood et al., 2011, Rommelse et al., 2008c). Although ADHD persists in a significant number of 




similar aetiological structure and share familial influences with ADHD in adolescents and adults 
is still unknown. 
 
In our recent follow-up study of adolescents and young adults with a childhood combined-type 
ADHD diagnosis, we found a separation between impairments in cognitive and brain function 
processes in relation to ADHD outcomes (persistence/remission) at follow-up. Cognitive and 
neurophysiological measures of preparation-vigilance processes (e.g., RTV, omission errors, 
ERPs of response preparation), error detection and IQ were uniquely linked to ADHD 
persistence/remission at follow-up (Cheung et al., 2016, Michelini et al., 2016a, James et al., 
2017), as individuals with persistent ADHD, but not with remitted ADHD, showed impairments 
in these measures. IQ in childhood further predicted ADHD persistence/remission, suggesting 
that IQ may represent a moderator of outcome (Cheung et al., 2015). In contrast, executive 
function measures (e.g., working memory and inhibition), despite being sensitive to 
impairments in ADHD persisters, were unrelated to ADHD outcome, as individuals with 
persistent and remitted ADHD were indistinguishable on these measures (Cheung et al., 2016, 
Michelini et al., 2016a). Overall, we proposed that, in adolescents and young adults with ADHD, 
cognitive-neurophysiological impairments may reflect three processes: (1) markers of 
persistence/remission (e.g., preparation-vigilance measures), (2) processes that are not 
associated with ADHD outcome (executive function), and (3) potential moderators of ADHD 
outcome (IQ) (Cheung et al., 2016). All three processes were impaired in adolescents and adults 
with persistent ADHD, suggesting a possible phenotypic separation of impairments in these 
three cognitive-neurophysiological processes in persistent ADHD. Yet, it remains unclear 
whether one or multiple aetiological factors underlie the association between such impairments 
and the disorder, as no study to date has examined the aetiology of multiple cognitive and brain 
impairments in adolescent and adult ADHD.  
 
The present study aims to investigate, for the first time, the aetiological structure underlying 
cognitive-neurophysiological processes in ADHD in adolescence and early adulthood, in our 
follow-up of individuals from ADHD and control sibling pairs initially assessed in childhood 
(Kuntsi et al., 2010, Andreou et al., 2007, Wood et al., 2011, Wood et al., 2009). In previous 
analyses at follow-up, we found a broad range of impairments in cognitive and brain functions 
in individuals with persistent ADHD compared to controls (Cheung et al., 2016, Michelini et al., 
2016a, Cheung et al., 2017). Here, we aim to take the most comprehensive approach to date in 
examining whether one or multiple aetiological processes underlie such impairments with 




in children (Frazier-Wood et al., 2012, Kuntsi et al., 2010, Wood et al., 2011), multiple and 
partially separable aetiological processes would account for the presence of impairments in 







The sample consisted of 404 participants, including 226 participants from ADHD sibling pairs 
(each including one DSM-IV ADHD proband and one affected or unaffected sibling) and 178 
participants from control sibling pairs (both without ADHD) who had taken part in our previous 
research (Kuntsi et al., 2010, Chen et al., 2008) (for further details on the sample, see Appendix 
C). At initial assessment (age range: 6-17 years), ADHD participants recruited from specialist 
clinics and their closest-age siblings were invited to participate. Control participants were 
recruited from schools. At follow-up, which took place on average 5.8 years after the childhood 
assessment, 30 childhood ADHD probands were excluded for no longer meeting DSM-IV ADHD 
criteria (n=25), not having combined-type ADHD in childhood (n=3), or due to EEG equipment 
failure (n=2). Nine siblings of ADHD probands were excluded as they were unaffected in 
childhood but met DSM-IV ADHD criteria at follow-up (n=3) or their diagnostic status could not 
be determined due to missing parent-reported data on impairment (n=6). Nine controls were 
excluded due to meeting ADHD criteria at follow-up based on parent-reported ADHD ratings 
(Barkley Informant Rating Scale; Barkley and Murphy, 2006). The final sample for analyses 
consisted of 87 individuals with persistent ADHD and 100 unaffected siblings (69 full pairs, 49 
singletons), and 169 control siblings (76 full pairs, 17 singletons) (Table 4.1). Among participants 
with persistent ADHD, 60% (n=52) met criteria for the combined subtype, 32% (n=28) met 
criteria for predominantly inattentive subtype and 8% (n=7) met criteria for predominantly 
hyperactivity-impulsivity subtype at follow-up. Written informed consent was obtained from all 
participants and the study was approved by the London-Surrey Borders Research Ethics 


























p p p 
Sex 
(M:F) 
72:15 43:57 129:40 <.001 .21 <.001 <.001 
Age 18.31 
(3.03) 
18.56 (3.33) 17.75 
(2.17) 
.08 .14 .53 .03 
Abbreviations: ADHD, attention deficit hyperactivity disorder; F, female; M, male. 
Notes: Significant (p<0.05) differences are indicated in bold. Group differences on sex were tested 
via Chi-square test; group differences on other measures were tested with linear regressions. 
Group differences between ADHD and control participants were reported in previous analyses on 







4.3.2 ADHD diagnosis 
 
ADHD diagnostic status in ADHD sibling pairs was assessed with the Diagnostic Interview for 
ADHD in Adults (DIVA) (Ramos-Quiroga et al., 2016), a semi-structured interview designed to 
evaluate the DSM-IV criteria for childhood and adult ADHD. Evidence of impairment commonly 
associated with ADHD was assessed with the Barkley’s functional impairment scale (BFIS) 
(Barkley and Murphy, 2006), by trained researchers, along with the DIVA during interviews with 
parents. A separate interview was conducted with the ADHD probands and their siblings. Parent-
report DIVA and impairments were used to determine ADHD status, as these were validated 
against objective markers (cognitive-performance and EEG measures) in this sample, whereas 
the same objective markers showed limited agreement with self-reported ADHD (Du Rietz et al., 
2016). ADHD symptoms were assessed in control participants using the parent-rated Barkley 




Participants attended a single 4-hour research session (including breaks) for IQ, digit span and 
cognitive–EEG assessments (Table 4.2). For each sibling pair in both ADHD and control groups, 
one of the siblings was administered the IQ and digit span assessment, followed by a battery of 
three cognitive-EEG tasks, and vice versa for the other sibling. This was counterbalanced by 
proband-sibling group. The three tasks in the cognitive-EEG battery were administered in the 
same order. For those prescribed stimulants (n=52), a 48-hour ADHD medication-free period 
was required prior to cognitive-EEG assessments.  
 
4.3.4 Electrophysiological recording and analysis  
 
The EEG was recorded from a 62 channel DC-coupled recording system (extended 10–20 
montage), using a 500 Hz sampling-rate, impedances under 10 kΩ, and FCz as the recording 
reference. The electro-oculograms (EOGs) were recorded from electrodes above and below the 
left eye and at the outer canthi. EEG data were analysed using Brain Vision Analyzer 2.0 (Brain 
Products, Germany). Raw EEG recordings were down-sampled to 256 Hz, re-referenced to the 
average of all electrodes, and filtered using Butterworth band-pass filters (0.1-30 Hz, 24 dB/oct). 
Electrical or movement artefacts were removed following visual inspection. Ocular artefacts 
were corrected using the infomax Independent Component Analysis (ICA) algorithm (Jung et al., 




were automatically rejected. ERPs were extracted from the CPT-OX (Cue-P3, CNV, NoGo-P3), 
arrow flanker task (N2, ERN, Pe in the incongruent condition) and Fast task (P3 in the baseline 
condition) following procedures used in previous analyses on this sample (Cheung et al., 2016, 











Table 4.2. Short description of the tasks included in the cognitive assessment and cognitive-EEG battery 
Task name Description Measures extracted from the task 
Wechsler Abbreviated Scale of 
Intelligence (WASI) (Wechsler, 1999) 
The vocabulary and block design subtests were used to derive an estimate of IQ. Total IQ. 
Digit span subtest from Wechsler 
Intelligence Scale for Children 
(WISC-III) (Wechsler, 1991), or the 
Wechsler Adult Intelligence Scale 
(WAIS-III) (Wechsler, 1997) 
The digit span subtest from the WISC-III or the WAIS-III was administered to 
participants aged below 16 and aged 16 or above, respectively, to obtain digit span 
forward (DSF) and backward (DSB). The forward test measures short-term verbal 
memory, while the backward test is a measure of working memory. 
DSF, DSB. 
Cued Continuous Performance Test 
(CPT-OX) (Doehnert et al., 2008, 
Valko et al., 2009) 
The CPT-OX task consists of 400 letter arrays formed of a centre letter with 
incompatible flankers on each side, and probes attention, preparation and response 
inhibition. Stimuli are presented for 150ms with a SOA (stimulus onset asynchrony) 
of 1.65s in a pseudorandomised order at the centre of a computer monitor. The task 
involves the presentation of 80 Cues (XOX) followed either by 40 Go (OXO) and 40 
NoGo (XDX) stimuli, alternated with random letter arrays as distractors. Participants 
are instructed to respond only to Cue-Go sequences, and to withhold the response 
in presence of a NoGo stimulus, of a Go not preceded by a Cue (40 trials), or of any 
other irrelevant letters. Task duration was approximately 11 min. 
Cognitive performance: mean 
reaction time (MRT), reaction time 
variability (RTV, i.e. SD of RTs), 
commission errors (CE, i.e. response 
to NoGo), omission errors (OE, i.e. 
non-response to Go). 
ERPs: Cue-P3 (attentional orienting), 
CNV (response preparation) and 
NoGo-P3 (response inhibition). 
Eriksen Arrow Flanker Task (Albrecht 
et al., 2008, McLoughlin et al., 2009) 
This performance monitoring task is an adaptation of the Eriksen Flanker paradigm 
designed to increase cognitive load for adults. In each trial, a central black fixation 
mark was replaced by a target arrow. Participants are instructed to indicate whether 
Cognitive performance: MRT, RTV 
and number of errors (left-right 











this arrow points towards the left or right by pressing corresponding response 
buttons with their left or right index fingers. Two flanker arrows identical in shape 
and size to the target appear above and below the centre of the target arrow 100ms 
prior to each target arrow. Both flankers either point in the same (congruent) or 
opposite (incongruent) direction to the target. Conflict monitoring is maximal during 
the incongruent condition. When the target appears, both target and flankers 
remain on the screen for a further 150ms, with a new trial being presented every 
1.65s. Trials were arranged in ten blocks of 40 trials. Task duration was 
approximately 13 min.  
chose the wrong response); all 
obtained separately for congruent 
and incongruent conditions. 
ERPs: N2 (conflict monitoring), ERN 
(automatic error processing) and Pe 
(conscious error processing), all 
obtained from the incongruent 
condition only. 
Fast task (Andreou et al., 2007) This is a four-choice reaction time task probing attentional processes. In a baseline 
(slow, unrewarded) condition (72 trials), four empty circles (warning signals, 
arranged horizontally) first appear for 8s, after which one of them (the target) is 
coloured in. Participants are instructed to press the response key that directly 
corresponds to the position of the target. Following a response, the stimuli 
disappear from the screen and a fixed inter-trial interval of 2.5s follows. Speed and 
accuracy are emphasized equally. If the participant does not respond within 10s, the 
trial terminates. The baseline condition lasts approximately 15 min. A comparison 
condition (80 trials) with a fast event rate (1s) and incentives follows the baseline 
condition. The fast-incentive condition lasts approximately 5 min. 
Cognitive performance: MRT, RTV 
from the baseline condition (more 
sensitive to ADHD; Kuntsi and Klein, 
2012, Kuntsi et al., 2013). 
ERPs: P3 (attentional allocation) from 
the baseline condition. 
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4.3.5 Statistical analyses 
 
4.3.5.1 Multivariate sibling-data model fitting 
Sibling-data model fitting was accomplished by structural equation modelling (SEM) analyses 
using the OpenMx package in R (Boker et al., 2011). Since siblings share on average 50% of their 
segregating genes and 100% of the common environment, we can decompose the 
variance/covariance of traits into contributions of familial influences (the combined effects of 
shared genetic and shared environmental effects) and non-familial influences (individual-
specific effects and possible measurement error) (Kuntsi et al., 2010, Cheung et al., 2012). 
Sibling-pair data allow us to derive: phenotypic correlations in each sibling, e.g., correlation 
between IQ and ADHD, constrained across birth order; cross-sibling/within-trait correlations, 
e.g., correlation between sibling 1 and sibling 2 for IQ; and cross-sibling/cross-trait correlations, 
constrained such that, for example, correlations between IQ in sibling 1 and ADHD in sibling 2 
equals the correlation of IQ in sibling 2 and ADHD in sibling 1. The cross-sibling/within-trait and 
the cross-sibling/cross-trait correlations allow to estimate, respectively, the familial variance of 
a trait and the familial overlap between traits. Given the selected nature of this sample (selection 
of ADHD probands), ADHD status was included in all models with its parameters fixed to 
population-known values, based on previous evidence and consistent with our previous work 
(Cheung et al., 2012, Frazier-Wood et al., 2012, James et al., 2016, Kuntsi et al., 2010): the cross-
sibling/within-trait correlation (correlation between siblings in each pair) was fixed to 0.40 
(Chang et al., 2013, Larsson et al., 2014); the familiality to 0.40 (representing 80% genetic 
variance in case of null shared environmental effects) (Larsson et al., 2013); and prevalence of 
5% (Willcutt, 2012) (z score set at 1.64). For further explanation of this approach see Appendix 
C and Rijsdijk and colleagues (2005). A liability threshold model framework, which assumes that 
the liability of ADHD is underpinned by a normally distributed continuum of risk (Rijsdijk and 
Sham, 2002, Rijsdijk et al., 2005), was used to account for the fact that ADHD was measured as 
present/absent. Model-fitting analyses were performed with raw data maximum likelihood 
estimation incorporating all available data points (thus allowing no listwise/pairwise deletion 
when data in sibling pairs were missing).  
 
4.3.5.2 Preliminary analyses and variable selection 
Preliminary constrained correlation bivariate models between ADHD and 22 cognitive-ERP 
variables extracted from our large cognitive-neurophysiological battery (sensitive to ADHD-
control differences in this sample; Cheung et al., 2016, Michelini et al., 2016a, Cheung et al., 
2017) were carried out to reduce the number of variables included in multivariate models. This 
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variable selection step was necessary due to the limit in the number of variables that can be 
included in multivariate SEM (Kuntsi et al., 2010, Loken et al., 2014). A phenotypical association 
with ADHD, and an evidence of familial effects, are prerequisites to any familial overlap between 
two variables. As such, cognitive-ERP variables were only included if they had (1) a phenotypic 
correlation with ADHD above the threshold of 0.20, corresponding to modest-to-large effect 
sizes (Cohen, 1988), and (2) significant cross-sibling/within-trait correlations, indicating 
similarity between siblings (Table S4.1, Appendix C).  
 
Following preliminary analyses, nine variables were included with ADHD status in multivariate 
models: IQ, DSF, DSB, ERN (Figure S4.2, Appendix C) and congruent errors (CongE) from the 
arrow flanker task, NoGo-P3 (Figure S4.3, Appendix C) and OE from the CPT-OX, and MRT and 
RTV from the Fast task (baseline condition) (Table S4.2, Appendix C). ERN, NoGo-P3 and MRT 
were transformed to normality using square root, while RTV was log-transformed. IQ, DSF and 
DSB residuals were normally distributed. These measures were included as continuous variables. 
OE and CongE were highly skewed and could not be normalised using any transformation 
methods. They were therefore modelled as ordinal using 3 and 4 equal-sized categories, 
respectively. Age and sex were controlled for in all analyses as is standard practice for family 
model-fitting studies (McGue and Bouchard, 1984), by regressing out age and sex effects from 
continuous variables (before transforming to normality) and estimating age and sex effects on 
the mean for ordinal variables.  
 
4.3.5.3 Cholesky and factor models 
A multivariate Cholesky decomposition (Rijsdijk and Sham, 2002) was used to decompose the 
variance/covariance structure of the cognitive-ERP variables and ADHD into familial and non-
familial influences. The correlated factors solution of this decomposition yielded familial and 
non-familial correlation matrices between all variables, which provide the degree of overlap 
between aetiological influences between two variables at a time (e.g., IQ and ADHD). We 
examined the aetiological factor structure underlying cognitive-ERP variables and ADHD in a 
more parsimonious model, following a two-step approach employed in previous work (Kuntsi et 
al., 2010, Frazier-Wood et al., 2012). Firstly, the derived familial and non-familial correlations 
between the nine cognitive-ERP variables were used as input to two separate exploratory factor 
analyses (EFAs) in R to extract the factor structure (Appendix C). Separate EFAs were carried out 
on the familial and non-familial correlations between the nine cognitive-ERP variables. This 
allowed detection of possible differences between the familial and non-familial effects on the 
number of extracted factors or in how they load on variables. Three factors with an eigenvalue 
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>1 were identified in both EFAs (Figure S4.1, Appendix C). Each factor explained >10% of the 
total variance in either EFA (Table S4.3, Appendix C). Since cognitive-ERP variables mapped onto 
cognitive processes which are likely to be interrelated (Kovas and Plomin, 2006, Jewsbury et al., 
2016), we allowed the extracted factors to correlate by applying an oblique (oblimin) rotation 
(Gerbing and Hamilton, 1996, Widaman, 1993).  
 
Secondly, we specified the three factors, their correlations and loadings (Table S4.3, Appendix 
C) separately for familial and non-familial influences in a confirmatory 3-factor model, including 
also ADHD, using OpenMx. Familial and non-familial paths from the extracted common factors 
were specified for each variable from the factor with strongest loading in the EFAs, while ADHD 
and its fixed familial and non-familial influences were modelled separately (Figure 4.1). Familial 
common paths on DSF and DSB, as well as non-familial common paths on MRT and RTV, were 
constrained to be equal for model identification purposes. Correlation paths were specified 
among each factor loading on cognitive-ERP measures and ADHD. The residual variance of 
cognitive-ERP variables not accounted for by common factors was measured by variable-specific 





4.4.1 Phenotypic correlations 
 
Phenotypic correlations between cognitive-ERP variables and ADHD were all significant, with 
positive correlations ranging from 0.17 to 0.88 and negative correlations from -0.19 to -0.39 
(Table 4.3). The only non-significant correlation was between ERN and DSF (rPh=0.12, CIs: -0.01; 
0.27). ADHD showed moderate negative correlations with IQ, DSF, DSB, ERN, NoGo-P3, and 
moderate positive correlations with MRT, RTV, OE and CongE.  
 
4.4.2 Multivariate Cholesky decomposition 
 
Familial correlations of ADHD with IQ, DSB, RTV, OE and CongE were significant and moderate-
to-large, and moderate but non-significant with DSF, ERN, NoGo-P3 (Table 4.3). Non-familial 
correlations of ADHD with IQ, ERN, NoGo-P3, MRT, RTV, OE and CongE were modest and 








Table 4.3. Phenotypic, familial and non-familial correlations between study variables  
Phenotypic  IQ DSF DSB ERN NoGo-P3 MRT RTV OE CongE ADHD 
IQ 1          
DSF 
0.40 

































































































           
           







           
Familial IQ DSF DSB ERN NoGo-P3 MRT RTV OE CongE ADHD 
IQ 1          
DSF 
0.50 











































































































Non-familial IQ DSF DSB ERN NoGo-P3 MRT RTV OE CongE ADHD 
IQ 1          
DSF 
0.31 

































































































Abbreviations: ADHD, attention-deficit/hyperactivity disorder; CongE, errors in the congruent condition of the flanker task; DSB, digit span backward; DSF, digit 
span forward; ERN, error-related negativity amplitude from the flanker task; IQ, intelligence quotient; MRT, mean reaction time from the Fast task; NoGo-P3, P3 
amplitude in the NoGo condition from the cued continuous performance test; OE, omission errors from the cued continuous performance test; RTV, reaction time 
variability from the Fast task. 
Note: Significant (p<0.05) correlations are indicated in bold. 
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4.4.3 Multivariate factor model 
 
Three familial and three non-familial factors emerged from EFAs, explaining the association 
between the nine cognitive-ERP variables (Figure S4.1, Appendix C). This factor structure 
informed the confirmatory factor model, which provided the best fit to the data (Table S4.4, 
Appendix C). The first familial factor (cF1) loaded onto IQ, MRT and RTV; the second factor (cF2) 
onto DSF and DSB; and the third factor (cF3) onto ERN, NoGo-P3, OE and CongE (Figure 4.1). The 
three familial factors accounted for most of the familial variance on cognitive-ERP measures, as 
variable-specific familial influences were in general low and non-significant, apart from those on 
DSF (0.13; 30% of familial variance) and NoGo-P3 (0.21; 81% of familial variance) (Table 4.4). The 
familial factors showed high inter-correlations and moderate-to-high correlations with familial 
influences on ADHD (Figure 4.1). 
 
The factor structure of non-familial influences resembled that of familial influences, except for 
IQ which loaded on the same factor capturing DSF and DSB (Figure 4.1). The majority of the non-
familial variance of most cognitive-ERP measures was not explained by these three factors (cNf1-
3), but by specific influences, apart from MRT and RTV which were more strongly influenced by 
a common non-familial factor (cNf1) (Table 4.4). The non-familial factors showed moderate-to-
high inter-correlations and moderate correlations with non-familial influences on ADHD. The 
phenotypic correlation between each cognitive-ERP variable and ADHD was explained to a 





Figure 4.1. Confirmatory Factor model between cognitive-ERP variables and ADHD  
Notes: Significant (p<.05) parameters are indicated with solid lines and nonsignificant 




Table 4.4. Factor structure and standardised familial (F) and non-familial (Nf) variance of 
cognitive-ERP measures, also split up by contribution of each factor and of specific (residual) 
effects, with 95% confidence intervals in brackets 
 Total Common F1 Common F2 Common F3 Specific 
 Familial influences 
IQ .49 (.38;.59) .41 (.24;.57)   .08 (.00;.24) 
DSF .43 (.31;.54)  .30 (.20;.40)  .13 (.02;.24) 
DSB .33 (.22;.43)  .33 (.22;.43)  .00 (.00;.00) 
ERN .17 (.02;.32)   .09 (.01;.22) .08 (.00;.21) 
NoGo-P3 .26 (.11;.40)   .05 (.01;.14) .21 (.08;.34) 
MRT .24 (.12;.37) .22 (.18;.34)   .02 (.00;.06) 
RTV .22 (.10;.35) .22 (.10;.35)   .00 (.00;.00) 
OE .30 (.10;.45)   .30 (.10;.47) .00 (.00;.00) 
CongE .20 (.05;.39)   .09 (.01;.22) .11 (.00;.25) 
 Non-familial influences 
IQ .51 (.41;.62)  .19 (.09;.33)  .32 (.19;.30) 
DSF .57 (.46;.69)  .17 (.08;.30)  .40 (.27;.52) 
DSB .68 (.57;.78)  .20 (.09;.33)  .48 (.37;.58) 
ERN .83 (.68;.98)   .19 (.08;.31) .64 (.49;.80) 
NoGo-P3 .74 (.61;.89)   .18 (.08;.31) .56 (.42;.72) 
MRT .76 (.63;.88) .67 (.54;.79)   .10 (.04;.15) 
RTV .78 (.65;.89) .64 (.53;.76)   .14 (.08;.19) 
OE .70 (.55;.90)   .16 (.06;.32) .54 (.38;.68) 
CongE .80 (.61;.95)   .32 (.16;.52) .48 (.31;.67) 
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; Common F1-F3, the standardised 
variance of each variable explained by familial and non-familial factors; CongE, errors in the 
congruent condition of the flanker task; DSB, digit span backward; DSF, digit span forward; ERN, 
error-related negativity amplitude from the flanker task; IQ, intelligence quotient; MRT, mean 
reaction time from the Fast task; NoGo-P3, P3 amplitude in the NoGo condition from the cued 
continuous performance test; OE, omission errors from the cued continuous performance test; 
RTV, reaction time variability from the Fast task; Specific, measure-specific standardised variance 
due to familial and non-familial influences; Total, total standardised variance of each variable 
due to familial and non-familial influences. 





This study represents the first comprehensive investigation to date, using a broad range of 
cognitive-performance and brain activity (EEG) measures, into the aetiology underlying 
cognitive-neurophysiological impairments in ADHD that has persisted from childhood to 
adolescence and early adulthood. We identified three familial and three non-familial factors 
underlying the association between impairments in these measures and ADHD. The familial 
factors captured: (1) response speed (MRT) and variability (RTV), and IQ; (2) short-term (DSF) 
and working (DSB) memory; and (3) sustained attention (OE, CongE), error processing (ERN) and, 
to a smaller extent, response inhibition (NoGo-P3). Familial influences on ADHD overlapped 
strongly with both the first and third factors; but only moderately with the memory (second) 
factor. The same number of factors emerged for non-familial influences, with the only exception 
that IQ clustered with memory rather than RT measures. These findings identify multiple 
partially separable aetiological processes that underlie cognitive-neurophysiological 
impairments in persistent ADHD, extending our understanding of the aetiological pathways to 
widespread cognitive and brain dysfunction in ADHD in adolescence and adulthood. 
 
Our results show substantial shared familial influences between cognitive-neurophysiological 
impairments and ADHD in adolescents and young adults. The factor model further indicates that 
the association between these impairments and ADHD (rcF1-ADHD=.50; rcF2-ADHD=-.36; rcF3-ADHD=-.66) 
may underlie multiple familial processes. The factor structure for familial effects pointed to a 
separation between a factor capturing IQ and RT performance (cF1), a factor capturing memory 
performance (cF2), and a factor capturing accuracy (number of errors) and brain activity of 
inhibitory/error-detection processes (cF3). The separation between factors indicates that the co-
occurring presence of impairments captured by the same factor could be largely explained by 
shared familial influences. For example, the finding that one familial factor captured both IQ and 
RT performance indicates a strong familial association between these measures (more than with 
other measures) in adolescents and adults. Conversely, impairments that are captured by two 
separate factors may be driven by at least partially separate familial pathways. A dissociation of 
this kind is shown for memory and RT performance, indicating that impairments in these 
processes may result from partly independent aetiological pathways. In addition, to our 
knowledge, this is the first family model-fitting study that simultaneously investigated multiple 
cognitive and brain measures to obtain a deeper understanding of ADHD. Our results provide 
new insights into how cognitive-performance impairments (omission and congruent errors) are 
aetiologically associated with neural processes of error detection (ERN) and response inhibition 
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(NoGo-P3), as these four measures clustered in one factor. As such, the aetiological factors 
underlying atypical brain activity of inhibitory and error-detection processes may overlap with 
those linked to task accuracy indices of sustained attention deficits. The familial factor capturing 
these four measures (cF3) also overlapped with two thirds of the familial influences on ADHD 
(rcF3-ADHD=-.66), indicating a strong aetiological association between this cognitive-EEG factor and 
the disorder.  
 
More generally, our results point to a multifactorial structure of impairments in cognitive and 
brain function in ADHD, in line with models on ADHD proposing that cognitive and brain 
dysfunction in the disorder may arise from multiple pathways (Castellanos and Proal, 2012, 
Halperin and Schulz, 2006, Johnson, 2012). This multifactorial structure may explain the 
observed individual differences in cognitive profiles that exist among adolescents and adults 
with ADHD, who may display various degrees of impairments in different cognitive domains 
(Mostert et al., 2015). A possible clinical implication of these findings is that future efforts to 
implement new treatments for ADHD could consider including various intervention 
components, each targeting these different cognitive processes. Given the partial aetiological 
dissociation between the identified cognitive clusters in ADHD, impairments in these factors 
may have different roles in relation to ADHD pathophysiology. For example, it may be that only 
some impairments represent mediators lying on the causal pathways to ADHD, while others may 
only represent associated characteristics (Kendler and Neale, 2010). This partial dissociation 
between these processes should be considered in future research efforts aiming to examine the 
role of these impairments in the pathways to ADHD. 
 
Our study provides new evidence on the aetiological processes underlying impairments in 
cognitive and brain function in ADHD adolescence and adulthood. These findings are largely 
consistent with two earlier findings in childhood (Kuntsi et al., 2010, Frazier-Wood et al., 2012). 
First, the separation of the factor capturing RT performance from the factor capturing response-
accuracy measures is consistent with the separation between one factor capturing MRT/RTV 
from another factor capturing omission/commission errors found in a multi-site study which 
included data from the sample of the current study in childhood (Kuntsi et al., 2010). Second, 
the separation between aetiological influences on RT and memory performance in adolescents 
and young adults is further consistent with another study in children where RTV and working 
memory were captured by two different factors (Frazier-Wood et al., 2012). Differences 
between this analysis and previous childhood studies were also observed in the extent of the 
aetiological overlap among IQ, RT performance and ADHD. In the present study, IQ and RTV/MRT 
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were captured by a single familial factor (cF1) highly correlated with ADHD, suggesting 
substantial overlap in familial variance between these measures. The previous analyses in 
childhood, however, found a separation of genetic/familial influences on IQ from influences on 
ADHD and other cognitive impairments (Wood et al., 2010, Wood et al., 2011, Rommelse et al., 
2008c), suggesting that IQ may represent a separate process. For example, two studies in 
children reported that the majority (66-81%) of the genetic/familial influences on IQ were 
independent of those shared between RT impairments and ADHD (Wood et al., 2010, Wood et 
al., 2011). Previous analyses on this sample, however, also indicate that lower IQ, both in 
childhood and at follow-up, predicted ADHD persistence (Cheung et al., 2015, Cheung et al., 
2016). As such, one possible explanation for the substantial overlap in familial influences 
between IQ and ADHD in this older age group is that IQ is a potential moderator of ADHD 
outcome from childhood to adolescence and adulthood. Future longitudinal analyses are 
needed to elucidate these developmental associations between ADHD and impairments in 
cognitive and neural processes throughout the development.  
 
It is of interest to note that the separation of familial factors was similar to the distinct processes 
underlying ADHD persistence and remission previously reported in phenotypic analyses on this 
sample (Cheung et al., 2016, Michelini et al., 2016a). Specifically, IQ/RT and attention/error-
processing measures, here captured by two factors with substantial familial sharing with ADHD, 
were associated with severity and persistence of ADHD in phenotypic analysis (Cheung et al., 
2016, Michelini et al., 2016a). One possible prediction from these findings is that, in individuals 
with persistent ADHD, these two factors may jointly contribute to the severity of ADHD and the 
presence of cognitive-neurophysiological impairments. Conversely, short-term and working 
memory (here captured by a familial factor that was only moderately overlapping with ADHD) 
and the response-inhibition NoGo-P3 (here mostly influenced by specific factors not shared with 
other variables or ADHD) were not sensitive to ADHD persistence/remission in our previous 
work, in that impairments in these measures did not distinguish individuals with persistent and 
remitted ADHD (Cheung et al., 2016). As such, we can hypothesise that impairments in short-
term/working memory and in brain activity of inhibition control may reflect separate enduring 
processes in ADHD associated with persistence of impairments in cognitive and brain function - 
regardless of severity of ADHD symptoms and impairment.  
 
Non-familial influences on ADHD showed moderate overlap with all three non-familial factors. 
Of note, the common factor cNf1 captured almost all of the non-familial variance shared 
between ADHD and RT measures, as limited residual variance was not shared with the disorder. 
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Conversely, the non-familial variance of IQ and short-term/working memory (cNf2), and of 
sustained attention and inhibitory/error-detection processes (cNf3) was largely measure-specific 
and not shared with ADHD. Non-familial influences include individual-specific environmental 
factors, representing any differences in the environment between siblings, and may include the 
effects of any treatment for ADHD. A possible prediction is that non-pharmacological 
interventions, for example cognitive training, aimed at alleviating ADHD symptoms may be more 
effective if they target RT rather than memory or response-accuracy processes. This prediction 
is in line with evidence suggesting that RTV may be more malleable than higher-level processes 
(Kuntsi et al., 2009) and may explain the low efficacy of treatments targeting working-memory 
impairments on ADHD (Cortese et al., 2015).  
 
The comprehensive investigation of impairments in cognitive and brain function, with both 
cognitive-performance and brain-activity measures, and application of sibling model-fitting 
analyses in a clinical sample are strengths of the current study. One limitation is that sibling data 
only allow the investigation of familial and non-familial effects, but cannot directly estimate the 
contribution of genetic factors. However, since previous research suggests a limited role of 
shared-environmental influences on either ADHD (Burt et al., 2012, Nikolas and Burt, 2010) or 
cognitive-neurophysiological markers (Anokhin et al., 2008, Kuntsi et al., 2013), the familial 
overlap between ADHD and such markers is expected to largely reflect genetic influences. Future 
twin studies are required to confirm this matter. In addition, the age range was wide in our 
sample. To allow the inclusion children with combined-type ADHD and their siblings at initial 
assessment, a wide age range was needed for adequate sample size and power for sibling 
analyses. This prevented us from examining whether the aetiological structure of impairments 
in ADHD may vary with age, as stratifying the analyses by age would have resulted in small 
samples for sibling analyses. Yet, since we controlled for age in all analyses, we can rule out that 
our results are confounded by age effects. Future studies using more restricted age ranges 
should examine these issues. 
 
In conclusion, by using a multivariate approach on a broad range of cognitive and 
neurophysiological measures, we have identified, for the first time in adolescents and young 
adults with ADHD, three partially separable factors that captured substantial familial influences 
(36-66%) on ADHD and impairments in cognitive and brain function, extending current 
knowledge from childhood to later development. The familial processes underlying both slower 
and more variable RTs and lower IQ in adolescents and young adults with ADHD may be partially 
distinct from familial influences on memory dysfunction and on impairments in sustained 
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attention and brain activity of inhibitory/error-detection processes. These partially distinct 
aetiological pathways may underlie dysfunctional brain networks which are, in turn, associated 
with impaired cognition and behaviour in the disorder. Future efforts should examine the 
developmental trajectories of these aetiological pathways, and test treatment effects on these 
partially separate cognitive-neurophysiological factors, which would refine causal models of the 
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5.3.2 Procedure and cognitive performance measures  
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5.3.3 Electrophysiological recording and analyses 
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CHAPTER 6 - Shared and disorder-specific event-related 
brain oscillatory markers of attentional dysfunction in 





Attention-deficit/hyperactivity disorder (ADHD) and bipolar disorder (BD) often present with 
overlapping symptoms and cognitive impairments, such as increased fluctuations in attentional 
performance measured by increased reaction time variability (RTV). In a direct 
electrophysiological comparison, we previously provided initial evidence of shared and distinct 
event-related potential (ERP) impairments in ADHD and BD, but the overlapping or specific 
neural mechanisms underlying attentional impairments in these disorders remain to be 
understood. Here, we aimed to further identify and compare the neural underpinnings of 
impaired attentional processes in ADHD and BD by examining event-related brain oscillations 
during a reaction time task under slow-unrewarded baseline and fast-incentive conditions. We 
measured cognitive performance, ERPs and brain-oscillatory modulations of power and phase 
variability in 20 women with ADHD, 20 women with BD (currently euthymic) and 20 control 
women. Compared to controls, both ADHD and BD groups showed increased RTV in the baseline 
condition and increased RTV, theta phase variability and lower contingent negative variation 
(CNV) in the fast-incentive condition. Unlike controls, neither clinical group showed an 
improvement from baseline to fast-incentive condition in attentional P3 amplitude or alpha 
power suppression. Most impairments did not differ between the disorders, as only an 
adjustment in beta suppression between conditions (lower in the ADHD group) distinguished 
between the clinical groups. These findings suggest shared impairments in women with ADHD 
and BD in cognitive and neural variability, preparatory brain activity and inability to adjust neural 
attention allocation and activation. The overlapping impairments in neural markers may 
represent shared neurobiological mechanisms of attentional dysfunction in ADHD and BD, and 







The abilities to regulate alertness and sustain attention are essential for efficient information 
processing and behaviour (Posner and Petersen, 1990). Such cognitive processes are 
traditionally measured with reaction time variability (RTV), capturing the consistency and short-
term fluctuations in response speed during attentional performance in cognitive tasks (Kuntsi et 
al., 2013, Ode et al., 2011). Increases in RTV are characteristic of several psychiatric disorders 
(Kaiser et al., 2008), including attention-deficit/hyperactivity disorder (ADHD) (Kofler et al., 
2013, Wood et al., 2010) and bipolar disorder (BD) (Brotman et al., 2009, Moss et al., 2016). 
ADHD and BD are common psychiatric conditions in adults (Merikangas et al., 2011, Willcutt, 
2012), which severely impact many aspects of individuals’ lives (Skirrow et al., 2012, Asherson 
et al., 2014). Although ADHD and BD represent distinct disorders, they present with common 
symptoms of distractibility and difficulty concentrating, which can lead to uncertainty regarding 
the boundaries of the two disorders (Asherson et al., 2014, Kitsune et al., 2016). These 
overlapping symptoms may reflect, at the cognitive level, the common fluctuations in 
attentional performance and increased RTV displayed by individuals with ADHD and BD (Kuntsi 
et al., 2014, Albaugh et al., 2017). Increased RTV is also observed in unaffected first-degree 
relatives of individuals with either disorder, compared to individuals without family risk, 
representing a candidate marker of genetic/familial risk for both disorders (Adleman et al., 2014, 
Thissen et al., 2014, Andreou et al., 2007). Direct comparisons of impairments in attentional 
performance between ADHD and BD may lead to new insights into the pathways to overlapping 
symptoms and cognitive dysfunction in both disorders. Yet, cross-disorder comparisons in ADHD 
and BD are limited to date (Michelini et al., 2016b, Torralva et al., 2011, Rommel et al., 2016). 
 
Previous research on RTV in psychiatric disorders has addressed the question of whether 
dysfunctions in alertness and attentional performance, rather than being stable, could be 
malleable and sensitive to context changes, such as task manipulations. RTV impairments in 
children and adolescents with ADHD are maximal in slow and unrewarded conditions, but with 
the introduction of faster event rate and incentives may improve significantly more than in 
neurotypical individuals (Andreou et al., 2007, Kuntsi et al., 2013, Cheung et al., 2017, Slusarek 
et al., 2001, Uebel et al., 2010). It remains unknown, however, whether RTV also improves in 
adults with ADHD. Initial evidence also indicates potential malleability of RTV in BD, as suggested 
by one study showing increased RTV in individuals with BD in a continuous performance task 
(CPT) with low target frequency, but not with high target frequency (Moss et al., 2016). The 
evidence of malleability in RTV is clinically relevant, as it may point to room for improvement in 
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the observed cognitive impairment, which could be targeted in new interventions for the 
disorders, aimed at reaching and maintaining an optimal state of alertness (Cheung et al., 2017, 
Kuntsi and Klein, 2012). Understanding whether the same or different mechanisms underlie 
attentional fluctuations and their potential reduction in individuals with ADHD and BD may thus 
potentially inform the development of interventions for ADHD and BD. No study to date, 
however, has compared adults with ADHD and adults with BD on the malleability of attentional 
fluctuation indexed by RTV. 
 
The investigation of brain responses using the millisecond temporal precision of 
electroencephalography (EEG) can help elucidate the neural correlates of a suboptimal 
attentional performance. Most EEG studies on attentional impairments in ADHD or BD samples 
have employed event-related potentials (ERPs), measuring transient enhancements in brain 
activity following an event (Luck, 2014). ERP studies in adults with ADHD have shown attenuated 
contingent negative variation (CNV) components over central regions (reflecting atypical 
response anticipation and preparation) (McLoughlin et al., 2010, Michelini et al., 2016b, Valko 
et al., 2009) and reduced attentional P3 components over parietal regions (reflecting impaired 
attentional resource allocation) (Cheung et al., 2017, Cheung et al., 2016, McLoughlin et al., 
2010, Szuromi et al., 2011). Similarly, impairments in P3 and CNV in BP during attentional tasks 
have also been found (Maekawa et al., 2013, Fridberg et al., 2009, Li et al., 2015). Yet, only a few 
direct comparisons have examined whether cognitive and ERP indices are affected to a similar 
extent in ADHD and BD. In a recent investigation using a cued CPT paradigm, we showed that 
increased RTV and reduced CNV may represent shared attentional impairments in ADHD and BD 
(Michelini et al., 2016b). Using quantitative EEG (QEEG), we further reported that both ADHD 
and BD groups showed higher spontaneous EEG theta power during rest and a lack of a task-
related increase in theta from rest to CPT task compared to controls (Rommel et al., 2016). These 
results indicate potentially shared impairments in attentional processes in both disorders. Yet, 
in ERP analyses, the attentional P3 components in response to Cue and Go stimuli were intact 
in both groups, consistent with other studies that also failed to report P3 reductions in adults 
with ADHD (Dhar et al., 2010, Michelini et al., 2016b, Grane et al., 2016) or BD (Bestelmeyer, 
2012, Chun et al., 2013, Michelini et al., 2016b). One possible reason for inconsistencies 
between studies using different attentional paradigms is that the attentional P3, similar to RTV, 
may reflect a context-dependent and potentially malleable, rather than stable, impairment 
(Cheung et al., 2017). We recently reported that a reduced parietal P3 in a slow and unrewarded 
condition in adolescents and young adults with ADHD improved with faster event rate and 
rewards significantly more than in neurotypical controls (Cheung et al., 2017). In contrast, for 
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CNV, the ADHD group showed reduced amplitude compared to controls only in the fast and 
rewarded condition. No study has examined the malleability of these ERPs with faster rate and 
incentives in BD. Further direct comparisons between ADHD and BD are needed to clarify what 
neurophysiological impairments overlap between the two disorders, and whether ADHD and BD 
may show similar malleability with a changed context.  
 
Advances in EEG methods called time-frequency analyses, combining the strengths of ERP and 
QEEG methods, further allow to capture event-related brain oscillatory dynamics, which reflect 
sub-second modulations of power and phase in response to an event across the full EEG 
spectrum (Loo et al., 2015, Pfurtscheller and Lopes da Silva, 1999, Makeig et al., 2004a, Klimesch, 
1999). Processing and focusing attention on a relevant stimulus have been associated with 
various event-related brain oscillatory phenomena in the time-frequency domain not captured 
by ERP or QEEG approaches: (1) an event-related synchronisation (ERS) or increase in theta (3-
7 Hz) power over fronto-central (Bickel et al., 2012, Mazaheri et al., 2014, Lenartowicz et al., 
2014) or parietal (Babiloni et al., 2004, Jacobs et al., 2006) regions, reflecting the initial 
processing of the stimulus; (2) an event-related desynchronisation (ERD) or suppression of 
power in posterior alpha (8-13 Hz), reflecting attentional selection and cortical activation 
(Klimesch, 2012, Mazaheri and Picton, 2005); and (3) an ERD in central beta (14-30 Hz) when a 
motor response is required (Pfurtscheller, 1981, Guntekin et al., 2013). Additionally, indices of 
consistency of the phase (i.e., the “timing”) of brain oscillations over trials can reveal whether 
the processing of a stimulus repeated over time reflects stable or variable neural mechanisms 
(Makeig et al., 2004a, Papenberg et al., 2013, Klimesch, 2012). Greater alpha and beta ERD and 
theta phase consistency have further been associated with better task performance (McLoughlin 
et al., 2014b, Klimesch, 2012, Bickel et al., 2012). Multiple brain-oscillatory correlates of 
attentional processes may be affected in ADHD and BD. Individuals with ADHD have been 
reported to show reductions in event-related phase consistency in the theta band (McLoughlin 
et al., 2014b, Groom et al., 2010a), alpha ERD (Lenartowicz et al., 2014, ter Huurne et al., 2013), 
and beta ERD (Hasler et al., 2016). Emerging evidence also suggests that individuals with BD 
show attenuations in event-related theta (Atagun et al., 2013, Ethridge et al., 2012) and alpha 
power (Ethridge et al., 2012, Basar et al., 2012) and increases in beta power (Ozerdema et al., 
2013, Tan et al., 2016). These studies in BD, however, applied time-frequency analyses on 
averaged ERP responses, thus not allowing the characterisation of both ERD and ERS dynamics 
(Bickel et al., 2012). The investigation of fine-grained brain-oscillatory indices underlying 
attentional processes with time-frequency analyses may allow a deeper investigation into the 
neural correlates of attentional performance, and help identify distinct or comparable 
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impairments in neural processes between the two disorders (Loo et al., 2015). However, no 
study to date has compared ADHD and BD on time-frequency indices of brain oscillations, or 
whether these indices, like RTV, show adjustments under context changes, such as fast and 
rewarded conditions. 
 
The present study aims to investigate and compare cognitive-performance, ERP and detailed 
event-related power modulations of theta, alpha and beta oscillations and of phase variability 
in theta oscillations, previously linked to attentional processes, in adults with ADHD and adults 
with BD. We used an all-female sample, to match the groups on sex but also because little is 
known on these processes in females, especially in relation to ADHD (McLoughlin et al., 2010, 
Saville et al., 2015). Participants completed the same four-choice RT task used in our previous 
studies of ADHD (Kuntsi et al., 2006, Andreou et al., 2007, Cheung et al., 2017), which compares 
a slow-unrewarded baseline condition with a fast-incentive condition designed to specifically 
reward reduction of RTV. A further aim is to examine whether differences in adjustments in the 
investigated cognitive-performance, ERP and brain-oscillatory indices with a faster event rate 
and incentives emerge between groups, which could inform the development of cognitive/brain 







The sample consisted of 20 women with ADHD, 20 with BD and 20 control women, aged 
between 20-52 years (Table 6.1). Participants with ADHD were recruited from the National Adult 
ADHD Clinic at the Maudsley Hospital, where any female cases meeting inclusion criteria were 
considered for potential inclusion in the study. Participants with BD were recruited from the 
Maudsley Psychosis Clinic and a sample that had previously participated in another research 
study (Hosang et al., 2012). Control participants were recruited from the Mindsearch volunteer 
database maintained by the Institute of Psychiatry, Psychology and Neuroscience, King’s College 
London, which comprises several thousand potential participants. Participants were randomly 
selected from all those meeting recruitment criteria for this study. 
 
Diagnosis in the clinical groups was confirmed by checking medical records for details of 
diagnosis and psychiatric history, following DSM-IV criteria. Participants in the ADHD group had 
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a current combined-type diagnosis or an inattentive-type diagnosis with sufficient symptoms of 
hyperactivity-impulsivity in childhood to meet a childhood combined-type diagnosis. 
Participants in the BD group had a diagnosis of BD Type I, having experienced at least one manic 
episode in the past. Those who were experiencing a manic episode at the time of the assessment 
were excluded; all participants included in the BD group were currently euthymic. Exclusion 
criteria for all groups were drug or alcohol dependency in the last 6 months, autism, epilepsy, 
neurological disorders, brain injury, past ECT treatment, current involvement in another 
research trial likely to alter symptom severity, pregnancy or a limited proficiency in English 
language. Individuals with ADHD and individuals with BD with a reported comorbidity of both 
ADHD and BD were also excluded. Control participants, who reported a history of psychiatric 
disorders or who were taking psychiatric medication, were excluded from the study. 
Comorbidity in the clinical groups and lack of psychiatric disorders in the control group were 
further assessed through clinical evaluations when participants underwent the cognitive-EEG 
assessment for this study. Further details on the clinical assessment of this sample can be found 
elsewhere (Kitsune et al., 2016). In brief, ADHD was excluded in the BD group after conducting 
the Diagnostic Interview for Adult ADHD (DIVA v. 2.0; Ramos-Quiroga et al., 2016). BD was 
excluded in the ADHD group by checking for a history of past episodes of depression or 
hypomania/mania and evaluating current mood symptoms using the Altman Self-Rating Mania 
Scale (Altman et al., 1997) and the Beck Depression Inventory (Beck et al., 1996), and current 
and lifetime ever symptoms using the Young Mania Rating Scale (Young et al., 1978). The ADHD 
and BD groups did not differ significantly on any of the mood scales for current symptoms 














Age 37.4 (7.7) 40.3 (7.7) 36.7 (4.3) 1.63 0.21 
IQ 104 (17.9) 108 (12.5) 112 (14.2) 1.37 0.26 
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; BD, bipolar disorder; Ctrl, control 
group; F, ANOVA statistic; p, p value from the ANOVA. 





6.3.2 Procedure  
 
Participants attended a single 4.5-hour research session (including breaks) for cognitive-EEG 
assessment, IQ assessment and clinical interviews. An estimate of IQ was derived with the 
Wechsler Abbreviated Scale of Intelligence Fourth Edition (WASI-IV; Wechsler, 1999). All 
participants were asked to refrain from caffeinated drinks and nicotine two hours before 
assessments. Participants with ADHD were asked to stop taking any stimulant medication 
prescribed for their ADHD 48 hours prior to the assessment. For ethical reasons, participants 
were not asked to stop taking mood stabilisers (70% of the BD group), anti-psychotic medication 
(40% of the BD group) or anti-depressants (7% of the ADHD group and 25% of the BD group) 
they had been prescribed. Ethical approval for the study was granted by the Camberwell St Giles 
Research Ethics Committee (approval number 11/LO/0438) and all participants provided 
informed consent.  
 
6.3.3 Fast task 
 
The task for this analysis was a computerised four-choice RT task which measures performances 
under a slow-unrewarded and a fast-incentive condition (Andreou et al., 2007, Kuntsi et al., 
2006). In both conditions speed and accuracy were emphasised equally. The baseline (slow-
unrewarded) condition followed a standard warned four-choice RT task (Figure S6.1, Appendix 
E). A warning signal (four empty circles, arranged side by side) first appeared on the screen. At 
the end of the fore-period lasting 8 s (presentation interval for the warning signal), the circle 
designated as the target signal for that trial was filled (coloured) in. The participant was asked 
to make a compatible choice by pressing the response key that directly corresponded in position 
to the location of the target stimulus. Following a response, the stimuli disappeared from the 
screen and a fixed inter-trial interval of 2.5 s followed. If the participant did not respond within 
10 s, the trial terminated. First, a practice session was administered, during which the participant 
had to respond correctly to five consecutive trials. The baseline condition, consisting of 72 trials, 
then followed.  
 
To investigate the extent to which a response style characterised by slow and variable speed of 
responding may be reduced, the task includes a comparison condition that uses a fast event rate 
(fore-period of 1 s) and incentives (Figure S6.1, Appendix E). This condition started immediately 
after the baseline condition and consisted of 80 trials, with a fixed inter-trial interval of 2.5 s 
following the response. The participants were told to respond as quickly as possible to each 
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target, in order to win smiley faces and earn real prizes at the end. Participants won a smiley 
face for responding faster than their own mean reaction time (MRT) during the baseline (first) 
condition consecutively for three trials. The baseline MRT was calculated here based on the 
middle 94% of responses (the exclusion of the top and bottom 3% of responses is only used 
when calculating a baseline MRT for the set-up of the fast-incentive condition, and is not used 
for analyses), therefore excluding extremely fast and extremely slow responses. The smiley faces 
appeared below the circles in the middle of the screen and were updated continuously. The fast-
incentive condition was always administered after the baseline condition and, as such, did not 
involve a similar learning phase. Participants earned £5 in cash after the task battery. RTV for 
correct responses in each condition was measured to assess task performance.  
 
6.3.4 EEG recording and pre-processing 
 
The EEG was recorded from a 62-channel DC-coupled recording system (extended 10-20 
montage) (Brain Products, Gilching, Germany), using a 500 Hz sampling-rate, impedances under 
10 kΩ, and FCz as the recording reference. The electro-oculograms (EOGs) were recorded from 
electrodes above and below the left eye and at the outer canthi. EEG recordings were pre-
processed and analysed using the EEGLAB toolbox (Delorme and Makeig, 2004) in Matlab 
(MathWorks, Natick, MA, USA). Researchers were blind to group status during EEG pre-
processing and analysis. Raw EEG recording were down-sampled to 256 Hz, re-referenced to the 
average of all electrodes (turning FCz into an active channel), and digitally filtered using a 0.25 
Hz (-6 dB cut-off) high-pass filter and a 35 Hz (-6 dB cut-off) low-pass filter. Independent 
component analysis (ICA) (Jung et al., 2000) was used to identify and remove ocular (blink-
related and vertical and horizontal eye movements) and muscular artefacts. Visual inspection 
was carried out for all trials to manually remove further artefacts. Channels showing technical 
problems or excessive electrical noise were removed and replaced with topographic spline 
interpolation after ICA, to estimate a virtual EEG activity based on artefact-free activity from 
other channels. 
 
6.3.5 ERP and time-frequency analyses 
 
Only participants with at least 20 artefact-free EEG segments in each condition were included in 
ERP/EEG analyses. All ERP/EEG analyses were performed using EEGLAB functions (Delorme and 
Makeig, 2004) and Matlab custom scripts. ERPs were identified within the selected electrodes 
and latency windows for which effects were expected to be maximal, based on our previous ERP 
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analyses of this task (Cheung et al., 2017, James et al., 2017) and verified against the topographic 
maps and the grand averages (Figure 6.1, Figure S6.2, Appendix E). Following our previous work 
(Cheung et al., 2017), P3 amplitudes were analysed at Pz between 300 and 550 ms (Figure S6.2, 
Appendix E) following the target as the area amplitude measure (μV*ms), to reduce bias due to 
the varying noise levels induced by the different task conditions (Luck, 2014). All trials were 
baseline-corrected by subtracting the mean activity (200 ms before target onset) from the P3 
ERPs. The mean amplitudes of this pre-target period between -200 and 0 ms were also analysed 
separately as a CNV measure at Cz (Figure 6.1) with technical zero-baseline approach (which 
measures the absolute state rather than the amount of neural change introduced by the event) 
following previous CNV work (Albrecht et al., 2013, Banaschewski et al., 2003, Cheung et al., 
2017). This short CNV interval, characterised by a typical CNV topography in the fast-incentive 
condition with its 1000 ms warning-target interval, was chosen as it captures the late CNV 
component unconfounded by the processing of warning stimuli. Although no typical CNV 
emerged in the slower baseline condition, CNV amplitude at Cz in the same corresponding time 
window was used to examine within-subject change in preparatory activity across conditions.  
 
Time-frequency analyses examined the target-related modulations of power and phase 
consistency of brain oscillations previously implicated in attentional processes. Modulations of 
power were quantified with the event-related spectral perturbation (ERSP) index (Delorme and 
Makeig, 2004). ERSP values were computed in a 4000 ms window (from -2000 to 2000 ms) 
centred around target onset by applying a Morlet wavelet decomposition of frequencies 
between 3-30 Hz, with linearly increasing number of cycles (frequency step of 0.80 Hz) from 2 
cycles for the lowest frequency (3 Hz) to 24.60 cycles for the highest frequency (30 Hz). Each 
ERSP trial was normalised with respect to the mean log-power spectrum from the pre-stimulus 
period, from -2000 to -1000 ms, corresponding to the 1000 ms preceding the warning onset in 
the fast-incentive condition; the same comparable window was used in the baseline condition 
as the long fore-period before targets did not produce a modulation of power before stimulus 
onset in the baseline condition (see Appendix E for further explanation). Averaging all ERSPs 
across trials produced a time-frequency representation in decibel (dB) units of increases (ERS, in 
red) and decrease (ERD, in blue) in the spectral power at a given frequency and latency with 
respects to pre-stimulus activity (Figures 6.2-6.3), from which frequency-specific ERSPs can be 
extracted. Phase consistency was calculated with the inter-trial phase coherence (ITC) index, 
measuring the degree to which the phase of the evoked response (derived from the same Morlet 
wavelet used for the ERSP index) at a given latency and frequency is consistent across trials 
(Tallon-Baudry et al., 1996, Makeig et al., 2004a, Delorme and Makeig, 2004). ITC values are 
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independent of power, and range from 0 (reflecting absence of phase consistency and highest 
phase variability across trials) to 1 (indicating perfect phase consistency and lowest phase 
variability) (Figure 6.4). 
 
Target-related ERSP in the theta (3-7 Hz), alpha (8-13 Hz) and beta (14-30 Hz) bands were 
extracted in the 1000 ms window capturing the broad target-related modulation of power, 
divided into two consecutive windows for earlier (0-500 ms) and later (500-1000 ms) processing 
(Figures 6.2-6.3, Figure S6.3, Appendix E). ITC was measured at target onset in the first window 
(0-500 ms), where greater phase consistency in response to the event was observed (Figure 6.4), 
as expected (Groom et al., 2010a). The ITC analysis was restricted to the theta band, consistent 
with previous studies reporting a role of this frequency band in neural consistency (Groom et 
al., 2010a, McLoughlin et al., 2014b, Papenberg et al., 2013). ERSP and ITC were measured at 
scalp locations where they were maximal (Figures 6.2-6.4, Figure S6.3, Appendix E), in line with 
previous studies on similar attentional processes: theta over parietal regions (average of 
electrodes: CPz, CP1-CP6, Pz, P3-P4) (Jacobs et al., 2006, DeLosAngeles et al., 2016); alpha over 
parieto-occipital regions (average of electrodes: Pz, P3-P4, P7-P8, POz, PO3-PO4, PO7-PO8) 
(Bickel et al., 2012, Mazaheri and Picton, 2005); beta over central regions (average of electrodes: 
Cz, C1-C4, CPz, CP1-CP4) (Bickel et al., 2012, Mazaheri and Picton, 2005).  
 
6.3.6 Statistical analyses 
 
All measures were investigated using random intercept linear models (i.e., multilevel regression 
models). Main effects of group (ADHD vs BD vs control), condition (baseline vs fast-incentive) 
and group-by-condition interactions were examined. Significant (p<0.05) and trend-level 
(p<0.09) effects were followed up with post-hoc analyses testing for (1) between-group 
differences in baseline and fast-incentive conditions separately, and (2) within- and between-
group effects of change between conditions with difference scores. Since ERSP indices were 
measures at two time windows (0-500 ms, 500-1000 ms), we tested for three-way group-by-
condition-by-time interactions for these measures, followed by additional post-hoc tests 
examining group differences in each time window. Since groups did not differ on IQ or age (Table 
6.1), these variables were not controlled for in analyses. Measures that showed skewed 
distributions were transformed to normal with square root (CNV, P3) and with logarithm using 
the “lnskew0” Stata command (MRT, RTV, beta ERSP). For between-group comparisons, we 
report both p-values and Cohen’s d effect sizes, calculated using the difference in the means 
divided by the pooled standard deviation, where d≥0.20 constitutes a small effect, d≥0.50 a 
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medium effect and d≥0.80 a large effect (Cohen, 1988). All statistical analyses were run in Stata 
14 (Stata Corp, College Station, TX, USA). Data on the fast-incentive condition were missing for 
one participant with ADHD due to technical issues during the testing session. Two control 
participants had outlier RTV (>5 SD) in the baseline condition, indicating that they did not follow 
task instructions, and were excluded from all analyses. As at least 20 artefact-free EEG segments 
are needed to obtain reliable ERP/EEG indices (McLoughlin et al., 2009), one participant with 
ADHD and one with BD were excluded from ERP/EEG analyses on the baseline condition, and 
one control from ERP/EEG analyses on both conditions. Due to the longer fore-period in the 
baseline condition, the two conditions were matched on the number of trials, but not on length. 
To control for this, we run the analyses of RTV performance first on the full baseline condition, 
and separately on a length-matched segment of the baseline (Andreou et al., 2007) (Appendix 
E). Condition length was not controlled for in the ERP/EEG analyses, as data from the full 






Significant group (p=0.01) and condition (p<0.001) effects, but no group-by-condition 
interaction (p=0.92), emerged for RTV. Post-hoc tests of group effects showed that the ADHD 
and the BD groups had significantly increased RTV compared to controls in both conditions, but 
did not differ significantly from one another (Table 6.2). Post-hoc analyses of condition effects 
showed that all three groups had a significant within-group decrease in RTV from the baseline 
to the fast-incentive condition, with no significant differences between groups in the degree of 
change between conditions (Table 6.3). Comparable results were obtained using the length-
matched segment of the baseline condition (Appendix E). 
 
6.4.2 ERPs  
 
CNV. Significant main effects of group (p=0.03) and condition (p<0.001), and a significant group-
by-condition interaction (p<0.01), emerged for the CNV. Post-hoc tests showed no group 
differences in the baseline condition (Table 6.2). In the fast-incentive condition, the CNV was 
significantly reduced in the ADHD compared to the control group (Figure 6.1). The BD group 
showed significantly reduced CNV compared to controls, and a trend-level effect for greater CNV 
compared to the ADHD group (Table 6.2). All three groups had a significant within-group 
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decrease from the baseline to the fast-incentive condition (Table 6.3, Figure 6.1). The degree of 
change in CNV between conditions in the ADHD group was significantly lower compared to the 
control group, and at trend level compared to the BD group. The BD group also showed a trend-
level reduction in CNV compared to the control group in the degree of change between 
conditions. 
 
P3. A trend-level group-by-condition interaction (p=0.06), but no main effects of group (p=0.84) 
or condition (p=0.56), emerged for the P3. Post-hoc tests did not show significant group 
differences in the baseline or in the fast-incentive condition (Table 6.2, Figure S6.2, Appendix E). 
A significant within-group change from the baseline to the fast-incentive condition in stimulus-
locked P3 emerged in controls, but not in participants with ADHD or BD (Table 6.3). The degree 
of change between conditions was significantly lower in the BD compared to the control group. 





Figure 6.1. Contingent negative variation (CNV) amplitude measured at Cz in the -200–0 ms 
window in the ADHD (in red), BD (in green) and control (in black) groups across the baseline and 
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fast-incentive conditions of the Fast task. (A) Grand average in the baseline condition; (B) Grand 
average in the fast-incentive condition; (C) Condition effects by group; (D) Topographic maps by 






6.4.3 Event-related power (ERSP) 
 
Theta. No effects of group (p=0.96), condition (p=0.11) or group-by-condition-by-time 
interaction (p=0.94) emerged for theta ERSP. After removing the three-way interaction, there 
were no significant group or group-by-condition interaction effects on this measure (p>0.61), 
and a significant main effect of condition emerged in the 0-500 ms window (p<0.001) but not in 
the 500-1000 ms window (p=0.41). In the 0-500 ms window, a significant within-group decrease 
from the baseline to the fast-incentive condition emerged in theta ERSP for the ADHD and BD 
groups, and at trend level for the control group (Table 6.3), but there were no group differences 
in the degree of change between conditions (Table 6.3). An additional analysis examined the 
event-related theta ERSP that was evident also at fronto-central regions (Figure S6.3, Appendix 
E), yielding the same results as found for parietal theta power (Tables 6.2-6.3).  
 
Alpha. A main effect of condition (p<0.001), but no effects of group (p=0.25) or group-by-
condition-by-time interaction (p=0.23), emerged for alpha ERSP. After removing the three-way 
interaction, there was a significant effect of condition (p<0.001), but no significant group 
(p=0.30) or group-by-condition interaction effects in the 0-500 ms time window for this measure 
(p=0.48). All three groups showed a significant within-group decrease in alpha ERSP (i.e., 
increase in alpha suppression) in the change from the baseline to the fast-incentive condition 
(Table 6.3), but there were no group differences in the degree of change between conditions. In 
the 500-1000 ms window, a main effect of condition (p=0.01), a trend-level group-by-condition 
interaction (p=0.08), but no main effect of group (p=0.23), emerged for alpha ERSP. Post-hoc 
tests showed no differences between groups in the baseline condition (Table 6.2). In the fast-
incentive condition, the ADHD group showed a significantly decreased alpha ERSP (i.e., lower 
alpha suppression) compared to controls (Figure 6.3). The BD group did not differ from the other 
groups. A significant within-group decrease from the baseline to the fast-incentive condition in 
alpha ERSP (i.e., increase in alpha suppression) emerged for the control group, but not for the 
ADHD or BD groups (Table 6.3). The ADHD group showed a significantly lower degree of change 
between conditions than the control group in this measure, while the BD group did not differ 






Figure 6.2. Alpha event-related spectral perturbation (ERSP) at parieto-occipital regions in the 
ADHD, BD and control groups in the baseline and fast-incentive conditions of the Fast task. (A) 
ERSP in the baseline condition; (B) ERSP in the fast-incentive condition; (C) Topographic maps by 
group in the 500-1000 ms window at each condition; (D) Condition effects in the 500-1000 ms 




Beta. A significant main effect of condition (p<0.001), but no significant effect of group (p=0.75) 
or group-by-condition-by-time interaction (p=0.61), emerged for beta ERSP. After removing the 
three-way interaction, there was no significant group effects in either time window (p>0.25), 
but there were significant condition (p<0.001) and trend-level group-by-condition interaction 
(p=0.06) effects in the in the 0-500 ms window, and significant group-by-condition interaction 
(p=0.01) and trend-level condition (p=0.08) effects in the 500-1000 ms window. A significant 
within-group decrease in beta ERSP (i.e., increase in beta suppression) from the baseline to the 
fast-incentive condition emerged for all groups in the 0-500 ms window, but only for control and 
BD groups in the 500-1000 ms window (Table 6.3, Figure 6.3). The ADHD group differed from 
the BD and control groups in the degree of change in beta ERSP between conditions in both time 







Figure 6.3. Beta event-related spectral perturbation (ERSP) at central regions in the ADHD, BD 
and control groups in the baseline and fast-incentive conditions of the Fast task. (A) ERSP in the 
baseline condition; (B) ERSP in the fast-incentive condition; (C) Topographic maps by group in the 
0-500 ms and 500-1000 ms windows at each condition; (D) Condition effects in at each time 





6.4.4 Theta phase consistency (ITC) 
 
A main effect of group (p=0.03) and condition (p<0.001), but no group-by-condition interaction 
(p=0.41), emerged for theta ITC in the 0-500 ms window. Post-hoc tests showed no differences 
between groups in the baseline condition (Table 6.2). In the fast-incentive condition, theta ITC 
was significantly decreased (i.e., phase was more variable) in the ADHD and BD groups compared 
to the control group, with no differences between ADHD and BD groups (Figure 6.4). A significant 
within-group increase in theta ITC (i.e., decrease in phase variability) from the baseline to the 
fast-incentive condition emerged in the control and BD groups, and at trend-level in the ADHD 
group (Table 6.3), but no differences between groups emerged in the degree of change between 
conditions. Further analyses compared groups prior to target onset, and found no differences in 





Figure 6.4. Theta inter-trials phase coherence (ITC) at parietal regions in the ADHD, BD and 
control groups across the baseline and fast-incentive conditions of the Fast task. (A) ITC in the 
baseline condition; (B) ITC in the fast-incentive condition; (C) Topographic maps by group in the 
0-500 ms window at each condition; (D) Condition effects in the 500-1000 ms window by group 







Table 6.2. Group comparison of cognitive and EEG measures in the baseline and fast-incentive condition  
  Baseline condition Fast-incentive condition 
ADHD vs BD ADHD vs Ctrl BD vs Ctrl ADHD vs BD ADHD vs Ctrl BD vs Ctrl 
d p d  p d  p d  p d  p d p 
RTV  0.19  0.544 0.82 0.016* 0.69 0.040* 0.20  0.541 0.75 0.027* 0.66  0.050* 
CNV  0.02  0.937 0.08  0.821  0.05  0.876  0.56  0.089† 1.41  <0.001** 0.69  0.044* 
P3  0.02  0.954 0. 11  0.736 0.11  0.751 0.13  0.686 0.44  0.193 0.56  0.099 
Theta ERSP (0-
500 ms, CP) 
0.08  0.818 0.20  0.561  0.11  0.735  0.11  0.729  0.23  0.497  0.31  0.353 
Theta ERSP (0-
500 ms, FC) 
0.31  0.341 0.06  0.859  0.17  0.614  0.19  0.565  0.25  0.462  0.41  0.221 
Alpha ERSP (0-
500 ms) 
0.30  0.368  0.39  0.389  0.13  0.967  0.50  0.129  0.48  0.160 0.04  0.908 
Alpha ERSP 
(500-1000 ms) 
0.29  0.382  0.31  0.363  0.04  0.896  0.27  0.399  0.78  0.026* 0.44  0.191 
Beta ERSP (0-
500 ms) 
0.38  0.251 0.17  0.613 0.52  0.129 0.10  0.764  0.56  0.105  0.38  0.248  
Beta ERSP 
(500-1000 ms) 
0.35  0.309  0.46  0.179 0.02  0.943 0.30  0.362  0.30  0.378  0.04  0.905  
Theta ITC  0.09  0.787  0.47  0.168  0.43  0.199  0.17  0.600 0.83 0.018* 0.72  0.036* 
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; BD, bipolar disorder; CNV, contingent negative variation; CP, centro-parietal region; Ctrl, control 
group; d, Cohen’s d; ERSP, event-related spectral perturbation; FC, fronto-central region; ITC, inter-trial phase coherence; MRT, mean reaction time; p, p value 
from random intercept linear models; RTV, reaction time variability. 








Table 6.3. Comparison of condition effects within group and between groups 
  
Within-group differences Between-group differences 
ADHD BD Ctrl ADHD vs BD ADHD vs Ctrl BD vs Ctrl 
p p p d  p d  p d  p 
RTV  <0.001** <0.0001** <0.001** 0.01  0.982 0.22  0.507 0.30  0.366 
CNV  0.019* <0.001** <0.001** 0.59 0.083† 1.17  0.002** 0.59  0.088† 
P3  0.723 0.331 0.026* 0.08  0.814 0.49  0.159 0.68 0.048* 
Theta ERSP (0-500 ms, CP) 0.039* 0.003** 0.085† 0.19  0.567  0.03  0.930  0.21  0.543  
Theta ERSP (0-500 ms, FC) 0.004* <0.001** 0.056† 0.40  0.231  0.17  0.612  0.55  0.106  
Alpha ERSP (0-500 ms) 0.001** <0.001** <0.001** 0.44  0.188  0.44  0.202  0.05  0.879  
Alpha ERSP (500-1000 ms) 0.568 0.510 <0.001** 0.13  0.701  0.71  0.045*  0.52  0.132  
Beta ERSP (0-500 ms) <0.001** <0.001** <0.001** 0.69  0.044*  0.72  0.040*  0.05  0.885  
Beta ERSP (500-1000 ms) 0.104 0.007** 0.054† 1.05  0.003**  0.87  0.014* 0.14  0.683 
Theta ITC  0.083† 0.018* <0.001** 0.16  0.634  0.43  0.216  0.30  0.379  
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; BD, bipolar disorder; CNV, contingent negative variation; CP, centro-parietal region; Ctrl, control 
group; d, Cohen’s d; ERSP, event-related spectral perturbation; FC, fronto-central region; ITC, inter-trial phase coherence; MRT, mean reaction time; p, p value 
from random intercept linear models; RTV, reaction time variability. 






In this comparison between ADHD and BD on cognitive, ERP and brain-oscillatory markers of 
attentional processes, women with ADHD and women with BD showed overlapping impairments 
in fluctuations in attentional performance (RTV), neural variability (theta ITC) and neural 
response preparation (CNV). Individuals with either disorder further displayed a similar inability 
to adjust neural attention allocation (P3) and activation (alpha suppression) from a baseline to 
a fast-paced and rewarded condition, suggesting no adaptation to a changed context in these 
processes. Additional disorder-specific alterations in alpha and beta suppression were displayed 
by women with ADHD only, but impairments in most processes were shared between the two 
disorders. By examining both ERP and fine-grained brain-oscillatory indices of brain activity, 
these findings reveal novel neural mechanisms of shared attentional dysfunction in ADHD and 
BD, which potentially underlie some of the common symptoms in both disorders.  
 
At the cognitive level, both ADHD and BD groups showed increased RTV in both task conditions, 
indicating more frequent fluctuations in response speed and impairments in the ability to 
sustain attention during the task. Increased RTV in both disorders is consistent with our results 
with this sample using a cued CPT task (Michelini et al., 2016b), and previous studies on ADHD 
(Cheung et al., 2016, Kuntsi et al., 2010, Kofler et al., 2013) and BD (Moss et al., 2016, Bora et 
al., 2006, Brotman et al., 2009). We further show novel evidence of intra-individual variability 
also at the neural level in the phase of theta oscillations in both women with ADHD and women 
with BD. Low phase variability over trials is thought to reflect an adaptive mechanism to 
maintain stable neural processing of a stimulus (Makeig et al., 2004a, Papenberg et al., 2013). 
The increased variability in theta oscillations, previously reported in adolescents with ADHD 
(Groom et al. 2010; McLoughlin et al. 2014), thus points to a reduced ability to maintain a 
consistent pattern in the timing of evoked theta response to targets over trials in adults with 
ADHD and BD (Cavanagh et al., 2009, McLoughlin et al., 2014b). Although these differences 
emerged as significant only in the fast-incentive condition, the group-by-condition interaction 
was not significant, suggesting that there may be subtle differences also in the baseline 
condition, non-significant in this sample. Further analyses in the pre-stimulus window indicated 
that, compared to individuals with ADHD or BD, control women displayed greater phase 
consistency upon target presentation, but lower consistency before targets. As such, with 
presentations of targets across trials, the controls displayed a consistent alignment and increase 
in consistency in the phase of theta (called phase resetting) (Palaniyappan et al., 2012, Lakatos 
et al., 2009) from the low consistency observed in the pre-stimulus window. This mechanism 
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may be lacking in women with either ADHD or BD as indicated by the more frequent fluctuations 
in this neural mechanism across trials. Overall, our findings of increased variability in cognitive 
and neural processes in women with ADHD or BD indicate an overlap in the neural underpinnings 
of impaired attentional fluctuations in both disorders, which may point to common 
neurobiological dysfunctions. 
 
By further examining pre-stimulus response preparation in ADHD and BD, we found shared 
preparatory impairments, as indicated by reduced CNV, in both clinical groups in the fast-
incentive condition. This finding is consistent with our previous results in this sample using a CPT 
task (Michelini et al., 2016b), and in adolescents and young adults with ADHD using the same 
task employed in this study (Cheung et al., 2017). Suggestive (trend-level) differences between 
ADHD and BD in this measure may also indicate more pronounced CNV impairment in ADHD, 
although this awaits replication in future studies. The pattern for P3 amplitude in response to 
targets, which was not different from controls in either ADHD or BD groups, indicates that 
women with either disorder may not be impaired in this ERP of attentional allocation. This result 
is consistent with our previous study with this sample (Michelini et al., 2016b), showing intact 
P3s following cue and target stimuli, and other previous studies reporting normal attentional P3 
amplitudes in adults with ADHD (McLoughlin et al., 2010, Barry et al., 2009) or BD (Bestelmeyer, 
2012). Yet, this P3 finding does not align with our previous larger-scale investigation using this 
task in ADHD, where our predominantly-male group of adolescents and young adults with ADHD 
(mean age: 18 years) showed a reduced P3 in the baseline condition (with a small effect size) 
compared to controls (Cheung et al., 2017). In the current study, the intact target P3 in ADHD 
may be due to gender or age, the present study being the first on this task using an all-female 
and all-adult sample (mean age: 37 years). In addition, the ADHD group had lower IQ than the 
control group in our previous study, and the ADHD-control difference on the P3 was non-
significant when IQ was controlled for (Cheung et al., 2017). The lack of IQ differences between 
groups in the current sample may have contributed to the lack of group differences in the P3. 
Taken together, these findings indicate that both ADHD and BD are associated with reduced ERP 
activity of attentional preparation and anticipation of motor responses.  
 
With faster target presentation and incentives, further shared impairments between ADHD and 
BD emerged in adjustments between conditions. These task manipulations, originally designed 
in ADHD studies to reward more consistent response times, produced comparable reductions in 
RTV in clinical and control groups. At the neural level, women with ADHD, and potentially (at 
trend-level) with BD, displayed significantly reduced increases in CNV amplitude compared to 
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controls, and no improvements in allocation of attentional resources (P3) (Polich, 2007) or 
attentional selection (alpha suppression) (Klimesch, 2012). The novel finding of a reduced ability 
to increase alpha suppression with task demands in both disorders points to a common inability 
in individuals with ADHD and BD to regulate brain activity implicated in attentional selection 
processes (Klimesch et al., 2007, Klimesch, 2012). A reduced adjustment in the response 
preparation CNV in women with ADHD replicates our previous findings in adolescents and young 
adults with the disorder (Cheung et al., 2017). Yet, in the P3, neither of the clinical groups 
showed the improvement between conditions displayed by controls. This pattern for the P3 
contrasts with our previous findings using this task in a sample of adolescents and young adults 
with ADHD, where the ADHD group showed improvements between conditions in the P3, which 
were greater than those observed in the control group, suggesting malleability in this attentional 
ERP component in ADHD (Cheung et al., 2017). Similarly, these results in ADHD do not align with 
studies in children, adolescents and young adults indicating greater RTV malleability and 
improvements in ADHD than in neurotypical samples (Andreou et al., 2007, Kuntsi et al., 2009, 
Kuntsi et al., 2013, Cheung et al., 2017). A possible explanation for the inconsistencies in P3 and 
RTV adjustments is the age difference between the samples of current and previous studies: it 
could be hypothesised that adults with ADHD, compared to younger individuals, may be less 
sensitive to task manipulations in these processes. Since this is the first study examining these 
processes in an all-female adult sample, gender effects represent another possible reason for 
these inconsistencies with previous studies, which used predominantly-male samples (Andreou 
et al., 2007), (Cheung et al., 2017). Finally, since the ADHD sample used in the current adult 
female study (n=20) was smaller than those used in previous studies (e.g., n=94, Cheung et al., 
2017), the possibility remains that the task manipulation effects would emerge with larger 
sample sizes also in adult women with ADHD. Longitudinal studies and replications in larger 
samples, including individuals of both sexes, are needed to examine potential developmental 
and gender effects on the malleability of markers of attentional processes in ADHD.  
 
While most impairments were shared between ADHD and BD, we further found impairments 
specific to ADHD. Women with the disorder displayed a dysfunction in attentional selection, as 
indexed by lower alpha power suppression in response to targets in the fast-incentive condition 
(Klimesch et al., 2007, Klimesch, 2012). These results are consistent with previous studies 
reporting attenuated event-related alpha suppression in ADHD (Hasler et al., 2016, Missonnier 
et al., 2013, Mazaheri et al., 2014, Lenartowicz et al., 2014). In addition, in the change from the 
baseline to the fast-incentive condition, individuals with ADHD were specifically associated with 
lower adjustments in the suppression of beta power than in individuals with BD and controls, 
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indicating reduced improvements in neural mechanisms associated with response execution 
(Mazaheri et al., 2014, Bickel et al., 2012). While the ADHD-specific impairment in alpha 
suppression did not distinguish women with ADHD from women with BD, the reduction in the 
adjustment in beta power suppression with task demands significantly differentiated the two 
clinical groups. The latter brain-oscillatory process may thus represent neurobiological 
dysfunctions specific to ADHD, which may potentially help delineate ADHD from BD in adults. 
 
The following limitations should be considered when interpreting our findings. First, although 
the groups were matched on gender, age and IQ, there were differences in the prescribed 
medications that participants were taking. We asked participants with ADHD to stop taking 
stimulant medication 48 hours before assessments, but it was not possible, for ethical reasons, 
to ask participants to stop mood-stabilising, anti-psychotic or antidepressant medications. 
Medication effects are difficult to control for in cross-disorder studies where different groups 
are prescribed different treatments, resulting in a limited number of participants within 
medication subgroups. However, previous studies suggest that medication may show positive 
effects (reducing differences from controls) or no effects on cognitive-EEG measures (Anderer 
et al., 2002, Karaaslan et al., 2003, Galletly et al., 2005, Degabriele and Lagopoulos, 2017, Groom 
et al., 2013). As such, it is unlikely that the group differences reported in this study reflect 
confounding medication effects. Second, while the two task conditions were matched on 
number of trials, they differed in duration and in length of the fore-period between warning and 
target stimuli. While we obtained comparable findings in RTV with length-matched segments, 
ERP/EEG analyses could not be repeated on length-matched segments, as doing so would have 
produced insufficient number of trials in the baseline condition to obtain reliable ERP/EEG 
indices. In addition, the different fore-periods and the use of a 0.25 Hz high-pass filter may 
reduce comparability of preparatory activity between the conditions. Yet, the analysis of the 
CNV (showing typical topographies at central sites) and the further analyses of EEG activity in 
the warning-target interval under fast-incentive conditions (Appendix E) allowed detailed 
investigation of neural preparatory processes in this latter condition. Future studies could 
examine stimulus-related and preparatory processes in ADHD and BD using other tasks, as well 
as examine the influences on slower frequencies on the CNV. Finally, although the current study 
and previous analyses on this sample (Michelini et al., 2016b, Rommel et al., 2016) represent 
the most comprehensive comparisons between ADHD and BD on cognitive, ERP and EEG 
markers to date, the sample is relatively small. While several significant differences between 
groups emerged with medium-to-large effects with current sample sizes, larger studies are 




Taken together, these findings further our understanding of the neural underpinnings of 
attentional impairments in both disorders, and provide new evidence into the overlap and 
specificity of impairments in these processes in women with ADHD and BD. The shared markers 
of attentional dysfunctions may represent biomarkers for both disorders. The shared atypical 
neural profiles related to attentional processes may underlie similarities in behavioural 
symptoms (e.g., distractibility) between ADHD and BD, which can lead to difficulty in delineating 
between ADHD and BD and incorrect treatment decisions. Finally, since ADHD and BD show 
genetic overlap (Lee et al., 2013, van Hulzen et al., 2016, Song et al., 2015), and increased 
attentional fluctuations may represent candidate markers of genetic/familial risk for both 
disorders (Adleman et al., 2014, Kuntsi et al., 2010), future studies could examine whether 
shared genetic factors may underlie overlapping attentional dysfunctions in ADHD and BD.   
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This concluding chapter provides a summary of the key findings from this thesis. Linking the 
findings from both parts of this thesis, I will consider the clinical and research implications of 
this body of work in relation to individuals with attention-deficit/hyperactivity disorder (ADHD) 
and bipolar disorder (BD). I will then review the strength and limitations of the studies included 





The overall aim of this thesis was to study cognitive and neurophysiological impairments in 
ADHD in adolescence and adulthood, by examining their developmental and aetiological 
pathways to remission and persistence in adolescents and adults with childhood ADHD, as well 
as the specificity of these impairments to ADHD, in comparison to BD.  
 
The first part of this thesis has investigated the developmental pathways of cognitive processes, 
brain activity and connectivity in relation to persistence and remission of ADHD. Clinical 
observations and previous studies of clinical samples have shown that ADHD persists, either in 
full or in partial remission, in the majority of individuals that receive a diagnosis in childhood 
(Cheung et al., 2015, Faraone et al., 2006, van Lieshout et al., 2016b). Yet, only few studies have 
previously aimed to understand what may be the mechanisms underlying the developmental 
outcomes of persistence and remission of ADHD in the transition to adolescence and young 
adulthood (Cheung et al., 2016, Biederman et al., 2009, Francx et al., 2015b). The first two 
studies focused on cognitive-performance, event-related potential (ERP) (Chapter 2) and brain 
connectivity (Chapter 3) measures during the arrow flanker task in relation to ADHD remission 
and persistence in a large sample of individuals with a childhood ADHD diagnosis and 
neurotypical individuals. Specifically, the aim of these two chapters was to examine whether the 
investigated measures are markers of remission, distinguishing ADHD “persisters” from 
“remitters”, or enduring deficits, unrelated to ADHD outcome. With the inclusion of the 
unaffected siblings of childhood ADHD probands, the aetiological structure of a broad range of 
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cognitive-neurophysiological impairments and ADHD was further investigated using a factor 
analysis and multivariate sibling model-fitting approach, to identify the aetiological pathways to 
impairments in persistent ADHD in adolescence and young adulthood (Chapter 4).  
 
The second part of this thesis aimed to examine whether alterations in cognitive and 
neurophysiological processes in adults with ADHD are specific to the disorder, or may be shared 
with BD, which often co-occurs or presents certain areas of symptomatic overlap with ADHD. In 
particular, adults with ADHD and adults with BD may show similar symptoms of distractibility 
and impulsivity, as well as cognitive impairments in attentional and inhibitory processes, but 
only a few studies prior to this thesis have directly compared individuals with ADHD and 
individuals with BD (Kitsune et al., 2016, Rommel et al., 2016). Cognitive and neurophysiological 
profiles in adults with ADHD, adults with BD and control adults were investigated, in order to 
identify distinct and shared cognitive and neurophysiological impairments in the two disorders. 
Groups were compared on cognitive-ERP (Chapters 5 and 6) and brain-oscillatory (Chapter 6) 
markers of attentional and inhibitory processes from the cued continuous performance task 
(CPT-OX), and of attentional fluctuations in the Fast task, a four-choice reaction time task. 
Shared alterations in cognitive and brain function can inform on the neurobiological pathways 
that are common between the two disorders, while distinct alterations may aid diagnostic 
delineation, which in some cases can be difficult due to symptomatic similarities between the 
two conditions. A further aim of the second part of this thesis was to provide new empirical data 
on impairments in these processes in females with ADHD, as the majority of previous studies 
have been conducted in male-only or predominantly-male samples (Albrecht et al., 2008, 
McLoughlin et al., 2009, Cheung et al., 2016, Kuntsi et al., 2010), due to the higher prevalence 





7.3.1 Neurophysiological error detection on attention-vigilance processes are markers of 
ADHD remission 
 
The first study in this thesis (Chapter 2) sought to investigate cognitive and neurophysiological 
measures during a performance monitoring task with congruent (low conflict) and incongruent 
(high conflict) conditions in a follow-up study of 110 adolescents and young adults with 
childhood ADHD and 169 age-matched control participants. The results show that ADHD 
 168 
 
remitters did not differ from control individuals, but showed more typical profiles compared to 
ADHD persisters in cognitive measures of attention-vigilance processes and neurophysiological 
markers of error processing. Given this pattern of results, these measures may represent 
markers of remission. Specifically, ADHD persisters showed greater reaction time variability 
(RTV) and number of errors in the low-conflict condition, likely reflecting impairments in 
attention-vigilance processes, compared to both ADHD remitters and controls, with the latter 
two groups showing indistinguishable profiles from one another. The same pattern of results 
emerged for ERP measures of automatic and conscious error processing (ERN and Pe, 
respectively), which were similarly associated with ADHD remission, with ADHD persisters 
showing reductions in these measures compared to both ADHD remitters and controls. In 
dimensional analyses within the childhood ADHD group, most of these measures were further 
associated with the continua of ADHD symptoms and functional impairments at follow-up.  
 
The results of this study further show that ADHD remitters displayed intermediate profiles and 
no significant differences from persisters and controls in incongruent errors (reflecting executive 
control) and mean reaction time (MRT) in this highly effortful task (reflecting processing speed). 
Such findings suggest that incongruent errors and MRT, despite showing differences between 
ADHD persisters and controls, were not sensitive to the different ADHD outcomes at follow-up. 
Neurophysiological conflict monitoring (N2) in the incongruent condition similarly showed 
significant reductions in ADHD persisters, suggesting suboptimal processing of conflicting 
stimuli, but no differences between the two childhood ADHD groups.  
 
The findings of this study extend previous results in this sample using cognitive-EEG measures 
from the CPT-OX and Fast task, as well as measures of IQ and digit span (Cheung et al., 2016). In 
this earlier study, measures of preparation-vigilance processes (RTV, omission errors, contingent 
negative variation [CNV], and delta and theta activity) were markers of remission, whilst 
measures of executive processes (commission errors, digit span backward, NoGo-P3) were not 
sensitive to ADHD remission or persistence. Taken together, these results indicate that 
potentially more automatic non-executive cognitive processes, such as preparation-vigilance, 
and neurophysiological error processing are associated with remission of ADHD from childhood 





7.3.2 Atypical brain connectivity in adolescents and young adults with remitted and 
persistent ADHD 
 
A subsequent analysis of the EEG data from the same arrow flanker task employed a brain-wide 
functional connectivity approach to examine brain connectivity in relation to ADHD outcomes 
of persistence and remission (Chapter 3). Results indicate that individuals with persistent ADHD, 
compared to controls, show widespread over-connectivity alterations and reduced ability to 
modulate connectivity with task demands. Specifically, ADHD persisters showed increased 
connectivity in theta, alpha and beta oscillations in a pre-stimulus window before target onset, 
as well as during target processing in the beta band. Increased EEG connectivity in the 
investigated frequency ranges may reflect exaggerated communication between brain regions, 
both during the inactive pre-stimulus period and during cognitive target processing. Considering 
the high cognitive demands induced by the high-conflict incongruent stimuli in this highly 
effortful task, where a response at every trial is required, enhanced connectivity in individuals 
with ADHD, especially in the beta frequency band, may reflect over-connectivity in brain 
networks underlying executive control. The persistent group further showed a reduced 
adjustment of connectivity in the theta band with appearance of the target between the pre-
stimulus and the post-stimulus window. This pattern of results may point to a dysfunctional 
regulation of brain network connectivity in slow oscillations in individuals with ADHD, and 
reduced ability to modulate brain connectivity patterns from a relatively inactive context to a 
condition requiring higher cognitive engagement. 
 
Individuals with remitted ADHD did not differ from ADHD persisters in any measure, but showed 
significant differences from controls in connectivity measures of network integration and in all 
measures of change between pre-stimulus and post-stimulus windows. In line with results of 
categorical analyses, the investigated brain connectivity markers showed little evidence of 
dimensional associations with the continua of ADHD symptoms and functional impairment 
within individuals with childhood ADHD. These findings indicate that hyper-connectivity and 
reduced ability to modulate connectivity with task demands characterise adolescents and young 
adults with both persistent and remitted ADHD. Atypical functional connectivity during cognitive 
control processes may thus represent an enduring deficit in adolescents and adults with 
childhood ADHD, irrespective of their current diagnostic status. These findings extend the results 
presented in Chapter 2 and in a previous investigation using the same sample (Cheung et al., 
2016), where the majority of investigated measures that were sensitive to impairments in ADHD 
persisters showed a pattern of markers of remission, distinguishing ADHD remitters from 
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persisters. Conversely, in this connectivity study, the findings point to a lack of differences 
between ADHD remitters and persisters in brain connectivity, with remitters showing, similar to 
persisters, neural alterations indicating over-connectivity and reduced modulation of 
connectivity with task demands. 
 
A further finding from this study is that, while connectivity alterations emerged in ADHD groups 
before and during processing of trials where a correct behavioural response was made, 
differences between groups were largely lacking when participants in any group made an 
incorrect response. In particular, while the ADHD groups showed widespread over-connectivity 
alterations compared to controls across all frequency bands before the onset of targets prior to 
making a correct response, neither group differed from the control group in error responses. In 
addition, increased connectivity was observed prior to and during error responses compared to 
correct responses in all groups, further indicating that higher EEG connectivity may be 
suboptimal during this task. These findings thus suggest that atypically increased EEG 
connectivity in this task may lead to an error, both in neurotypical individuals and in individuals 
with persistent or remitted ADHD. 
 
7.3.3 Aetiological structure of cognitive-neurophysiological impairments in ADHD in 
adolescence and young adulthood 
 
The different developmental patterns observed for different types of impairments in cognitive 
and brain function in relation to ADHD outcomes may suggest a separation in the aetiological 
pathways leading to these alterations in ADHD. Previous studies in children with ADHD have 
shown that separable familial factors may underlie cognitive dysfunctions in the disorder 
(Frazier-Wood et al., 2012, Kuntsi et al., 2010, Wood et al., 2011), but no study prior to this thesis 
has examined the aetiological factor structure of cognitive impairments in ADHD in adolescence 
and young adulthood. Using a multivariate sibling model-fitting approach, this thesis extends 
previous studies by (1) examining these cognitive processes in adolescents and young adults 
with persistent ADHD, their unaffected siblings and control sibling pairs, and by (2) also including 
neurophysiological (ERP) measures (Chapter 4). Among the widespread cognitive and 
neurophysiological impairments that were associated with ADHD in this sample in previous 
studies (Cheung et al., 2016, Cheung et al., 2017) and in this thesis (Chapter 2), multivariate 
analyses were restricted to measures showing the strongest phenotypic overlap with ADHD and 
evidence of underlying familial influences, as indicated by phenotypic similarity between siblings 
in a same pair. Based on this first preliminary step, multivariate analyses examined the 
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aetiological factor structure of ADHD and impairments in a variety of processes associated with 
ADHD, including intelligence (IQ), short-term and working memory (digit span forward [DSF] and 
backward [DSB]), response speed (MRT) and variability (RTV), sustained attention (omission 
errors [OE], congruent errors [CongE]), inhibitory control (NoGo-P3), and error processing (ERN).  
 
Factor analysis and sibling model-fitting approaches were applied to study the aetiological 
structure of impairments in these measures and ADHD in terms of familial and non-familial 
influences, representing the combined contribution of the genetic and environmental influences 
shared within sibling pairs, and individual-specific influences, respectively. Three familial factors 
emerged, underlying the association between impairments in these measures and ADHD. The 
familial factors captured: (1) response speed (MRT), response variability (RTV), and IQ; (2) short-
term (DSF) and working (DSB) memory; and (3) sustained attention (OE, CongE), error processing 
(ERN) and, to a smaller extent, response inhibition (NoGo-P3). This factor structure points to a 
separation between familial influences accounting for measures of IQ and RT performance, 
measures of memory performance, and measures of response accuracy and brain activity of 
inhibition/error processes. The familial influences underlying ADHD overlapped strongly with 
both the first and third factors, and moderately with the second factor. Three factors also 
emerged for non-familial influences, with the only exception that IQ clustered with measures of 
memory rather than response speed and variability. These findings indicate a partial separation 
in the aetiological processes underlying cognitive-neurophysiological impairments in persistent 
ADHD, which may explain individual differences between individuals with the disorder in these 
processes. These results provide novel insights into the aetiological pathways to widespread 
impairments in cognitive and brain function, showing a multifactorial architecture of such 
alterations in ADHD in adolescence and adulthood. These findings extend evidence from studies 
in childhood, by examining an older age group but also including a broad range of cognitive and 
neurophysiological impairments, rather than only cognitive-performance measures, as in 
previous childhood studies (Frazier-Wood et al., 2012, Kuntsi et al., 2010, Wood et al., 2011).  
 
7.3.4 Disorder-specific and shared impairments in ERPs of attention and inhibitory processes 
in ADHD and BD 
 
The first study of the second part of this thesis investigated whether cognitive-
neurophysiological measures of attention and inhibition differ between ADHD and BD, to 
identify impairments that are specific to either disorder or shared between ADHD and BD. Three 
groups of 20 women with ADHD, 20 women with BD and 20 control women were compared on 
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cognitive-performance measures (MRT, RTV, OE and commission errors [CE]) and ERPs of 
attentional orienting (Cue-P3), response preparation (CNV), conflict monitoring (NoGo-N2), 
response inhibition (NoGo-P3) and response execution (Go-P3) from the CPT-OX. The results 
showed that both ADHD and BD groups displayed a reduced NoGo-P3, indicating atypical 
inhibitory control, compared to controls. The CNV, reflecting ERP activity of response 
preparation, was significantly reduced in women with ADHD, and at trend level in women with 
BD, compared to controls. These findings indicate overlapping impairments in inhibitory control 
and, potentially, in response preparation in ADHD and BD. Instead, the N2 in response to NoGo 
stimuli, indexing conflict monitoring, was attenuated in women with BD only, compared to 
women with ADHD and controls. This neurophysiological alteration in conflict monitoring may 
thus be specific to BD and insensitive to impairments in ADHD in this task that induces low 
conflict demands (McLoughlin et al., 2010), unlike tasks inducing higher conflict demands, which 
are sensitive to N2 impairments in ADHD (McLoughlin et al., 2009, Chapter 2). Since the NoGo-
N2 reduction in women with BD was temporally followed by the inhibitory control deficit in the 
NoGo-P3, this pattern may indicate broader alterations in both conflict and inhibitory processes 
in BD, among the processes implicated in withholding an incorrect response. Instead, women 
with ADHD only displayed the latter alteration, which suggests impairments primarily in 
response inhibition in women with ADHD during the processing of NoGo trials. Neither women 
with ADHD nor those with BD showed impairments in P3 components in response to Cue or Go 
stimuli, indicating potentially intact brain activity underlying attentional orienting and 
attentional allocation with response execution in women with either disorder. 
 
Along with neurophysiological alterations, impairments in ADHD or BD, or both, emerged also 
in measures of cognitive performance. Specifically, relative to controls, women with ADHD 
showed increased OE and CE, and potentially higher (at trend level) RTV, while women with BD 
showed significantly increased RTV and potentially increased (at trend level) OE. Yet, none of 
these cognitive-performance indices differentiated women with ADHD from women with BD. 
This pattern of results may suggest greater ability of neurophysiological markers compared to 
cognitive-performance measures in detecting differences between individuals with ADHD and 





7.3.5 Shared and disorder-specific event-related brain oscillatory markers of attentional 
dysfunction in ADHD and BD 
 
A second study on the same sample (Chapter 6) focused on attentional dysfunction in ADHD and 
BD. Individuals with either disorder were compared on measures of brain-oscillatory 
modulations of power and phase variability from EEG data, as well as RTV and ERPs, during a 
reaction time task under slow-unrewarded baseline and fast-incentive conditions. The results of 
this study indicate that both women with ADHD and women with BD showed increased RTV in 
the baseline condition and increased RTV, theta phase variability and reduced CNV in the fast-
incentive condition. These findings point to overlapping alterations in increased fluctuations in 
attentional performance, neural variability and neural response preparation in women with 
ADHD and women with BD. Similar to the attentional P3 components examined in Chapter 5 
(Cue- and Go-P3) with this sample, the P3 was intact in both clinical groups in both conditions 
of this task. In addition, while increased RTV and reduced CNV have been previously reported in 
both disorders, this chapter provides new evidence for increased intra-individual neural 
variability in the phase of theta oscillations in both women with ADHD and women with BD. Low 
phase consistency over trials points to a suboptimal ability to maintain a consistent pattern over 
trials in theta responses to targets in adults with ADHD and BD (Cavanagh et al., 2009, 
McLoughlin et al., 2014b, Groom et al., 2010a). Although this atypical theta phase variability 
emerged as significant only in the fast-incentive condition, the lack of a group-by-condition 
interaction may suggest that there may be subtle differences also in the baseline condition, non-
significant in this sample. Further similarities between ADHD and BD emerged in the ability to 
adapt cognitive and neural profiles to a changed context, from a slow, unrewarded condition to 
a fast and incentivised condition. Both individuals with ADHD and with BD, unlike controls, failed 
to display an improvement between conditions in neural attention allocation (P3) and 
attentional selection and activation (suppression of alpha power). This shared alteration may 
index a similar inability of women with either disorder to adapt these neural processes to a 
changed context.  
 
Additional impairments emerged in women with ADHD only. Specifically, women with the 
disorder showed reduced alpha suppression in the fast-incentive condition and lower 
adjustment in beta suppression between conditions relative to controls. These alterations in 
ADHD may indicate additional impairments in a brain-oscillatory marker of attentional selection 
(alpha suppression) and reduced improvements between conditions in neural mechanisms 
associated with response execution (adjustment in beta suppression). Yet, only the adjustment 
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in beta suppression distinguished between ADHD and BD, as impairments in most processes 
were shared between the two disorders 
 
Overall, by examining both ERP and fine-grained brain-oscillatory indices of brain activity and 
variability, these findings reveal novel neural mechanisms of shared attentional dysfunction in 
ADHD and BD. The overlapping impairments in neural markers identified in this study may 
represent shared neurobiological mechanisms underlying attentional dysfunction in ADHD and 
BD. One prediction from these findings is that the common neural impairments may underlie 




7.4.1 Mechanisms underlying remission and persistence of ADHD 
 
Two studies in this thesis (Chapters 2 and 3) provide new insights into the processes that may 
be markers of remission from ADHD, distinguishing between individuals with remitted and 
persistent ADHD, or enduring deficits, showing atypical profiles in both groups. Processes of 
attention-vigilance and neurophysiological error processing emerged as markers of remission 
from ADHD, and may represent cognitive and neural mechanisms linked to decline in ADHD 
symptoms and impairments from childhood to adolescence and early adulthood. A clinical 
implication of these findings is that these markers may be suitable targets for the development 
of new interventions for ADHD, such as those based on cognitive training and neurofeedback. 
Future studies should examine whether improvements in these processes following 
interventions may promote remission from the disorder and prevent detrimental long-term 
outcomes in individuals with a childhood diagnosis. Conversely, cognitive measures of executive 
control, neurophysiological conflict monitoring and functional connectivity were not sensitive 
to ADHD outcome, as they did not distinguish between individuals with remitted and persistent 
ADHD. Among these measures, atypical connectivity profiles (hyper-connectivity and reduced 
adjustment in connectivity with task demands) may further represent enduring deficits despite 
clinical remission, as remitters differed from neurotypical individuals in some of these measures, 
but were indistinguishable from persisters. Since these measures do not seem to follow the 
reduction with development in ADHD symptoms and impairment, it is possible that they may 




Overall, initial convergence across cognitive and neurophysiological markers of ADHD 
persistence and remission is starting to emerge between studies from the follow-up sample used 
in this thesis (Chapters 2 and 3; Cheung et al., 2016, James et al., 2017) and previous studies 
(Pazvantoglu et al., 2012, McAuley et al., 2014, Biederman et al., 2009, Roman-Urrestarazu et 
al., 2016). Most measures showing the pattern of markers of remission may map onto largely 
non-executive processes, such as vigilance, preparation and attentional allocation, which 
potentially reflect lower-level or more bottom-up mechanisms (Chapters 2; Cheung et al., 2016, 
James et al., 2017). Instead, the majority of measures unrelated to ADHD outcome (Chapters 2 
and 3) may reflect more executive or top-down cognitive and neural processes, in line with most 
longitudinal studies of executive functions to date (Pazvantoglu et al., 2012, McAuley et al., 
2014, Biederman et al., 2009, Roman-Urrestarazu et al., 2016).  
 
The empirical data on the separation between these impairments in relation to ADHD remission 
may be related to studies showing improvements in RTV and ERPs of error processing under 
certain context manipulations, such as rewards and faster event rate, where children and 
adolescents with ADHD show greater improvements than neurotypical individuals (Kuntsi et al., 
2009, Uebel et al., 2010, Groom et al., 2013, Andreou et al., 2007). Improvements in these 
indices in individuals with ADHD have further been shown with ADHD stimulant medication 
(Rhodes et al., 2006, Bron et al., 2014, Groom et al., 2013). An improvement with incentives, 
conversely, has not been shown in measures of executive function, such as CE (Kuntsi et al., 
2009, Uebel et al., 2010), and more inconsistent evidence exists on the effect of medication on 
executive impairments (Scheres et al., 2003, Rhodes et al., 2006). These studies indicate that 
response variability and error processing are malleable and may improve with the additional 
allocation of cognitive arousal and motivational incentives in ADHD samples, while impairments 
in executive functions may be more “fixed” and less malleable. Taken together, the results on 
ADHD remission and on improvements in neurocognitive impairments with incentives may lead 
to the hypothesis that the more malleable non-executive or bottom-up processes may be more 
sensitive to developmental improvements and to positive environmental influences (e.g., high 
SES, supportive family environment) that may promote remission in a subgroup of individuals 
with childhood ADHD. Instead, the more fixed and less malleable executive impairments may be 
less sensitive to such influences, and represent risk factors or characteristics associated with the 
disorder in childhood (Johnson, 2012), which may not follow the developmental improvements 
in clinical symptoms in individuals that remit from the disorder. Yet, the follow-up studies 
included in this thesis and the majority of previous studies on ADHD remission are in conflict 
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with a prominent developmental theory of ADHD (Halperin and Schulz, 2006), which proposes 
that the remission or persistence of ADHD from childhood to adulthood would be predicted by 
the degree of maturation and improvement over time in prefrontally-mediated executive 
functions, which could act as mechanisms of compensation. Conversely, lower-level functions 
would be linked to the presence of ADHD in childhood, irrespective of later clinical status, 
according to this model (Halperin and Schulz, 2006). Future studies are needed to formally test 
the hypotheses presented here and refine theoretical developmental models of ADHD based on 
available empirical evidence.  
 
7.4.2 Multiple pathways to cognitive-neurophysiological impairments in ADHD 
 
The study into the aetiological structure of cognitive-neurophysiological impairments in ADHD 
in adolescence and early adulthood (Chapter 4) indicates a partial separation between three 
processes, accounting for IQ and response speed/variability, short-term and working memory, 
and sustained attention and error/inhibition processes. Alterations in cognitive processes and 
brain activity may thus result from multiple atypical neurobiological pathways, supporting 
theoretical models that emphasise the role of multiple functions in the pathogenesis of ADHD 
(Halperin and Schulz, 2006, Castellanos et al., 2006). This multifactorial structure may explain 
the observed heterogeneity in cognitive profiles that exists among individuals with ADHD 
(Mostert et al., 2015, Coghill et al., 2014), who display various degrees of impairments in several 
cognitive functions. The partial aetiological dissociation between the identified cognitive 
clusters in ADHD may indicate that impairments in these factors have different roles in relation 
to ADHD pathophysiology. For example, only some impairments may represent mediators lying 
on the causal pathways to ADHD, while others may only represent associated characteristics 
(Kendler and Neale, 2010).  
 
A possible clinical implication of these findings is that, in the development of new non-
pharmacological treatments for ADHD, such as those based on cognitive training and 
neurofeedback, multiple processes could be targeted by different intervention components, and 
tailored based on the specific impairments manifested by each individual, with a personalised 
approach. Yet, limited evidence exists on the fact that interventions targeting cognitive 
processes can an effect on ADHD symptomatology (Cortese et al., 2015). In particular, it has 
been shown that treatments targeting working-memory impairments have limited-to-no effects 
on ADHD symptoms (Cortese et al., 2015). The results of non-familial influences on the identified 
factors may provide an explanation for the lack of efficacy of working-memory training 
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programmes. At the non-familial level, the variance of most measures, including working 
memory, was largely captured by measure-specific influences, which were not shared with 
ADHD. In sibling model fitting, non-familial influences include individual-specific environmental 
factors, representing any differences in the environment between siblings, and may also include 
the effects of any treatment for ADHD. Since the memory or response-accuracy processes 
appear to be captured by aetiological influences that are largely not shared with those on ADHD, 
any improvement in these measures may not mediate or moderate improvements in ADHD. 
Conversely, the non-familial variance of MRT and RTV was almost entirely accounted for by a 
non-familial factor which moderately overlapped with non-familial influences on ADHD, with 
limited residual variance in these measures not shared with the disorder. A possible prediction 
is that non-pharmacological cognitive training interventions aimed at alleviating ADHD 
symptoms may be more effective if they target reaction time processes rather than memory or 
response accuracy. This is in line with the evidence that RTV in children and adolescents may be 
more malleable than executive processes (Kuntsi et al., 2009, Uebel et al., 2010), and that RTV 
is associated with ADHD remission in follow-up studies (Chapter 2; Cheung et al., 2016).  
 
7.4.3 Modulation of neural processes with task demands in ADHD and BD 
 
The findings from two of the studies included in this thesis (Chapters 3 and 6) suggest that 
individuals with ADHD or BD may show reduced modulations of neural processes with task 
demands. Controls showed increases in P3 and alpha power suppression in changing from a 
slow, unrewarded task condition to a faster and incentivised condition in the Fast task. Instead, 
adults with ADHD or BD showed a lack of adjustment between conditions in both measures 
(Chapter 6). These alterations in brain activity of attentional allocation and attentional selection, 
respectively, may indicate that these attentional processes in adult women with ADHD or BD are 
less sensitive than in controls to the manipulations of this task. This finding may point to lower 
malleability in these neural processes in adults with ADHD or BD with changed task demands. 
This interpretation is further supported by the pattern of findings of atypically increased neural 
variability in the phase of theta oscillations in both clinical groups, also pointing to an altered 
modulations of brain processes in both ADHD and BD. Specifically, women with ADHD and 
women with BD, compared to controls, showed a lower increase in theta phase consistency over 
trials in switching from a preparatory (pre-stimulus) to a cognitively active (post-stimulus) 
condition upon target appearance. This process has previously been referred to as “phase-
resetting” (Palaniyappan et al., 2012, Lakatos et al., 2009). Significantly more variable event-
related theta phase responses over trials were further observed in both clinical groups relative 
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to controls in the fast-incentive condition, but not in the baseline condition. Phase-resetting in 
theta responses over trials has been suggested as a mechanism underlying enhancements of P3 
components after stimulus presentation in cognitive tasks, along with increases in allocation of 
brain activity (Mazaheri and Picton, 2005, Basar-Eroglu et al., 1992). As such, the results of 
atypical phase consistency and P3 in this study may converge in indicating reduced sensitivity to 
task manipulations in adults with ADHD or BD.  
 
The lack of modulation in neural processes with task demands in adults with ADHD and adults 
with BD may be linked to results of previous studies, indicating a lack of adaptation in theta 
power in switching from a resting state condition to the CPT-OX task in adults with ADHD or with 
BD (Rommel et al., 2016, Skirrow et al., 2015). The lack of such a neural mechanism could 
indicate a reduced ability to modulate brain activity with changing cognitive demands (Rommel 
et al., 2016, Skirrow et al., 2015). A similar alteration to that observed in these resting-to-task 
studies could also underlie the lack of modulation in the P3 and suppression of alpha power in 
Chapter 6, both linked to attentional processes, in changing from the baseline condition, where 
participants spend the majority of time in a condition similar to “resting”, to the fast-incentive 
condition that has an event rate more similar to that of other attentional tasks, such as the CPT-
OX (Rommel et al., 2016, Skirrow et al., 2015). The atypical modulations in theta activity in 
changing from resting to active attentional states have been hypothesised to be related to 
alterations in the default-mode network (DMN) (Rommel et al., 2016, Skirrow et al., 2015), as 
studies in ADHD have shown that the DMN may be inadequately suppressed during cognitive 
tasks (Cortese et al., 2012). Future studies, potentially combining EEG and fMRI techniques, are 
needed to test whether DMN alterations underlie impairments in adapting to context changes 
in ADHD and BD. 
 
Adolescents and young adults with ADHD further showed a reduced modulation in brain 
connectivity in theta oscillations from a pre-stimulus condition to an actively engaging cognitive 
processing condition, following target onsets in high-conflict trials of the arrow flanker task 
(Chapter 3). This finding suggests that individuals with the disorder have difficulties in adapting 
their connectivity profiles in slow oscillations to task demands in this highly effortful task. 
Previous studies have associated connectivity in theta oscillations during cognitive tasks with 
cognitive processes engaging control networks and requiring co-ordination of activity between 
distributed brain areas (Buzsaki and Draguhn, 2004, Uhlhaas and Singer, 2006, Wang, 2010). 
Given the high levels of cognitive control enhanced by incongruent stimuli in this task, the 
modulation from pre-stimulus to post-stimulus windows of theta connectivity may have a role 
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in co-ordinating activity between various regions of the executive network and maintaining 
optimal cognitive control during the task. Alterations in modulating theta connectivity in ADHD 
may point to dysfunctional regulation of slow oscillations in brain networks of executive control, 
and to an inability to adapt brain connectivity from a relatively-inactive context to a condition 
requiring cognitive engagement. An alternative explanation for the reduced modulation of theta 
connectivity, as discussed above, is a dysfunctional modulation of the DMN in individuals with 
ADHD, who may engage in irrelevant cognitive activities (e.g., mind wandering) before stimulus 
onset (Mowlem et al., 2016, Jonkman et al., 2017), potentially producing reduced preparation 
for the upcoming stimulus. Yet, the inter-stimulus interval (1.65 s) in the fast-paced task used in 
this study may be too short to allow participants to reach a neural condition similar to rest. An 
atypical modulation of connectivity linked to executive networks is thus a more likely 
explanation. Future studies performing similar pre-stimulus/post-stimulus comparisons in other 
tasks mapping onto potentially less executive processes, as well as examining connectivity 
between brain regions with more precise spatial resolution, will be useful to clarify this matter 
further. 
 
7.4.4 Developing biomarkers for ADHD and BD 
 
The diagnosis of ADHD and BD, similar to other psychiatric diagnoses, is based on clinical 
observations and descriptions of behavioural symptoms. The subjective nature of such indices 
contrasts with the more objective indicators and diagnostic tools that are commonly used in 
other branches of medicine to assign diagnoses and monitor treatment outcomes, in 
conjunction with reports on symptoms. The identification of objective markers of alterations at 
the cognitive and neurophysiological levels, together with being useful for understanding the 
mechanisms underlying clinical symptoms and impairment, may have future clinical 
applications, as they may aid in diagnostic and treatment decisions (Jeste et al., 2015). The 
identification of biomarkers for psychiatric disorders with high sensitivity and specificity may 
help parse the complexity of the clinical manifestations of these conditions and aid in disease 
prediction, diagnosis, and treatment monitoring in addition to behavioural symptoms (Loo and 
Makeig, 2012, Loo et al., 2015, McLoughlin et al., 2014a). Amongst putative biomarkers, 
objective measures derived from high-density electroencephalography (EEG) may hold practical 
advantages as clinical biomarkers (Jeste et al., 2015, Loo et al., 2015): they are non-invasive, 
cost-effective, sensitive to individual differences in behaviour (Loo and Makeig, 2012, Loo et al., 
2015, McLoughlin et al., 2014a), and provide the millisecond temporal resolution necessary to 
capture fast-changing cognitive and neural functions (Jeste et al., 2015, Loo et al., 2015). 
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The second part of this thesis includes two cross-disorder neurophysiological studies in ADHD 
and BD, aimed at finding objective measures of differences and similarities between the two 
disorders. In Chapter 5, evidence emerged for differences in conflict monitoring (NoGo-N2) 
between women with BD and women with ADHD, as only the former group showed impairments 
in this process in this task inducing low levels of conflict-monitoring demands. In Chapter 6, a 
further difference between the disorders was observed in a measure of change between a slow, 
unrewarded condition to a fast, incentivised condition, as women with ADHD showed a lower 
increase between conditions in suppression of beta power, reflecting a lower improvement 
between conditions in neural activity of motor execution, relative to women with BD. When 
referred for clinical consultation, some cases of ADHD or BD may present with certain 
overlapping symptoms of the two disorders, which may lead to uncertainty regarding the 
diagnostic boundaries and, in turn, treatment decisions. These initial results represent some of 
the first findings of potentially distinct neurophysiological profiles in ADHD and BD. If replicated 
in future studies with larger samples, the identified measures may represent candidate 
biomarkers to aid in the delineation of the diagnostic boundaries between the two disorders in 
adults. Yet, it remains unclear to what extent these candidate biomarkers for BD and ADHD may 
be specific to these two disorders, or rather shared with other psychiatric or 
neurodevelopmental diagnoses. Since the comparison with further disorders was not a focus of 
this thesis, future research is needed to clarify this issue. To move forward towards a potential 
clinical application of the identified measures as biomarkers to aid in diagnostic and treatment 
decisions, future studies could also explore whether combining markers from different domains 






7.5.1 Sample sizes 
 
The large size of the sample used in the first three chapters of this thesis is one of the main 
strengths of this work. The sample of individuals with childhood ADHD (n=110) and neurotypical 
individuals (n=169) used in Chapters 2 and 3 represents the largest study in ADHD that have 
used cognitive-ERP and EEG connectivity measures from a performance monitoring task. 
However, due to the high persistence rates of ADHD in this sample of adolescents and young 
adults, the sample size for the remitted ADHD group was modest (n=23) compared to the 
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persistent and control groups. As such, these results await replication in samples with greater 
numbers of remitted individuals. The full ADHD and control sibling-pair samples used in Chapter 
4 consisted of 404 participants in total, making it one of the largest cognitive-EEG studies of 
ADHD to date.  
 
The two cross-disorder comparison analyses of ADHD and BD used a sample of modest size 
(n=60 participants in total, 20 with ADHD, 20 with BD, 20 controls), as this study was originally 
designed as a pilot study to inform larger-scale investigations. Although medium-to-large effects 
were detected as significant with current sample sizes, this study may be limited in its ability of 
detecting more subtle differences between groups, which will require future larger-scale 
investigations. 
 
7.5.2 Sibling model fitting 
 
The analyses on the ADHD and control sibling-pair samples allowed to gain valuable insight not 
only into the association between ADHD and a range of cognitive-EEG alterations, but also to 
examine whether there are similarities or differences in certain traits between affected and 
unaffected siblings growing up in the same family. The advantage of having such information is 
that, in the presence of a phenotypic association between ADHD and other traits, one can then 
decompose their covariation into contributions of familial and non-familial factors, and thus 
examine aetiological pathways to the disorder. Yet, although sibling samples can estimate the 
aggregated contribution of familial effects on phenotypic similarities between siblings in the 
same family, they do not allow to distinguish between genetic and shared environmental 
factors. The contribution of genetic factors cannot thus be directly estimated with sibling 
samples, and should be tested in future studies using twin samples. 
 
7.5.3 Categorical and dimensional definitions of ADHD 
 
Another strength of this thesis is the use of both categorical and dimensional approaches to 
ADHD remission (Chapters 2 and 3). Specifically, categorical analyses compared individuals 
classified as ADHD persisters and remitters based on clinical cut-offs of ADHD as present or 
absent. Dimensional analyses examined how the investigated measures were associated with 
the continua of ADHD symptoms and impairments. Given the complexity of defining ADHD 
outcome based on categorical diagnosis or dimensional measures of ADHD symptoms and 
impairment, adopting both approaches is valuable to obtain a more complete picture of ADHD. 
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The former approach better reflects clinical diagnostic discriminations between affected and 
unaffected individuals. The latter approach uses symptom count and level of impairment as 
observed, thus not relying on arbitrary thresholds, and is thought to parallel the continuous 
nature of pathophysiology (Brown and Barlow, 2005). A dimensional approach also allowed us 
to examine ADHD symptoms and impairment separately. 
 
7.5.4 Multi-method cognitive and EEG approach 
 
Throughout this thesis, a combination of cognitive-performance, ERP, EEG activity and 
connectivity measures were used. Measures of cognitive performance provide global 
information on participants’ speed and accuracy during cognitive tasks. The precise temporal 
resolution and direct measurement of brain activity with EEG further provide insights into sub-
second stages of information processing underlying overt and covert cognitive processes. The 
analysis of ERP components employed in most studies (Chapters 2, 4, 5, 6) is a robust and well-
validated approach to investigate, with millisecond resolution, differential information-
processing stages in evoked brain responses to task stimuli (Banaschewski and Brandeis, 2007, 
Luck et al., 2011). More recent and advanced analytic approaches were also employed to 
examine event-related modulations of brain activity and connectivity. Time-frequency analyses 
examined changes in power and phase variability (Chapters 6), which provided fine-grained 
information beyond evoked brain activity captured by ERPs. Of particular relevance for ADHD 
and BD, which have both been associated with increased response variability, the examination 
of inter-trial coherence (ITC) in EEG phase (Chapter 6) provided an index of neural variability in 
the processing of a stimulus repeated over trials, which may parallel variability at the cognitive 
level (McLoughlin et al., 2014b, Groom et al., 2010a). Finally, while most EEG indices employed 
in this thesis have been measured at a single scalp location or a region where activity was 
maximal, as is common practice in ERP and time-frequency analyses, connectivity analyses 
examined the brain-wide interaction between brain activities from different scalp regions 
(Chapter 3). The use of network-based metrics allowed to examine brain network properties in 
the way brain connectivity differs between groups, with consistent results both for measures of 




The age ranges of the samples included in this thesis were restricted to adolescence (Chapters 
2-4) and early or middle adulthood (Chapters 2-6). Considering that maturational effects on 
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cognitive and neurophysiological indices are well documented in previous studies (Liechti et al., 
2013, Valko et al., 2009, Michels et al., 2013, Poil et al., 2014, Rommel et al., 2015), the results 
cannot be generalised to age groups outside those studied. Since the samples used in the first 
three chapters spanned both adolescence and young adulthood, age was controlled for in all 
analyses to account for age effects. Participants included in the last two chapters were all in 
early or middle adulthood, thus further studies are needed to compare ADHD and BD earlier or 
later in the lifespan. To understand how the association of cognitive-neurophysiological 
impairments with ADHD and BD may differ with development, replication of these studies at 
different developmental stages is required. With regard to generalisability across genders, the 
majority of participants in the samples for the studies in the first part of this thesis were males, 
thus providing limited information on the investigated impairments in females with ADHD. 
Conversely, the sample used for the last two thesis chapters was an all-female sample, in order 
to match groups on sex in this smaller-scale study. It remains unclear, however, if the results 
would generalise to adult men, warranting further investigation. In relation to IQ, participants 
with ADHD and unaffected siblings showed significantly lower IQ than control participants, as is 
typical for individuals with the disorder (Frazier et al., 2004) and reported in previous family 
studies (Rommelse et al., 2008c, Wood et al., 2011). This variable was directly examined in 
relation to cognitive-neurophysiological impairments in ADHD in the first part of this thesis, by 
performing analyses with and without controlling for IQ (Chapters 2 and 3) and including IQ into 
multivariate model-fitting analyses (Chapter 4). The sample for the ADHD and BD study was well 
matched on IQ, thus results may not be fully representative of more heterogeneous clinical 
populations. Yet, lower IQ scores relative to neurotypical individuals have been reported both 
in individuals with ADHD (Frazier et al., 2004) and individuals with BD (Joseph et al., 2008, Olvet 
et al., 2013). As such, whether the findings based on these groups generalise to more typical 
individuals with ADHD or BD remains to be tested in future studies of individuals with more 
characteristic IQ profiles. 
 
7.5.6 Effects of medication 
 
Potential effects of medication are difficult to control for in psychiatric research, especially when 
differences may exist in the type of prescribed medication to individuals with psychiatric 
conditions. In all studies included in this thesis, individuals with ADHD were asked to stop taking 
the medication they had been prescribed for the disorder 48 hours before the testing sessions. 
This is a standard procedure in cognitive and neurophysiological studies of ADHD (Cheung et al., 
2016, McLoughlin et al., 2009). As such, the findings in individuals with ADHD reported in this 
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thesis cannot be attributed to short-term effects of ADHD medication on the investigated 
measures. However, long-term effects of ADHD medication use cannot be fully excluded. In 
Chapters 2 and 3, a comparable proportion of individuals in remitted and persistent ADHD 
groups were taking medication at follow-up. This potentially suggests that medication at the 
time of the assessments may not impact the differences in clinical or cognitive-EEG measures 
between ADHD remitters and persisters. Yet, information on previous use of medication 
between the childhood and follow-up assessments were not available in this study. As such, it 
cannot be determined whether the findings of these studies could be partly attributed to 
individual differences in long-term effects of ADHD medication.  
 
In the studies described in the second part of this thesis, it was not possible, for ethical reasons, 
to ask participants to stop taking mood-stabilising, anti-psychotic or antidepressant 
medications. The effects of medication pose a particularly difficult challenge in cross-disorder 
studies where different groups are prescribed different drug treatments. Due to the limited 
number of participants in medication sub-groups, it was not possible to directly test the effect 
of medication on impairments in cognitive and EEG measures in ADHD and BD, which represents 
a limitation of the current study. However, previous studies suggest that medications may show 
positive effects (reducing differences from controls) or limited effects on cognitive-EEG 
measures (Anderer et al., 2002, Karaaslan et al., 2003, Galletly et al., 2005, Degabriele and 
Lagopoulos, 2017). As such, it seems unlikely that the group differences and impairments 
reported in individuals with ADHD or BD in the studies included in this thesis reflect confounding 
effects of medication.  
 
7.5.7 Multiple testing 
 
Due to the exploratory nature of the cognitive-electrophysiological investigations included in 
this thesis, multiple testing corrections were not applied in most analyses, in order to limit the 
chance of introducing type-two errors (false negatives). When applying multiple-testing 
corrections was deemed not appropriate, analyses were restricted to variables that were 
expected to be sensitive to impairments in ADHD or BD. For example, ERP analyses were limited 
to amplitude measures, and did not examine group differences on peak latencies, as most 
previous studies using the tasks included in this thesis found that alterations primarily involve 
amplitude differences (McLoughlin et al., 2010, McLoughlin et al., 2009). In the cross-disorder 
comparison study between ADHD and BD multiple testing corrections were further not applied 
to reduce false negatives, as this study was set up as a pilot investigation to identify potential 
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biomarkers to validate in larger-scale studies. Due to the exploratory nature of these analyses, 
future replication of the results will be important before drawing conclusions on shared and 
distinct alteration in ADHD and BD. In addition, in interpreting the results, emphasis was placed 
both on effects sizes and p-values of significance. Given the large number of variables included 
in the brain connectivity study (Chapter 3), which was higher than in the other more hypothesis-







As all the studies in this thesis are novel, replication of the findings in independent samples will 
be required, both using the same measures and using different measures capturing comparable 
cognitive and neurophysiological processes. The studies on cognitive, EEG activity and 
connectivity markers in individuals with remitted and persistent ADHD (Chapters 2 and 3) are 
the first of their kind using a performance monitoring task, and future studies are needed to 
confirm the results and conclusions. Similarly, the study on the aetiological structure of 
cognitive-neurophysiological impairments is ADHD (Chapter 4) is the first conducted in a clinical 
sample of adolescents and young adults, as well as using both cognitive-performance and ERP 
measures; thus replication is warranted. Performing comparable analyses on a twin sample 
would further help establish to what extent the identified familial factors reflect largely shared 
genetic influences or also shared environmental influences.  
 
Replication in large samples will be especially important for the studies on ADHD and BD 
(Chapters 5 and 6), which included a relatively small sample compared to the studies in the 
previous chapters. Despite the modest sample size, these studies represent some of the first 
empirical data comparing adults with ADHD and adults with BD on ERP and brain-oscillatory 
markers of attentional and inhibitory processes. Although initial internal replication emerged 
(e.g., for the CNV and attentional P3 components, comparable results were obtained in both 
chapters), future studies with larger samples and including individuals of both sexes are needed 





7.6.2 Examining other definitions of ADHD 
 
In all chapters included in this thesis, ADHD was defined based on diagnostic criteria from the 
DSM-IV (APA, 2000), which was the DSM version in use at the time of setting up the data 
collection for the samples included in this thesis. Future studies should aim to replicate these 
findings using the current DSM-5 criteria for ADHD. In addition, clinical guidelines recommend 
different informant to ascertain ADHD symptoms and impairments at different stages of 
development; i.e., parent-report in childhood and adolescence (Taylor et al., 2004) and self-
report in adulthood (Kooij et al., 2010). Given the wide age range (11-27 years) of the ADHD and 
control sibling-pair sample (Chapters 2, 3 and 4), consistency in reports to establish ADHD 
diagnosis was achieved by using parent-report symptoms and impairments in all participants. 
Parent-report measures were chosen over self-report measures, as the latter showed limited 
agreement with objective markers (cognitive-performance and EEG measures) of ADHD 
remission and persistence in this sample (Du Rietz et al., 2016). Specifically, the same cognitive-
EEG measures that distinguished between ADHD remitters and persisters using parent-reported 
ADHD outcome (Cheung et al., 2016) distinguished poorly between ADHD groups based on self-
report (Du Rietz et al., 2016). Future studies should further investigate the reliability and value 
of different informant accounts, and how these results may vary using different informants. 
ADHD diagnosis in Chapters 5 and 6 was based on self-report ADHD symptoms and impairment, 
as all participants in this cross-disorder study were adults (age range: 20-52 years), and self-
report is also commonly used for BD in adulthood. Future studies may, however, benefit from 
the collection of clinical information also from co-informants. 
 
7.6.3 Developmental associations between ADHD and cognitive impairments 
 
Chapter 4 investigated the aetiological structure of cognitive and neurophysiological 
impairments in ADHD in adolescence and young adults, using both cognitive-performance and 
EEG data. Although data used in this analysis represent a follow-up investigation in a subsample 
of a study investigating cognitive impairments in ADHD in childhood (Kuntsi et al., 2010), the 
cognitive batteries used in the two assessments were partly different, and EEG data was not 
available in childhood. Given the strong emphasis on neurophysiological markers in this thesis, 
analyses were restricted to the follow-up assessment where both cognitive and EEG data were 
available. Future analyses could examine the aetiology of the longitudinal association between 
ADHD and cognitive measures available at both time points (IQ, DSF, DSB, MRT and RTV from 
the Fast task). Previous analyses at each time point have shown evidence of substantial familial 
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risk factors underlying the association between cognitive impairments and ADHD (Kuntsi et al., 
2010, Chapter 4). Longitudinal analyses will allow to examine the extent to which familial and 
non-familial aetiological factors explain the developmental relationships between ADHD and 
cognitive measures. The sibling-pair nature of this sample will further enable to examine the 
contribution of familial and non-familial aetiological factors to the developmental stability and 
change in these cognitive measures and ADHD symptoms from childhood to young adulthood.  
 
7.6.4 Source-based and single-trial EEG analyses 
 
The neurophysiological indices used in this thesis were extracted with a variety of traditional 
and more advanced EEG analytic approaches applied to scalp-level data from EEG channels, in 
line with most previous EEG studies in ADHD (Albrecht et al., 2008, Cheung et al., 2016, 
McLoughlin et al., 2010, Groom et al., 2010b). Analyses of channel activities usually rely on 
averaging of EEG signals to enhance the signal-to-noise ratio, in order to obtain meaningful 
waveforms, connectivity matrices and brain-oscillatory indices. Due to the relatively poor signal-
to-noise ratio of scalp-EEG activity, analysis of EEG signals on a single-trials basis is difficult with 
EEG scalp data. In addition, despite EEG provides excellent temporal resolution, EEG scalp 
distributions derived from traditional EEG methods result from a mixing of several overlapping 
brain sources simultaneously projecting at the scalp (Makeig et al., 1997, Makeig et al., 2004a). 
As such, these traditional methods do not allow to precisely localise neural processes in the 
brain.  
 
Advances in EEG methodologies provide an alternative to the analysis of channel data, by using 
statistical and computational approaches to derive and separate the activity of underlying brain 
sources with enhanced spatial resolution (McLoughlin et al., 2014a, Loo and Makeig, 2012, 
Makeig et al., 2004a). One such analysis technique is independent-component analysis (ICA), 
which allows to decompose the mixing of brain sources and isolate the activity of temporally 
independent individual sources of EEG activity, thus improving signal-to-noise ratio in detecting 
brain activity (Makeig et al., 1997, Makeig et al., 2004a). Although investigators have only 
recently begun to apply these approaches to data from individuals with psychiatric or 
neurodevelopmental disorders, it has been suggested that analysing source activity may 
potentially capture impairments in clinical conditions more in detail (Grin-Yatsenko et al., 2010, 
Loo et al., 2015, McLoughlin et al., 2014b, McLoughlin et al., 2014a). These methods may, in 
turn, allow further characterisation of developmental outcomes of ADHD or delineation 
between ADHD and BD. For example, the improved signal-to-noise ratio gained with source-
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based analyses may allow the examination of EEG signals on a trial-by-trial analyses, which 
would be particularly valuable to study ADHD and BD, as individuals with either disorder are 
characterised by high intra-individuals variability in cognitive processes (Kuntsi et al., 2013, Bora 
et al., 2006). It would be therefore useful to examine this variability at the neural level in future 
studies, linking variability at the neural level to variability at the cognitive level with single-trial 
analyses. Finally, these source-based methods allow more precise localisation of brain activity 
in anatomical brain regions, bridging the gap in spatial resolution between EEG and other 
neuroimaging techniques such as fMRI (McLoughlin et al., 2014a, Loo and Makeig, 2012, Makeig 
et al., 2004a). Future studies could further perform brain connectivity analyses on these source 
activities, rather than on scalp-based data, which would enable the investigation of functional 
connectivity between more localised functional networks without contamination of volume 
conduction (Loo et al., 2015, Coben et al., 2014). The examination of the dynamic formation of 
functional networks between brain sources during cognitive processes could also be examined 
(Lenartowicz et al., 2014). 
 
7.6.5 Persistence and remission of ADHD in middle and late adulthood 
 
The follow-up assessment in the sample used for the first part of this thesis was in adolescence 
and early adulthood. Since about half of the participants were still adolescents, not all 
participants may have remitted by the follow-up assessment, but may still remit later in 
development. Although longitudinal studies of cognitive and neurophysiological processes in 
ADHD samples are limited to date, a small-scale longitudinal ERP study suggests that there may 
be a maturational lag in the development of neurophysiological inhibitory control (NoGo-P3), 
but not for attentional processes (Cue-P3), in individuals with ADHD (Doehnert et al., 2010). 
Further evidence also indicates that longitudinal studies using structural MRI show that 
prefrontal brain areas continue to develop until young adulthood (Shaw et al., 2006). Therefore, 
the possibility remains that the lack of differences between ADHD persisters and remitters in 
largely prefrontally-mediated executive functions could be due to the young age at follow-up, 
as these processes may continue to develop, and potentially improve in remitters, into 
adulthood. As such, a further future direction for research should be to carry out additional 
follow-up assessments of the ADHD and control sibling-pair sample in middle and late 
adulthood.  
 
Extending the investigation to a new follow-up with cognitive and EEG assessments when all the 
participants have reached adulthood would provide the new data on markers of remission and 
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enduring deficits, as well as of the developmental changes in clinical, cognitive and 
neurophysiological profiles from childhood to adulthood. In particular, identical EEG measures 
between follow-up assessments would allow to examine differences between ADHD remitted 
and persistent groups while controlling for baseline assessments. Since data from the arrow 
flanker task were not available in the childhood assessments, these analyses on data from a 
further follow-up with identical measures would be needed to rule out the possibility that 
differences in the measured identified as markers of remission between ADHD remitters and 
persisters could not be already explained by subtle differences between the two groups at 





Overall, by using a combination of cognitive, neurophysiological, developmental, and sibling-
modelling approaches, the work presented in this thesis furthers our understanding of 
impairments in cognitive and brain function in adolescents and adults with ADHD. This thesis 
focused, in particular, on the developmental and aetiological pathways to ADHD outcomes, and 
on the specificity or overlap with BD. These findings indicate that certain cognitive-
neurophysiological impairments are sensitive to different developmental outcomes of the 
disorder, map onto multiple familial factors, and largely overlap with alterations observed also 
in BD. The identification of cognitive and neurophysiological measures linked to the varied 
clinical outcomes of ADHD provides new evidence of neural markers that may underlie remission 
of symptoms and impairments, but also of neural alterations that may not be sensitive to 
developmental outcomes of remission or persistence. By examining the aetiological structure of 
cognitive and neurophysiological impairments in ADHD, this thesis further provides new insights 
into the relationship and separation between these impairments in ADHD in adolescence and 
early adulthood, both at the phenotypic and aetiological level. Finally, the cross-disorder 
examination of ADHD in comparison with BD provides novel evidence of widespread overlap in 
cognitive and neurophysiological impairments, but also of few distinct alterations in ADHD and 
BD.  
 
The findings and implications discussed in this final chapter highlight the value of combining 
multiple methodological approaches and levels of analysis from aetiological factors, neural 
mechanisms, cognitive processes and behavioural outcomes to gain a deeper understanding of 
the pathways to ADHD. The temporal precision of EEG provided sub-second temporal resolution 
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to characterise impairments in various stages of information processing and brain function. The 
use of multiple EEG analysis approaches further allowed the investigation of various aspects of 
neural processes, including brain activity, variability and connectivity. Future longitudinal 
studies integrating repeated assessments of cognitive measures and neurophysiological indices 
at various developmental stages will be particularly useful in further characterising the 
developmental trajectories of the various separable processes in relation to the course of ADHD 
into adulthood. Further research efforts should also aim to continue examining the 
neurobiological mechanisms that may be specific to ADHD or shared with other disorders, such 
as BD. The neurophysiological measures able to discriminate between ADHD and BD may be 
candidate biomarkers which, if replicated in larger studies, could be examined and validated in 
clinical settings to aid in the distinction between the two disorders when this is unclear from 
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The version of Eriksen flanker task used in this study consisted of 10 blocks of 40 trials where 
congruent versus incongruent conditions and the direction of responses (left versus right) were 
counter-balanced and randomized. Participants were seated on an adjustable chair in an 
acoustically shielded, video-monitored room. Two practice blocks were administered before the 
task blocks and task comprehension was ascertained prior to task performance. On congruent 
trials, flanker and target arrowheads pointed in the same direction; on incongruent trials, they 
pointed in opposite directions. Flankers were presented every 1650 ms (inter-trial interval (ITI), 
therefore an inter-block interval (IBI) was 1400 ms). ITI and IBI were fixed. After each block, 
feedback was presented on screen to emphasize both speed and accuracy, in order to encourage 
participants to make enough errors to enable analysis of ERN/Pe components, and enough 
correct responses for analysis of the N2. Where participants made > 10% errors on congruent or 
> 40% errors on incongruent trials, they were instructed to slow down. Where participants made 
< 10% errors on congruent or < 40% errors on incongruent trials, they were instructed to 
perform faster. If neither rule applied, feedback informed participants to continue the same 
way. The task was run during a 1.5-hour recording session between two other tasks not reported 
here: preceded by the cued continuous performance test (CPT-OX) and followed by the Fast task 
(see (Cheung et al., 2016) for details). Breaks of at least 5 minutes were given in between tasks. 





In the present study, the ERN was measured with reference to the previous preceding positive 
peak (the PNe, occurring between -100 and 50ms), consistently with several previous studies in 
the literature (Falkenstein et al., 2000, Falkenstein et al., 2001, Frank et al., 2005, Gentsch et al., 
2009, Kopp et al., 1996, Nieuwenhuis et al., 2001, Nieuwenhuis et al., 2003). In these studies, 
this measurement of the ERN has proven useful to account for individual variability in amplitude 
range and to reduce latent low-frequency noise. The peak-to-peak ERN measure is also a robust 
index of early error processing, which has been shown to delineate ADHD from controls in 
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independent samples using this version of the Eriksen flanker task (Albrecht et al., 2008, 
Albrecht et al., 2010, McLoughlin et al., 2009). Since some previous studies on ADHD samples 
have instead measured the ERN as a peak-to-baseline measure (Groom et al., 2010, O'Connell 
et al., 2009, Wiersema et al., 2009), we also investigated the differences between ADHD 
remitters, persisters and controls on this peak-to-baseline measure and on the PNe directly, for 
completeness and to allow comparison with previous results.  
 
For the peak-to-baseline ERN we found significant overall group differences (p=.05) and ADHD 
persisters vs. controls difference (p<.01), but ADHD remitters did not significantly differ from 
either persisters (p=.47) or controls (p=.34). We did not find any group differences on the PNe 
(overall group effect: p=.18; ADHD remitters vs. persisters: p=.27; ADHD remitters vs. controls: 
p=.69; ADHD persisters vs. controls: p=.14).  
 
Considering these results, the peak-to-baseline ERN may be less sensitive to ADHD 
remission/persistence compared to the peak-to-peak ERN. Of note, the analysis of PNe alone 
showed no group differences on this measure, thus the inclusion of this earlier peak in the peak-
to-peak measure of the ERN did not explain the group differences on the peak-to-peak ERN, 






Table S2.1. Pearson correlations between cognitive and ERP measures and age, divided by group 
  
  
Pearson r with age 
Controls ADHD-R ADHD-P 
Congruent errors 0.01  -0.19 -0.23* 
Incongruent errors -0.14† -0.27 -0.29* 
Congruent MRT (ms) 0.13 0.02 0.17 
Incongruent MRT (ms) -0.15† -0.02 -0.20† 
Congruent RTV (ms) 0.18* 0.07  0.23* 
Incongruent RTV (ms) 0.25** 0.05 0.18 
N2 at Fz (µV) -0.42** -0.41† -0.39* 
N2 at FCz (µV) -0.28** -0.03 -0.15 
ERN (peak) at FCz (µV) -0.25** 0.19 -0.09 
ERN (peak-to-peak) at FCz (µV) -0.12 0.10 0.07 
Pe at CPz (µV) -0.36** -0.46* -0.25* 
Abbreviations: ADHD-R = ADHD remitters; ADHD-P = ADHD persisters; Congruent = congruent 
condition; Incongruent = incongruent condition; MRT = reaction time of correct response to 











Table S2.2. Full results of random intercept linear models showing main effects of group, condition (congruency), site (for the N2 only), and interaction effects 










Abbreviations: MRT = reaction time of correct response to targets; RTV = reaction time variability to targets (SD of reaction time). 
Data on performance measures were available for the full sample (87 ADHD-P, 23 ADHD-R and 169 controls); data on the N2 were available for 84 ADHD-P, 23 
ADHD-R and 169 controls. Age was also included as a covariate and its effects not presented here for simplicity, but available on request. Only group effects were 
tested on the ERN and Pe, thus regression models (rather than random intercept linear models) were used and the full results are presented in Table 2.2 of Chapter 








 Group effect Congruency effect Group-by- 
Congruency 
Site effect Group-by- 
Site 
 z p z p z p z p z p 
Errors 7.95 <.01** 43.39 <.01** -5.22 <.01** - - - - 
MRT 0.16 .87 582.71 <.01** 2.91 <.01** - - - - 
RTV -10.24 <.01** -90.07 <.01** 6.95 <.01** - - - - 











Table S2.3. Descriptive statistics and group comparison on cognitive-performance and ERP measures performed only on males 
 ADHD-P ADHD-R Ctrl Group Comparison 
Performance mean (SD) mean (SD) mean (SD) p ADHD-P vs Ctrl ADHD-P vs ADHD-R ADHD-R vs Ctrl 
d p d p d p 






<.01** .73 <.01** .68 .01** .00 .97 






<.01** .46 <.01** .09 .81 .35 .13 






<.01** .42 <.01** .19 .43 .23 .32 






<.01** .41 <.01** .02 .95 .42 .02* 






<.01** .99 <.01** .53 .01** .43 .05* 






<.01** .97 <.01** .45 .05* .53 .02* 
ERPs mean (SD) mean (SD) mean (SD) p ADHD-P vs Ctrl ADHD-P vs ADHD-R ADHD-R vs Ctrl 
d p d p d p 






.02* .34 .10 .05 .64 .29 .05* 






.09† .26 .11 .14 .30 .12 .85 






<.01** .52 <.01** .47 .09† .06 .78 

















Abbreviations: ADHD-P = ADHD persisters, ADHD-R = ADHD remitters, Ctrl = Control group, SD = standard deviation, p = regression model significant testing, d = 
Cohen’s d effect size (0.2 small, 0.5 medium and 0.8 large), Congruent = congruent condition, Incongruent = incongruent condition, MRT = reaction time of correct 
response to targets, RTV = reaction time variability to targets (i.e., SD of reaction time). 
Notes: Data on performance measures and N2 were available for 72 ADHD-P, 23 ADHD-R and 128 controls; data on the ERN and Pe were available for 69 ADHD-
P, 19 ADHD-R and 111 controls. Age was included as a covariate in all analyses and its effects are not presented here for simplicity, but available on request. 
Bold denotes a large effect size, italics denotes a medium effect size. **p≤.01; *p≤.05; †p≤.09.
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Figure S2.1. Difference wave (in blue) showing the difference between ADHD persisters (ADHD-
P, in red) and control participants (Controls, in black) in grand average stimulus-locked ERPs of 
the N2 at Fz and FCz electrodes between 250 and 450 ms after incongruent stimuli where a 
correct response was made, with t-map. 
Note: Topographical differences between ADHD persisters and controls can be observed here, 
which likely led to an enhanced N2 in persisters at Fz but with a trend for reduction at FCz. This 
is indicated in the grand average ERP showing the difference wave (in blue, ADHD persisters 
minus controls), which appears in the positive region of the graph at Fz (corresponding to the 
positive frontal difference in yellow-red in the t-map) and in the negative region of the graph at 
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The version of Eriksen flanker task used in this study consisted of 10 blocks of 40 trials where 
congruent vs incongruent conditions and the direction of responses (left vs right) were counter-
balanced and randomised. Participants were seated on an adjustable chair in an acoustically 
shielded, video-monitored room. Two practice blocks were administered before the task blocks 
and task comprehension was ascertained prior to task performance. On congruent trials, flanker 
and target arrowheads pointed in the same direction; on incongruent trials, they pointed in 
opposite directions. Flankers were presented every 1650 ms (inter-trial interval [ITI], therefore 
an inter-block interval [IBI] was 1400 ms). ITI and IBI were fixed. After each block, feedback was 
presented on screen to emphasise both speed and accuracy, to encourage participants to make 
enough errors to enable analysis of trials with incorrect responses, and enough correct 
responses for analysis of correct responses. Where participants made >10% errors on congruent 
or >40% errors on incongruent trials, they were instructed to slow down. Where participants 
made <10% errors on congruent or <40% errors on incongruent trials, they were instructed to 
perform faster. If neither rule applied, feedback informed participants to continue the same 
way. The task was run during a 1.5-hour recording session between two other tasks: preceded 
by a continuous performance test (CPT-OX) and followed by the Fast task (see Chapter 4). Breaks 
of at least 5 minutes were given in between tasks. When necessary, participants were told to 





Several challenges exist when measuring functional brain connectivity from EEG recordings 
(Siegel et al., 2012). The phenomenon of volume conduction refers to the near-instantaneous 
spreading of electrical potential from brain sources throughout the brain volume, skull and scalp 
(Onton and Makeig, 2006, Lopes da Silva, 2004, Nunez et al., 1997). At the scalp level, artefacts 
due to volume conduction mean that the activity of a same source may be measured at multiple 
distant scalp sites with near-zero phase delays (Onton and Makeig, 2006, Makeig et al., 2004). 
This can substantially limit the ability to measure functional associations between brain signals 
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from different scalp channels. One effective way to capture connectivity between brain regions 
using scalp-level signals is to measures their non-instantaneous associations, which are phase-
lagged (i.e., phase-shifted) and may thus not arise from artefacts of volume conduction. One of 
the main measures to assess phase-lagged connectivity is the imaginary part of the measure 
coherence (iCoh) (Nolte et al., 2004). In the present study, iCoh values were calculated between 
pairs of brain signals from every EEG channel in order to obtain a measure of functional 
association between brain signals without contamination of volume conduction (Nunez et al., 
1997). The phase coherence values between EEG signals were estimated by calculating their 
cross-spectrum for each time point with Fast Fourier Transforms using the “newcrossf” function 
in the EEGLAB toolbox (Delorme and Makeig, 2004) and the BioNeCt toolbox 
(https://sites.google.com/site/bionectweb/home; Coben et al., 2017) for Matlab. The imaginary 
part of the complex number phase coherence between two signals of same frequency was then 
isolated (Nolte et al., 2004). iCoh is measured in a scale between 0 and 1. When a zero-phase 
relationship exists between two signals, possibly due to volume conduction artefacts, iCoh is 
equal to 0. Instead, if two signals are phase lagged, this will result in a value of iCoh greater than 





When EEG signals are measured with high-density EEG recordings, performing a large number 
of statistical tests on the functional interactions between all pairs of electrodes carries problems 
of multiple comparisons. By applying network-based approaches, such as graph-theoretical 
metrics, it is possible to derive global network-based measures that can describe functional 
associations in terms of network properties and summarise information from multiple 
functional interactions between electrode pairs (Siegel et al., 2012, Bullmore and Sporns, 2009, 
Sporns, 2013). Graph theory is based on mathematical algorithms able to quantify the 
relationships (“edges”) between brain signals from EEG channels, representing the “nodes” of a 
network. Here, a graph-theory approach was applied on iCoh values using undirected weighted 
graphs. A weighted graph is defined by a symmetric matrix of functional association values 
between 0 and 1, which shows the strengths of the connections between the corresponding 
nodes (EEG channels). In contrast to binary graphs, where connections are measured as present 
or absent, weighted graphs have been shown to preserve essential information of a network 
structure (Ahmadlou et al., 2012, Bullmore and Sporns, 2009, Barrat et al., 2004). Graphs were 





Given the large number of hypotheses tested, sensitivity analyses applied multiple-testing 
corrections with false discovery rate (FDR) on post-hoc tests with the “multproc” package in 
Stata, using the Simes method, which identifies those tests that remain significant (Simes, 1986). 
Multiple-testing corrections (controlling the FDR at 15%) on post-hoc group comparisons 
(separately for ADHD persisters vs controls, ADHD remitters vs controls, ADHD persisters vs 
remitters) showed that all significant differences between controls and ADHD remitters, and 
between controls and ADHD persisters remained significant. The only previously significant 
difference between ADHD persisters and remitters (in beta diameter) was no longer significant 
when correcting for multiple testing. All significant group differences on measures of pre-
stimulus/post-stimulus change remained significant after correcting for multiple testing. 
Similarly, the statistically significant associations that emerged between a few connectivity 






The majority of individuals in our sample (80%) were males. Since groups were not fully matched 
on sex (Table 3.1), analyses were repeated with females (15 ADHD persisters, 41 controls) 
removed. Results were largely unchanged when rerunning analyses on the male-only sample 
(Table S3.3-S3.4). Only a few tests that were significant in the full sample on connectivity in the 
theta band became trend-level effects (p=0.05-0.10) in males only: the comparison between 
ADHD persisters and controls in pre-stimulus global efficiency in correct responses, and the 
comparison between ADHD remitters and controls in pre-stimulus diameter in correct responses 
and in post-stimulus average clustering coefficient, global efficiency and iCoh in error responses 
(Table S3.3). When repeating the analyses of within- and between-group change between time 
windows, differences between ADHD persisters and controls on the change between time 
windows in average clustering coefficient, global efficiency and mean iCoh during error trials, as 
well as between ADHD remitters and controls in theta diameter in correct trials and in alpha 







ADHD persisters in this sample had a lower IQ than ADHD remitters and controls (Cheung et al., 
2016), and childhood IQ predicted ADHD outcome at follow-up (Cheung et al., 2015). To examine 
whether IQ contributes to the differences between groups in brain connectivity, all analyses 
were re-run controlling for IQ. Results of group comparisons in the pre-stimulus and post-
stimulus windows for correct and error responses remained the same when controlling for IQ 
(Table S3.5), with the only exceptions being that the comparisons between ADHD remitters and 
controls in alpha pre-stimulus global efficiency and alpha diameter in correct trials became 
significant (while they were at trend-level in the main analyses). When repeating the analyses 
of within- and between-group change between time windows covarying for IQ, differences 
between ADHD persisters and controls on the change between time windows in theta average 
clustering coefficient, global efficiency and mean iCoh during error trials, and in alpha global 
efficiency, path length and mean iCoh during error trials were no longer significant (Table S3.6). 
 
When controlling for IQ in dimensional analyses, the results on the association between 
connectivity measures and DIVA ADHD symptoms (revealing no significant associations in the 
main analyses) remained unchanged. The statistically significant associations of impairment with 
post-stimulus global efficiency in the alpha band and pre-stimulus path length in the beta band 
in correct trials were no longer significant (at trend-level) when controlling for IQ, while the non-
significant (trend-level) associations of impairment with pre-stimulus average clustering 
coefficient, global efficiency, path length and mean iCoh in the beta band in incorrect trials 





In addition to whole-brain connectivity analysis, we also examined patterns of local brain 
connectivity within cortical regions. Local connectivity was quantified with mean iCoh values 
between groups of electrodes. First, we computed mean iCoh within anterior (AF3, AF4, Fz, F1, 
F2, F3, F4, F5, F6, F7, F8, AF7, AF8), central (Cz, C1, C2, C3, C4, C5, C6, FCz, FC1, FC2, FC3, FC4, 
FC5, FC6, CPz, CP1, CP2, CP3, CP4, CP5, CP6), and posterior (Pz, P3, P4, P7, P8, PO7, PO8, PO3, 
PO4, POz, Oz, O1, O2) scalp regions. Secondly, we analysed connectivity within left (AF3, AF7, 
F1, F3, F5, F7, FC1, FC3, FC5, FT7, FT9, C1, C3, C5, T7, CP1, CP3, CP5, TP7, TP9, P3, P7, PO3, PO7, 
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PO9, O1) and right (AF4, AF8, F2, F4, F6, F8, FC2, FC4, FC6, FT8, FT10, C2, C4, C6, T8, CP2, CP4, 
CP6, TP8, TP10, P4, P8, PO4, PO8, PO10, O2) hemispheres (Figure S3.1). Both groups of analyses 
focused on correctly-responded trials only, where group differences where maximal. For the 
analysis of connectivity within each local region, random intercept linear models tested for main 
effects of group (ADHD persisters vs ADHD remitters vs controls), time window (pre-stimulus vs 
post-stimulus) and region (anterior vs central vs posterior region; left vs right hemisphere), and 
three-way group-by-window-by-region interactions on mean iCoh in the theta, alpha and beta 
bands separately. For the analysis of connectivity between anterior/central/posterior regions, 
random intercept linear models tested for main effects of group (ADHD persisters vs ADHD 
remitters vs controls), time window (pre-stimulus vs post-stimulus) and region (anterio-central 
vs anterio-posterior vs centro-posterior connectivity), and for three-way group-by-window-by-
region interactions on mean iCoh between each of these regions in the theta, alpha and beta 
bands separately. Finally, for the analysis of connectivity between right and left hemispheres, 
random intercept linear models tested for main effects of group (ADHD persisters vs ADHD 
remitters vs controls) and time window (pre-stimulus vs post-stimulus), and for two-way group-
by-window interactions on mean iCoh measured between the two hemispheres in the theta, 
alpha and beta bands separately.  
 
For iCoh within anterior/central/posterior cortical regions, the three-way group-by-window-by-
region and two-way group-by-region interactions were not significant for theta, alpha or beta 
(all p>0.23). These results indicate that the pattern of group differences did not vary in the three 
local regions. For beta, the two-way group-by-window interaction was further not significant 
(p=0.50), indicating that the group differences did not vary in the two time windows, in line with 
the whole-brain analysis. After removing these non-significant interactions, results of analyses 
on group differences in local connectivity within cortical regions were consistent with those on 
whole-brain connectivity. Specifically, post-hoc group comparisons showed that, for theta and 
alpha bands in the pre-stimulus window, ADHD persisters had significantly greater values of iCoh 
than controls (p<0.02) but did not differ from remitters (p>0.21). Relative to controls, remitters 
showed no differences in pre-stimulus theta (p=0.39) but significantly greater iCoh in pre-
stimulus alpha (p=0.04). No group effects emerged in post-stimulus theta or alpha iCoh (all 
p>0.10). For beta, there were significant differences between ADHD persisters and controls 
(p<0.001) and between remitters and controls (p=0.02), with both ADHD groups showing greater 




In the analyses of local connectivity within left/right hemispheres, the three-way group-by-
window-by-hemisphere and two-way group-by-hemisphere interactions were not significant for 
theta, alpha or beta iCoh (all p>0.60). Group differences thus did not vary in the two 
hemispheres. For beta, the two-way group-by-window interaction was further not significant 
(p=0.85), indicating that the group differences did not vary in the two time windows, in line with 
the whole-brain analysis. After removing these non-significant interactions, results of analyses 
on group differences in local connectivity within left/right hemispheres were consistent with 
those on whole-brain connectivity. Post-hoc group comparisons showed, for theta and alpha 
iCoh in the pre-stimulus window, that ADHD persisters had significantly greater iCoh than 
controls (p<0.02) but did not differ from remitters (p>0.29). Relative to controls, remitters 
showed no differences in pre-stimulus theta (p=0.55) but differences approaching statistical 
significance emerged in pre-stimulus alpha (p=0.05), indicating greater iCoh in remitters than 
controls. No group effects emerged in post-stimulus theta or alpha iCoh (all p>0.19). For beta 
iCoh, there were significant differences between ADHD persisters and controls (p<0.01), 
between remitters and controls (p=0.04), indicating greater iCoh in both ADHD groups 
compared to controls, but no differences between persisters and remitters (p=0.11). 
 
The analyses of local connectivity between anterior, central and posterior cortical regions 
showed that the three-way group-by-window-by-region and two-way group-by-region 
interactions were not significant for theta, alpha or beta iCoh (all p>0.23), indicating that the 
group differences at all frequency bands were comparable across anterio-central, anterio-
posterior and centro-posterior connectivity. For beta iCoh, the two-way group-by-window 
interaction was further not significant (p=0.50), indicating that the group differences did not 
vary in the two time windows, in line with the whole-brain analysis. After removing these non-
significant interactions, post-hoc comparisons showed the same pattern of differences between 
groups of whole-brain iCoh measures. In pre-stimulus theta and alpha, ADHD persisters showed 
significantly greater iCoh than controls (all p<0.01) but no differences from remitters (all 
p>0.25). Compared to controls, remitters showed no differences in theta iCoh (p=0.44) but 
significantly greater alpha iCoh (p=0.01). No group effects emerged in post-stimulus theta or 
alpha (all p>0.48). For beta iCoh, significant differences emerged between ADHD persisters and 
controls (p<0.01) and between remitters and controls (p=0.02), with both ADHD groups showing 
greater iCoh than controls, but not between persisters and remitters (p=0.22). 
 
The analyses of connectivity between the left/right hemispheres showed that the two-way 
group-by-window interaction was significant for theta and alpha (all p<0.02), but not for beta 
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(0.92), in line with the analysis of whole-brain iCoh. Group differences on iCoh between the two 
hemispheres showed the same pattern of group differences yielded in the main analyses on 
whole-brain connectivity. Post-hoc group comparisons showed that, for theta and alpha iCoh in 
the pre-stimulus window, ADHD persisters showed significantly greater iCoh than controls 
(p<0.05) but did not differ from remitters (p>0.39). Relative to controls, remitters showed no 
differences in pre-stimulus theta (p=0.40) but differences approaching statistical significance 
emerged in pre-stimulus alpha (p=0.05), indicating greater iCoh in remitters than controls. No 
group effects emerged in post-stimulus theta or alpha (all p>0.30). For beta iCoh, there were 
significant differences between ADHD persisters and controls (p<0.01) and between remitters 
and controls (p=0.02), with both ADHD groups showing greater iCoh than controls, but no 








Table S3.1. Descriptive statistics (mean and standard deviation [SD]) for study variables divided by group  
  Controls ADHD-R ADHD-P 
THETA Mean SD Mean SD Mean SD 
Average clustering 
coefficient  
Pre, Corr 0.058 0.011 0.061 0.009 0.066 0.014 
Pre, Err 0.091 0.019 0.085 0.016 0.091 0.018 
Post, Corr 0.097 0.021 0.092 0.015 0.095 0.022 
Post, Err 0.127 0.026 0.119 0.023 0.118 0.025 
Global efficiency 
Pre, Corr 0.063 0.015 0.065 0.010 0.070 0.016 
Pre, Err 0.096 0.023 0.089 0.017 0.095 0.020 
Post, Corr 0.109 0.026 0.100 0.020 0.105 0.027 
Post, Err 0.138 0.030 0.129 0.029 0.128 0.029 
Path length 
Pre, Corr 17.571 3.084 16.671 2.374 15.797 3.095 
Pre, Err 11.504 2.281 12.270 2.246 11.571 2.304 
Post, Corr 10.561 2.157 11.143 2.152 10.942 2.331 
Post, Err 8.132 1.630 8.659 1.762 8.810 1.898 
Diameter 
Pre, Corr 30.563 4.579 28.348 3.892 27.499 5.175 
Pre, Err 19.506 3.649 20.356 3.265 19.781 3.882 
Post, Corr 21.238 3.910 21.084 3.558 21.155 3.643 
Post, Err 15.307 2.904 15.729 2.714 16.192 3.139 
Mean imaginary coherence 
Pre, Corr 0.060 0.012 0.063 0.009 0.068 0.015 
Pre, Err 0.094 0.020 0.087 0.017 0.093 0.019 
Post, Corr 0.102 0.023 0.095 0.017 0.099 0.024 
Post, Err 0.132 0.027 0.124 0.025 0.122 0.026 
ALPHA Mean SD Mean SD Mean SD 
Average clustering 
coefficient  
Pre, Corr 0.069 0.019 0.077 0.018 0.078 0.024 







Post, Corr 0.074 0.014 0.075 0.010 0.078 0.013 
Post, Err 0.104 0.017 0.095 0.014 0.100 0.017 
Global efficiency 
Pre, Corr 0.082 0.030 0.094 0.033 0.092 0.035 
Pre, Err 0.107 0.030 0.102 0.020 0.113 0.034 
Post, Corr 0.081 0.018 0.082 0.015 0.084 0.016 
Post, Err 0.111 0.019 0.100 0.015 0.106 0.018 
Path length 
Pre, Corr 14.516 3.913 12.714 3.416 13.230 4.125 
Pre, Err 10.552 2.569 10.909 1.969 10.219 2.555 
Post, Corr 13.795 2.544 13.363 2.035 13.169 2.364 
Post, Err 9.907 1.678 10.850 1.524 10.294 1.730 
Diameter 
Pre, Corr 27.304 5.210 24.828 5.459 24.927 5.713 
Pre, Err 18.570 3.770 19.499 3.374 18.534 3.988 
Post, Corr 25.133 3.944 24.676 3.278 23.665 3.940 
Post, Err 17.246 2.797 18.710 2.806 17.870 3.163 
Mean imaginary coherence 
Pre, Corr 0.073 0.022 0.081 0.021 0.082 0.027 
Pre, Err 0.101 0.024 0.096 0.017 0.105 0.027 
Post, Corr 0.077 0.015 0.078 0.011 0.081 0.014 
Post, Err 0.107 0.018 0.097 0.014 0.103 0.017 
BETA Mean SD Mean SD Mean SD 
Average clustering 
coefficient  
Pre, Corr 0.056 0.009 0.060 0.009 0.065 0.013 
Pre, Err 0.090 0.016 0.086 0.015 0.089 0.016 
Post, Corr 0.057 0.008 0.061 0.009 0.064 0.014 
Post, Err 0.091 0.016 0.087 0.016 0.089 0.017 
Global efficiency 
Pre, Corr 0.059 0.010 0.062 0.009 0.067 0.014 
Pre, Err 0.092 0.016 0.088 0.016 0.091 0.017 







Post, Err 0.093 0.016 0.088 0.016 0.091 0.017 
Path length 
Pre, Corr 18.294 2.502 17.130 2.342 16.292 2.892 
Pre, Err 11.648 2.054 12.183 2.151 11.783 2.028 
Post, Corr 18.216 2.161 17.010 2.265 16.374 2.927 
Post, Err 11.515 2.039 12.139 2.264 11.852 2.053 
Diameter 
Pre, Corr 30.381 3.795 28.345 3.480 26.796 4.702 
Pre, Err 18.936 3.392 19.749 3.795 19.290 3.519 
Post, Corr 29.972 3.522 28.124 4.187 26.857 4.818 
Post, Err 18.726 3.295 19.627 3.623 19.506 3.549 
Mean imaginary coherence 
Pre, Corr 0.058 0.009 0.062 0.009 0.066 0.014 
Pre, Err 0.092 0.016 0.087 0.015 0.091 0.017 
Post, Corr 0.058 0.008 0.062 0.009 0.066 0.014 
Post, Err 0.092 0.016 0.088 0.016 0.090 0.017 
Abbreviations: ADHD-P = ADHD persisters; ADHD-R = ADHD remitters; Corr = correctly-responded trials; Ctrl = Control group; Err = incorrectly-responded trials; Pre 
= pre-stimulus time window; Post = post-stimulus time window. Data in correctly-responded trials were available for 83 ADHD persisters, 22 remitters, 166 controls; 
and in incorrectly-responded trials for 75 ADHD persisters, 20 remitters, 145 controls.
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Table S3.2. Full results of random intercept linear models, showing p values for all main and 
interaction effects 











coefficient  0.258 <0.001*** <0.001*** 0.001** 0.007** 0.688 
Global efficiency 0.176 <0.001*** <0.001*** 0.001** 0.045* 0.673 
Path length 0.509 <0.001*** <0.001*** <0.001*** 0.002** 0.018* 
Diameter 0.307 <0.001*** <0.001*** 0.001** <0.001*** 0.029* 
Mean imaginary 
coherence 0.232 <0.001*** <0.001*** 0.001** 0.014* 0.676 











coefficient  0.392 0.114 <0.001*** 0.024* <0.001*** 0.853 
Global efficiency 0.507 0.005** <0.001*** 0.002** 0.005** 0.721 
Path length 0.305 0.507 <0.001*** 0.022* <0.001*** 0.713 
Diameter 0.158 <0.001*** <0.001*** 0.106 <0.001*** 0.642 
Mean imaginary 
coherence 0.345 0.529 <0.001*** 0.004** <0.001*** 0.794 











coefficient  0.038* 0.728 <0.001*** 0.856 <0.001*** 0.945 
Global efficiency 0.047* 0.904 <0.001*** 0.849 <0.001*** 0.887 
Path length <0.001*** 0.831 <0.001*** 0.8305 <0.001*** 0.989 
Diameter <0.001*** 0.695 <0.001*** 0.630 <0.001*** 0.997 
Mean imaginary 
coherence 0.047* 0.866 <0.001*** 0.864 <0.001*** 0.939 
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Notes: Random intercept linear models tested for main effects of group (ADHD remitters vs ADHD 
persisters vs controls), time window (pre-stimulus vs post-stimulus) ad response (correctly- vs 
incorrectly-responded trials), two-way interactions (group-by-window, group-by-response, time 
window-by-response), and three-way interactions (group-by-window-by-response) on 
connectivity measures. Age was included as a covariate of no interest in all analyses. Data in 
correctly-responded trials were available for 83 ADHD persisters, 22 remitters, 166 controls; and 
in incorrectly-responded trials for 75 ADHD persisters, 20 remitters, 145 controls. 













Overall Group ADHD-P vs Ctrl ADHD-R vs Ctrl ADHD-R vs ADHD-P 
p p d p d p d 
Average clustering 
coefficient 
Pre, Corr 0.052 0.019* 0.55 0.972 0.20 0.148 0.36 
Pre, Err 0.642 - - - - - - 
Post, Corr 0.569 - - - - - - 
Post, Err 0.014* 0.008** 0.28 0.058 0.26 0.878 0.03 
Global efficiency 
Pre, Corr 0.129 0.061 0.43 0.803 0.08 0.156 0.38 
Pre, Err 0.637 - - - - - - 
Post, Corr 0. 398 - - - - - - 
Post, Err 0.019* 0.012* 0.28 0.062 0.26 0.835 0.02 
Path length 
Pre, Corr <0.001*** <0.001*** 0.49 0.213 0.22 0.134 0.31 
Pre, Err 0.540 - - - - - - 
Post, Corr 0.499 - - - - - - 
Post, Err 0.376 - - - - - - 
Diameter 
Pre, Corr <0.001*** <0.001*** 0.54 0.051 0.38 0.330 0.19 
Pre, Err 0.806 - - - - - - 
Post, Corr 0.975 - - - - - - 
Post, Err 0.578 - - - - - - 
Mean imaginary 
coherence 
Pre, Corr 0.073 0.028* 0.52 0.957 0.16 0.151 0.37 
Pre, Err 0.654 - - - - - - 
Post, Corr 0.511 - - - - - - 
Post, Err 0.015* 0.009** 0.28 0.062 0.26 0.881 0.03 
ALPHA  







p p d p d p d 
Average clustering 
coefficient 
Pre, Corr 0.006** 0.001** 0.41 0.219 0.30 0.403 0.13 
Pre, Err 0.217 - - - - - - 
Post, Corr 0.365 - - - - - - 
Post, Err 0.130 - - - - - - 
Global efficiency 
Pre, Corr 0.013* 0.004** 0.31 0.146 0.28 0.678 0.04 
Pre, Err 0.143 - - - - - - 
Post, Corr 0.871 - - - - - - 
Post, Err 0.283 - - - - - - 
Path length 
Pre, Corr 0.004** 0.003** 0.28 0.027* 0.36 0.824 0.06 
Pre, Err 0.402 - - - - - - 
Post, Corr 0.334 - - - - - - 
Post, Err 0.426 - - - - - - 
Diameter 
Corr 0.003** 0.001** 0.36 0.177 0.21 0.422 0.19 
Err 0.524 - - - - - - 
Mean imaginary 
coherence 
Pre, Corr 0.004** 0.001** 0.38 0.174 0.28 0.425 0.11 
Pre, Err 0.126 - - - - - - 
Post, Corr 0.548 - - - - - - 
Post, Err 0.152 - - - - - - 
BETA  
Overall Group ADHD-P vs Ctrl ADHD-R vs Ctrl ADHD-R vs ADHD-P 
p p d p d p d 
Average clustering 
coefficient 
Corr <0.001*** <0.001*** 0.69 0.214 0.40 0.092 0.32 
Err 0.433 - - - - - - 
Global efficiency 
Corr <0.001*** <0.001*** 0.63 0.291 0.33 0.092 0.31 








Corr <0.001*** <0.001*** 0.66 0.027* 0.41 0.091 0.27 
Err 0.624 - - - - - - 
Diameter 
Corr <0.001*** <0.001*** 0.76 0.024* 0.42 0.042* 0.32 
Err 0.588 - - - - - - 
Mean imaginary 
coherence 
Corr <0.001*** <0.001*** 0.67 0.214 0.38 0.092 0.31 
Err 0.434 - - - - - - 
Abbreviations: ADHD-P = ADHD persisters; ADHD-R = ADHD remitters; Corr = correctly-responded trials; Ctrl = Control group; d = Cohen’s d effect size; Err = 
incorrectly-responded trials; p = random intercept linear model significant testing; Pre = pre-stimulus time window; Post = post-stimulus time window. 
Notes: Random intercept linear models tested for main effects of group (ADHD remitters vs ADHD persisters vs controls), time window (pre-stimulus vs post-
stimulus) ad response (correctly- vs incorrectly-responded trials), two-way interactions (group-by-window, group-by-response, time window-by-response), and 
three-way interactions (group-by-window-by-response) on connectivity measures. Since neither diameter in the alpha band, nor any measures in the beta band 
showed a significant group-by-window interaction, post-hoc effects of group were tested with correctly- and incorrectly-responded trials collapsed across pre-
stimulus and post-stimulus time windows. Post-hoc comparisons between groups were run only on measures showing a significant overall group effect. Age was 
included as a covariate of no interest in all analyses. Data in correctly-responded trials were available for 68 ADHD persisters, 22 remitters, 125 controls; and in 
incorrectly-responded trials for 63 ADHD persisters, 20 remitters, 110 controls. 







Table S3.4. Within- and between-group effects on measures of change between pre-stimulus and post-stimulus windows in graph-theory and imaginary 
coherence measures in male participants only 
  
 
Within-Group Change Between-Group Change 
THETA 
 
Ctrl ADHD-P ADHD-R ADHD-P vs Ctrl ADHD-R vs Ctrl ADHD-R vs ADHD-P 
p p p p d p d p d 
Average clustering 
coefficient  
Corr <0.001*** <0.001*** <0.001*** 0.009* 0.37 0.025* 0.36 0.962 0.04 
Err <0.001*** <0.001*** <0.001*** 0.078 0.26 0.741 0.03 0.471 0.23 
Global efficiency 
Corr <0.001*** <0.001*** <0.001*** 0.018* 0.33 0.034* 0.34 0.929 0.03 
Err <0.001*** <0.001*** <0.001*** 0.125  0.22 0.801  0.01 0.801  0.22 
Path length 
Corr <0.001*** <0.001*** <0.001*** <0.001*** 0.52 0.025* 0.36 0.678 0.17 
Err <0.001*** <0.001*** <0.001*** 0.173 0.23 0.719 0.09 0.263 0.31 
Diameter 
Corr <0.001*** <0.001*** <0.001*** <0.001*** 0.51 0.061 0.33 0.491 0.20 
Err <0.001*** <0.001*** <0.001*** 0.200  0.20 0.755  0.12 0.256  0.30 
Mean imaginary 
coherence 
Corr <0.001*** <0.001*** <0.001*** 0.012* 0.35 0.027* 0.36 0.941 0.03 
Err <0.001*** <0.001*** <0.001*** 0.089  0.25 0.765  0.02 0.480  0.22 
ALPHA 
 
Ctrl ADHD-P ADHD-R ADHD-P vs Ctrl ADHD-R vs Ctrl ADHD-R vs ADHD-P 
p p p p d p d p d 
Average clustering 
coefficient  
Corr 0.031* 0.849 0.770 0.108 0.25 0.136 0.32 0.807 0.04 
Err 0.005** 0.990 0.604 0.283 0.26 0.117 0.17 0.537 0.12 
Global efficiency 
Corr 0.362 0.003** 0.050 0.108  0.27 0.203  0.32 0.848  0.04 
Err 0.218 0.039* 0.691 0.027* 0.38 0.133  0.25 0.397  0.16 
Path length 
Corr 0.083 0.930 0.323 0.275  0.15 0.091 0.34 0.372  0.19 
Err 0.024* 0.753 0.931 0.025* 0.38 0.087 0.32 0.700  0.09 
Mean imaginary 
coherence 
Corr 0.142 0.327 0.477 0.113 0.25 0.163 0.30 0.858  0.03 







Abbreviations: ADHD-P = ADHD persisters; ADHD-R = ADHD remitters; Corr = correctly-responded trials; Ctrl = Control group; d = Cohen’s d effect size; Err = 
incorrectly-responded trials; p = random intercept linear model significance testing. 
Notes: Random intercept linear models tested for main effects of group (ADHD remitters vs ADHD persisters vs controls), time window (pre-stimulus vs post-
stimulus) ad response (correctly- vs incorrectly-responded trials), two-way interactions (group-by-window, group-by-response, time window-by-response), and 
three-way interactions (group-by-window-by-response) on connectivity measures. Post-hoc tests on within- and between-group effects of change were run only 
on measures showing a significant group-by-window interaction. Since in diameter in the alpha band and in all measures in the beta band this interaction was not 
significant, post-hoc within- and between-groups effects of change were not tested. Age was included as a covariate of no interest in all analyses. Data in correctly-
responded trials were available for 68 ADHD persisters, 22 remitters, 125 controls; and in incorrectly-responded trials for 63 ADHD persisters, 20 remitters, 110 
controls. 







Table S3.5. Group comparisons on graph-theory and imaginary coherence measures covarying for IQ 
    Group comparison 
THETA   
Overall Group ADHD-P vs Ctrl ADHD-R vs Ctrl ADHD-R vs ADHD-P 
p p d p d p d 
Average clustering 
coefficient  
Pre, Corr 0.002** <0.001*** 0.46 0.690 0.20 0.086 0.25 
Pre, Err 0.501 - - - - - - 
Post, Corr 0.649 - - - - - - 
Post, Err 0.004** 0.003** 0.11 0.030** 0.22 0.759 0.12 
Global efficiency 
Pre, Corr 0.011* 0.003** 0.36 0.923 0.09 0.095 0.28 
Pre, Err 0.502 - - - - - - 
Post, Corr 0.442 - - - - - - 
Post, Err 0.005** 0.004** 0.12 0.032* 0.23 0.743 0.11 
Path length 
Pre, Corr <0.001*** <0.001*** 0.42 0.068 0.24 0.097 0.20 
Pre, Err 0.441 - - - - - - 
Post, Corr 0.591 - - - - - - 
Post, Err 0.320 - - - - - - 
Diameter 
Pre, Corr <0.001*** <0.001*** 0.50 0.009** 0.43 0.298 0.09 
Pre, Err 0.735 - - - - - - 
Post, Corr 0.848 - - - - - - 
Post, Err 0.503 - - - - - - 
Mean imaginary 
coherence 
Pre, Corr 0.004** 0.001** 0.43 0.762 0.17 0.087 0.26 
Pre, Err 0.505 - - - - - - 
Post, Corr 0.594 - - - - - - 
Post, Err 0.005** 0.004** 0.11 0.032* 0.22 0.764 0.11 







p p d p d p d 
Average clustering 
coefficient  
Pre, Corr 0.001** <0.001*** 0.37 0.078 0.38 0.567 0.02 
Pre, Err 0.353 - - - - - - 
Post, Corr 0.227 - - - - - - 
Post, Err 0.090 - - - - - - 
Global efficiency 
Pre, Corr 0.003** 0.001** 0.28 0.044* 0.37 0.954 0.07 
Pre, Err 0.247 - - - - - - 
Post, Corr 0.685 - - - - - - 
Post, Err 0.228 - - - - - - 
Path length 
Pre, Corr <0.001*** <0.001*** 0.29 0.004** 0.45 0.626 0.15 
Pre, Err 0.506 - - - - - - 
Post, Corr 0.117 - - - - - - 
Post, Err 0.355 - - - - - - 
Diameter 
Corr <0.001*** <0.001*** 0.36 0.036* 0.28 0.497 0.10 
Err 0.581 - - - - - - 
Mean imaginary 
coherence 
Pre, Corr 0.001** <0.001*** 0.34 0.058 0.36 0.608 <0.01 
Pre, Err 0.250 - - - - - - 
Post, Corr 0.350 - - - - - - 
Post, Err 0.114 - - - - - - 
BETA   
Overall Group ADHD-P vs Ctrl ADHD-R vs Ctrl ADHD-R vs ADHD-P  
p p d p d p d 
Average clustering 
coefficient  
Corr <0.001*** <0.001*** 0.57 0.073 0.39 0.075 0.21 
Err 0.254 - - - - - - 
Global efficiency 
Corr <0.001*** <0.001*** 0.53 0.108 0.33 0.075 0.22 








Corr <0.001*** <0.001*** 0.56 0.003** 0.42 0.082 0.16 
Err 0.432 - - - - - - 
Diameter 
Corr <0.001*** <0.001*** 0.61 0.003** 0.43 0.042* 0.20 
Err 0.299 - - - - - - 
Mean imaginary 
coherence 
Corr <0.001*** <0.001*** 0.56 0.080 0.38 0.074 0.21 
Err 0.261 - - - - - - 
Abbreviations: ADHD-P = ADHD persisters; ADHD-R = ADHD remitters; Corr = correctly-responded trials; Ctrl = Control group; d = Cohen’s d effect size; Err = 
incorrectly-responded trials; p = random intercept linear model significance testing; Pre = pre-stimulus time window; Post = post-stimulus time window. 
Notes: Random intercept linear models tested for main effects of group (ADHD remitters vs ADHD persisters vs controls), time window (pre-stimulus vs post-
stimulus) ad response (correctly- vs incorrectly-responded trials), two-way interactions (group-by-window, group-by-response, time window-by-response), and 
three-way interactions (group-by-window-by-response) on connectivity measures. Since neither diameter in the alpha band nor any measures in the beta band 
showed a significant group-by-window interaction, post-hoc effects of group were tested for with correctly- and incorrectly-responded trials collapsed across pre-
stimulus and post-stimulus time windows. Post-hoc comparisons between groups were run only on measures showing a significant overall group effect. Age was 
included as a covariate of no interest in all analyses. Data in correctly-responded trials were available for 83 ADHD persisters, 22 remitters, 166 controls; and in 
incorrectly-responded trials for 75 ADHD persisters, 20 remitters, 145 controls. 








Table S3.6. Within- and between-group effects on measures of change between pre-stimulus and post-stimulus windows in graph-theory and imaginary 
coherence measures covarying for IQ 
    Within-Group Change Between-Group Change 
THETA 
  Ctrl ADHD-R ADHD-P ADHD-P vs Ctrl ADHD-R vs Ctrl ADHD-R vs ADHD-P 
p p p p d p d p d 
Average clustering 
coefficient  
Corr <0.001*** <0.001*** <0.001*** 0.021* 0.21 0.022* 0.32 0.747 0.07 
Err <0.001*** <0.001*** <0.001*** 0.120 0.14 0.770 <0.01 0.557 0.14 
Global efficiency 
Corr <0.001*** <0.001*** <0.001*** 0.041* 0.19 0.033* 0.30 0.718 0.08 
Err <0.001*** <0.001*** <0.001*** 0.161 0.13 0.793 <0.01 0.589 0.13 
Path length 
Corr <0.001*** <0.001*** <0.001*** <0.001*** 0.39 0.025* 0.35 0.678 0.06 
Err <0.001*** <0.001*** <0.001*** 0.173 0.17 0.719 0.14 0.263 0.29 
Diameter 
Corr <0.001*** <0.001*** <0.001*** <0.001*** 0.43 0.021* 0.36 0.567 0.09 
Err <0.001*** <0.001*** <0.001*** 0.273 0.12 0.630 0.17 0.238 0.28 
Mean imaginary 
coherence 
Corr <0.001*** <0.001*** <0.001*** 0.027* 0.20 0.024* 0.31 0.730 0.08 
Err <0.001*** <0.001*** <0.001*** 0.130 0.14 0.784 <0.01 0.566 0.14 
ALPHA 
  Ctrl ADHD-R ADHD-P ADHD-P vs Ctrl ADHD-R vs Ctrl ADHD-R vs ADHD-P 
p p p p d p d p d 
Average clustering 
coefficient  
Corr 0.002** 0.767 0.910 0.086 0.23 0.092 0.36 0.710 0.11 
Err 0.001** 0.599 0.981 0.261 0.16 0.396 0.12 0.696 0.05 
Global efficiency 
Corr 0.728 0.045* 0.004** 0.110 0.23 0.143 0.38 0.716 0.12 
Err 0.155 0.683 0.029* 0.072 0.27 0.193 0.21 0.510 0.08 
Path length 
Corr 0.002** 0.319 0.856 0.127 0.17 0.047* 0.40 0.378 0.24 
Err 0.011* 0.931 0.831 0.075 0.27 0.118 0.29 0.849 <0.01 
Mean imaginary 
coherence 
Corr 0.020* 0.472 0.491 0.096 0.23 0.111 0.35 0.746 0.11 







Abbreviations: ADHD-P = ADHD persisters; ADHD-R = ADHD remitters; Corr = trials with correct responses; Ctrl = Control group; d = Cohen’s d effect size; Err = 
trials with incorrect responses; p = random intercept linear model significance testing. 
Notes: Random intercept linear models tested for main effects of group (ADHD remitters vs ADHD persisters vs controls), time window (pre-stimulus vs post-
stimulus) ad response (correctly- vs incorrectly- responded trials), two-way interactions (group-by-window, group-by-response, time window-by-response), and 
three-way interactions (group-by-window-by-response) on connectivity measures. Post-hoc tests on within- and between-group effects of change were run only 
on measures showing a significant group-by-time window interaction. Since this interaction was not significant in diameter in the alpha band and in all measures 
in the beta band, post-hoc within- and between-groups effects of change were not tested. Age was also included as a covariate of no interest in all analyses. Data 
in correctly-responded trials were available for 83 ADHD persisters, 22 remitters, 166 controls; and in incorrectly-responded trials for 75 ADHD persisters, 20 
remitters, 145 controls. 
*p<0.05; **p<0.01; ***p<0.001. d≥0.20 = small effect size, d≥0.50 = medium effect (in italics). 
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Table S3.7. Dimensional associations between graph-theory and imaginary coherence measures 
and interview-based DIVA ADHD symptom counts and clinical impairment within the ADHD 
group only, controlling for age, gender and IQ 
THETA 
  
ADHD symptoms Impairment 
β (95% CIs) p β (95% CIs) p 
Average 
clustering 
coefficient    
Pre, Corr <0.001 (-0.001;0.001) 0.844 <0.001 (-0.000;0.001) 0.183 
Pre, Err <0.001 (-0.001;0.001) 0.734 0.001 (-0.000;0.001) 0.065 
Post, Corr <0.001 (-0.001;0.001) 0.696 <0.001 (-0.000;0.001) 0.290 
Post, Err -0.001 (-0.002;0.001) 0.343 <0.001 (-0.001;0.001) 0.823 
Global 
efficiency 
Pre, Corr <0.001 (-0.001;0.001) 0.637 <0.001 (-0.000;0.001) 0.318 
Pre, Err <0.001 (-0.001;0.001) 0.856 0.001 (-0.000;0.001) 0.069 
Post, Corr <0.001 (-0.002;0.001) 0.547 <0.001 (-0.001;0.001) 0.580 
Post, Err -0.001 (-0.002;0.001) 0.210 -0.001 (-0.001;0.000) 0.159 
Path length 
Pre, Corr 0.040 (-0.123;0.202) 0.632 -0.059 (-0.147;0.028) 0.182 
Pre, Err -0.031 (-0.168;0.107) 0.664 -0.064 (-0.137;0.008) 0.079 
Post, Corr 0.046 (-0.086;0.178) 0.496 -0.017 (-0.091;0.058) 0.662 
Post, Err 0.041 (-0.059;0.140) 0.425 -0.001 (-0.056;0.055) 0.983 
Diameter 
Pre, Corr 0.082 (-0.181;0.345) 0.540 -0.076 (-0.220;0.070) 0.308 
Pre, Err -0.062 (-0.288;0.163) 0.589 -0.098 (-0.216;0.020) 0.104 
Post, Corr 0.033 (-0.177;0.244) 0.756 -0.065 (-0.178;0.048) 0.262 




Pre, Corr <0.001 (-0.001;0.001) 0.799 <0.001 (-0.000;0.001) 0.207 
Pre, Err <0.001 (-0.001;0.001) 0.768 0.001 (-0.000;0.001) 0.066 
Post, Corr <0.001 (-0.002;0.001) 0.642 <0.001 (-0.000;0.001) 0.370 
Post, Err -0.001 (-0.002;0.001) 0.280 <0.001 (-0.001;0.001) 0.531 
ALPHA 
  
ADHD symptoms Impairment 
β (95% CIs) p β (95% CIs) p 
Average 
clustering 
coefficient    
Pre, Corr <0.001 (-0.001;0.001) 0.918 <0.001 (-0.001;0.001) 0.653 
Pre, Err <0.001 (-0.001;0.001) 0.666 0.001 (-0.001;0.001) 0.151 
Post, Corr <0.001 (-0.001;0.001) 0.804 <0.001 (0.000;0.001) 0.037* 
Post, Err 0.001 (-0.000;0.001) 0.190 0.001 (0.000;0.001) 0.020* 
Global 
efficiency 
Pre, Corr -0.001 (-0.002;0.001) 0.596 <0.001 (-0.001;0.001) 0.587 
Pre, Err <0.001 (-0.001;0.002) 0.807 0.001 (-0.000;0.002) 0.251 
Post, Corr <0.001 (-0.001;0.001) 0.852 <0.001 (-0.000;0.001) 0.111 
Post, Err 0.001 (-0.000;0.001) 0.221 0.001 (0.000;0.001) 0.020* 
Path length 
Pre, Corr -0.004 (-0.212;0.204) 0.969 0.029 (-0.089;0. 481) 0.629 
Pre, Err -0.011 (-0.153;0.130) 0.876 -0.045 (-0. 121;0.031) 0.246 
Post, Corr -0.015 (-0.146;0.116) 0.819 -0.060 (-0.129;0.009) 0.090 
Post, Err -0.061 (-0.115;0.034) 0.208 -0.054 (-0.105;-0.004) 0.036* 
Diameter 
Pre, Corr -0.051 (-0.365;0.263) 0.749 -0.036 (-0.210;0.138) 0.688 
Pre, Err -0.083 (-0.302;0.137) 0.461 -0.100 (-0.216;0.017) 0.093 
Post, Corr -0.035 (-0.253;0.183) 0.751 -0.119 (-0.234;-0.004) 0.043* 






Pre, Corr <0.001 (-0.001;0.001) 0.971 <0.001 (-0.001;0.001) 0.905 
Pre, Err <0.001 (-0.001;0.002) 0.726 0.001 (-0.000;0.001) 0.175 
Post, Corr <0.001 (-0.001;0.001) 0.810 <0.001 (0.000;0.001) 0.049* 
Post, Err 0.001 (-0.000;0.001) 0.195 0.001 (0.000;0.001) 0.020* 
BETA 
  
ADHD symptoms Impairment 
β (95% CIs) p β (95% CIs) p 
Average 
clustering 
coefficient    
Pre, Corr <0.001 (-0.000;0.001) 0.370 <0.001 (0.000;0.001) 0.029* 
Pre, Err <0.001 (-0.001;0.001) 0.534 0.001 (0.000;0.001) 0.035* 
Post, Corr <0.001 (-0.001;0.001) 0.581 <0.001 (-0.000;0.001) 0.096 
Post, Err <0.001 (-0.001;0.001) 0.592 <0.001 (-0.000;0.001) 0.086 
Global 
efficiency 
Pre, Corr <0.001 (-0.001;0.001) 0.433 <0.001 (0.000;0.001) 0.026* 
Pre, Err <0.001 (-0.000;0.001) 0.572 0.001 (0.000;0.001) 0.031* 
Post, Corr <0.001 (-0.001;0.001) 0.696 <0.001 (-0.000;0.001) 0.110 
Post, Err <0.001 (-0.001;0.001) 0.618 <0.001 (-0.001;0.001) 0.087 
Path length 
Pre, Corr -0.064 (-0.220;0.091) 0.419 -0.081 (-0.165;0.002) 0.057 
Pre, Err -0.044 (-0.163;0.076) 0.474 -0.064 (-0.127;-0.002) 0.044* 
Post, Corr -0.036 (-0.188;0.117) 0.649 -0.058 (-0.142;0.025) 0.171 
Post, Err -0.048 (-0.171;0.075) 0.446 -0.051 (-0.116;0.012) 0.116 
Diameter 
Pre, Corr -0.136 (-0.387;0.114) 0.286 -0.139 (-0.274;-0.005) 0.042* 
Pre, Err -0.103 (-0.313;0.106) 0.335 -0.093 (-0.203;0.018) 0.100 
Post, Corr -0.085 (-0.337;0.168) 0.510 -0.089 (-0.227;0.050) 0.210 




Pre, Corr <0.001 (-0.000;0.001) 0.389 <0.001 (0.000;0.001) 0.028* 
Pre, Err <0.001 (-0.001;0.001) 0.544 0.001 (0.000;0.001) 0.033* 
Post, Corr <0.001 (-0.001;0.001) 0.620 <0.001 (-0.000;0.001) 0.102 
Post, Err <0.001 (-0.001;0.001) 0.604 <0.001 (-0.000;0.001) 0.087 
Abbreviations: β = regression coefficient; CIs = confidence intervals; Corr = correctly-responded 
trials; Err = in correctly-responded trials; p = random intercept linear model significance testing; 
Pre = pre-stimulus time window; Post = post-stimulus time window. 
Notes: Random intercept linear models tested the effect of ADHD symptoms and impairment on 
each connectivity measure, accounting for sibling relatedness. Data in correctly-responded trials 
were available for 105 childhood ADHD participants (83 ADHD persisters, 22 remitters); and in 
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Participants for this study are members of the Sibling EEG Follow-Up Study (SEFOS) (Cheung et 
al., 2016, Michelini et al., 2016), which investigated neurophysiological and cognitive 
impairments in a follow-up sample of ADHD and control sibling pairs. Adolescents and young 
adults, who had taken part in the UK subsample of the International Multicenter ADHD Genetics 
(IMAGE) project (Chen et al., 2008, Cheung et al., 2012, Kuntsi et al., 2010) when they were 
children, were invited to participate in this follow-up assessment. During the initial study, ADHD 
participants aged between 6 and 17 years were recruited from specialist clinics in the UK from 
among those who had a clinical diagnosis of DSM-IV combined subtype ADHD during childhood. 
Childhood ADHD was assessed based on the Parental Account of Childhood symptoms (PACS) 
(Taylor et al., 1986a, Taylor et al., 1986b), a semi-structured, standardised, investigator 
interview with high inter-rater reliability, to establish the research diagnosis of DSM-IV 
combined-type ADHD in childhood. Closest-age siblings were also then recruited and assessed 
for ADHD using the same procedures. A control group, which was initially recruited from primary 
(ages 6-11 years) and secondary (ages 12-18 years) schools in the UK (Kuntsi et al., 2010), was 
also invited to take part in this follow up study. The total sample in childhood consisted of 267 
participants from ADHD sibling pairs and 258 participants from control sibling pairs (n=525 
participants). Exclusion criteria included IQ<70, autism, epilepsy, brain disorders and any genetic 
or medical disorder associated with externalising behaviours that might mimic ADHD. All 
participants were of European Caucasian decent. At follow up, participants were contacted by 
telephone and scheduled for a single testing session including clinical, cognitive and EEG 





ERP measures which showed ADHD-control differences in our previous work on this sample 
were included in this study (Cheung et al., 2017, Cheung et al., 2016, Michelini et al., 2016). ERPs 
from the cued performance task (CPT-OX) included the Cue-P3, the CNV and the NoGo-P3 
(Cheung et al., 2016). The Cue-P3 amplitude was measured as the maximum positive peak 
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between 250-600ms following cue trials at Pz. The CNV was analysed as mean amplitudes 
between 1300 and 1650ms following cues at Cz. The NoGo-P3 amplitude was measured as the 
maximum positive peak between 250-600 ms following NoGo trials at Cz. As in our previous 
work (Michelini et al., 2016), ERPs from the arrow flanker task included the N2, the ERN and the 
Pe from the incongruent condition only, as an N2 reduction in ADHD compared to neurotypical 
individuals is only observed in the incongruent condition (but not in the congruent condition) of 
this task (Albrecht et al. 2008; McLoughlin et al. 2009), and a sufficient number of errors to allow 
at least 20 ERP segments for robust ERP averaging is made in incongruent trials only (McLoughlin 
et al. 2009). The N2 amplitude was measured as maximum negative peak at Fz and FCz between 
250-450 ms after target onset. The ERN amplitude was defined with respect to the preceding 
positivity (PNe, -100-50 ms) (Albrecht et al., 2008, McLoughlin et al., 2009, Nieuwenhuis et al., 
2001), and was measured at FCz between 0-150 ms. The Pe amplitude was measured as 
maximum positive peak at CPz between 150-450 ms. The baseline-P3 was extracted from the 
baseline condition of the Fast task, and measured as the area amplitude measure at Pz between 
250 and 450 ms (Cheung et al., 2017). CNV, Cue-P3, NoGo-P3, N2 and baseline-P3 were stimulus-
locked and measured on correct trials only, while the ERN and Pe were response-locked and 





Our analysis started with an examination of the correlated factors solution of the Cholesky 
decomposition, which gives separate correlation matrices for the underlying familial and non-
familial influences. On the basis of the familial and non-familial correlation matrices between all 
9 cognitive-ERP measures, data were simulated in R for 1000 participants within two EFAs, 
separately for familial and non-familial influences. EFA approaches give an indication of the 
underlying factor structure, but no specification of the underlying covariance matrices can be 
deduced. Factors were extracted using an unweighted least squares estimator approach 
following previous work (Loken et al., 2014). An unweighted least squares estimator was chosen 
over other extraction methods as it has shown robust as a method of factor analysing ordinal 
data yielding polychoric correlations (Forero et al., 2009, Lee et al., 2012). Factors with an 
eigenvalue of greater than 1 (Figure S4.1) were extracted and rotated using an oblique (oblimin) 
rotation, which allows correlation between factors. The extracted factor structure and factor 
loadings (Table S4.3) were specified separately for familial and non-familial influences in a 
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confirmatory factor model in OpenMx. This confirmatory model was aimed at examining the 





Using our large cognitive battery, previous phenotypic analyses on this sample found that 
individuals with ADHD showed atypical profiles, compared to controls, in the following 22 
cognitive and ERP variables (Cheung et al., 2017, Cheung et al., 2016, Michelini et al., 2016): 
commission errors, omission errors, mean reaction time (MRT), reaction time variability (RTV), 
Cue-P3, NoGo-P3 and CNV from the CPT-OX; number of errors in congruent trials (congruent 
error) and in incongruent trials (incongruent errors), MRT and RTV in both congruent and 
incongruent conditions, N2, ERN and Pe from the incongruent condition of the arrow flanker 
task; MRT, RTV and P3 from the baseline condition of the Fast task; IQ and digit span forward 
and backward. In multivariate analyses, due to constraints in the number of variables that can 
be included in a multivariate SEM model, it was not possible to include all measures (similar to 
previous quantitative genetic analyses on neurocognitive data; Frazier-Wood et al., 2012, Kuntsi 
et al., 2010, McLoughlin et al., 2014). Since our aim was to identify measures associated with 
ADHD and that would inform on the underlying familial relationships with the disorder, 
preliminary analyses were thus carried out to objectively select variables more strongly related 
to ADHD and that showed evidence of underlying familial influences. We ran constrained 
correlation bivariate models between ADHD and each of the 22 cognitive-ERP variables (Table 
S4.1) extracted from our large cognitive-neurophysiological battery, in order to select variables 
that had (1) modest-to-large (Cohen, 1988) phenotypic correlation with ADHD (phenotypic 
correlation above .20) and (2) significant cross-sibling/within-trait sibling correlations, 
suggesting the influence of familial factors (Table S4.1). These models give maximum likelihood 
estimates of correlations between two traits within and across pairs while applying specific 
constraints. Applied constraints reflect the assumptions of the familial model, i.e. that 
phenotypic correlations across traits within individuals are the same across siblings and that 
cross-sibling/cross-trait correlations are independent of sibling order. Given the selected nature 
of this sample (selection of ADHD probands) and ADHD modelled as present/absent, we further 
included constraints reflecting the assumptions of the liability distributions underlying ADHD 
status: we fixed the sibling correlation for ADHD status to .40 and the threshold on ADHD liability 
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to a z-value of 1.64, corresponding to a population prevalence of 5%. Cognitive-ERP variables 
were modelled as continuous if their age- and sex- residuals were normally distributed or could 
be normalised using transformations methods, and included with ADHD status in combined 
continuous-ordinal bivariate models. In these analyses, a model for the thresholds of ordinal 
variables in specified along with a model for the means of continuous variables. Cognitive-ERP 
variables which could not be normalised using any transformation methods were modelled as 
ordinal using equal-sized categories, and included with ADHD status in bivariate ordinal liability-
threshold models, estimating age and sex effects on their mean. Ordinal models and combined 
continuous-ordinal models were used to derive, respectively, the polychoric and polyserial 
phenotypic correlations between ADHD and each cognitive-ERP variable, the cross-
sibling/within-trait sibling correlation for each cognitive-ERP variable, and the cross-sibling 
cross-trait sibling correlation between ADHD and each cognitive-ERP variable (Table S4.1). 
 
Information about the precision of parameter estimates was obtained by likelihood-based 
confidence intervals (CIs). According to the criteria outlined above, IQ, DSF, DSB; MRT and RTV 
from the Fast task (baseline condition); RTV, OE and NoGo-P3 (Figure S4.3) from the CPT-OX; 
and RTV in the congruent and incongruent condition, congruent errors (CongE) and ERN (Figure 
S4.2) from the arrow flanker task could be retained for inclusion with ADHD status in the 
multivariate models, as they met both inclusion criteria. Since all measures of RTV across tasks 
showed large correlations with one another (r=.45-.76), only RTV from the baseline condition of 
the Fast task was included, as this variable showed the strongest phenotypic correlation with 





The Akaike information criterion (AIC) and χ2 difference tests were used to inform on model fit 
when comparing models. The confirmatory 3-factor model showed a significantly better fit 
compared to the Cholesky decomposition (p=.08) (Table S4.4), indicating support for this more 
parsimonious description of the data. As a sensitivity test, the 3-factor model was also compared 
to a 1-factor model. In this 1-factor model, all cognitive-ERP variables were influenced by 1 
familial factor and 1 non-familial factor, with correlation paths to the familial and non-familial 
influences on ADHD, respectively. The 1-factor model provided a significantly worse fit than the 
3-factor model (p<.01). This suggests that, although the 3 familial and non-familial factors are 
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inter-correlated, they represent processes that are at least partly separable and cannot be 




The proportion of phenotypic correlation between ADHD and each cognitive-ERP variable 
explained by contributions of shared familial and non-familial influences could be further 
derived from the factor model (note that these phenotypic correlations could be slightly 
different from those estimated from the saturated Cholesky model in Table 4.1 in Chapter 4). 
For example, the proportion of phenotypic correlation between IQ and ADHD is calculated by 
two pathways: (1) via linked familial factors: the product of the standardised factor loading of 
IQ (path from cF1 to IQ), the correlation between cF1 and the ADHD-specific familial factor, and 
the standardized factor loading of ADHD (√.40), [-.64*.50*√.40=-.20]; and (2) via linked non-
familial factors: [.43*-.40*√.60=-.13]. These two pathways sum up to the predicted phenotypic 
correlation according to this model, and the proportions of familial and non-familial overlap 
work out to be -.20/-.34=60% and -.13/-.34=40%, respectively. Note that proportions can only 
be derived if the contributions have the same sign. All correlations were similarly explained by 
shared familial and non-familial factor influences (Table S4.5). 
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Table S4.1. Constrained correlation sibling models of all cognitive-neurophysiological measures  
  rPh with ADHD Sibling r Cross-sib/cross-trait r with ADHD 
CPT-OX 
OE  0.30 (0.18; 0.42) 0.22 (0.03;0.40) 0.26 (0.13; 0.39) 
CE 0.14 (0.01; 0.26) 0.11 (-0.09; 0.30) 0.11 (-0.03; 0.23) 
MRT 0.19 (0.09; 0.30) 0.25 (0.10; 0.39) 0.09 (-0.03; 0.20) 
RTV 0.28 (0.16; 0.38) 0.27 (0.13; 0.40) 0.16 (0.05; 0.27) 
Cue-P3 -0.16 (-0.27; -0.05) 0.14 (-0.02; 0.28) 0.03 (-0.08; 0.15) 
CNV 0.25 (0.13; 0.34) 0.14 (-0.03; 0.31) 0.08 (-0.04; 0.20) 
NoGo-P3 -0.25 (-0.36; -0.14) 0.25 (0.10; 0.39) -0.16 (-0.31; -0.04) 
Fast task 
MRT-baseline 0.35 (0.24; 0.45) 0.32 (0.18; 0.44) 0.15 (0.03; 0.26) 
RTV-baseline 0.44 (0.34; 0.54) 0.28 (0.13; 0.41) 0.19 (0.07; 0.30) 
P3-baseline -0.07 (-0.19; 0.06) 0.26 (0.09; 0.42) -0.03 (-0.16; 0.10) 
Flanker task 
CongE  0.33 (0.20; 0.43) 0.22 (0.04; 0.38) 0.13 (0.00; 0.25) 
IncongE 0.22 (0.10; 0.33) 0.10 (-0.05; 0.25) 0.14 (0.02; 0.25) 
MRT-cong 0.17 (0.05; 0.28) 0.22 (0.06; 0.36) 0.05 (-0.07; 0.17) 
MRT-incong 0.13 (0.01; 0.24) 0.24 (0.09; 0.37) 0.03 (-0.09; 0.16) 
RTV-cong 0.35 (0.24; 0.45) 0.21 (0.07; 0.34) 0.12 (0.01; 0.23) 
RTV-incong 0.35 (0.24; 0.45) 0.20 (0.05; 0.33) 0.14 (0.03; 0.25) 
N2 0.14 (0.03; 0.26) 0.29 (0.14; 0.43) 0.07 (-0.04; 0.20) 
ERN -0.24 (-0.35; -0.12) 0.21 (0.04; 0.36) -0.09 (-0.21; 0.03) 
Pe -0.19 (-0.30; -0.06) 0.24 (0.08; 0.40) -0.06 (-0.19; 0.07) 
IQ and Digit Span 
IQ -0.38 (-0.48; -0.27) 0.50 (0.39; 0.60) -0.17 (-0.28; -0.06) 
DSF -0.23 (-0.35; -0.11) 0.45 (0.32; 0.56) -0.14 (-0.25; -0.01) 
DSB -0.30 (-0.41; -0.19) 0.30 (0.15; 0.43) -0.22 (-0.33; -0.10) 
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; CE, commission errors from the 
cued continuous performance test; CongE, errors in the congruent condition of the flanker task; 
CPT-OX, cued continuous performance test; Cross-sib/cross-trait r with ADHD, cross-
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sibling/cross-trait correlation between each variable and ADHD; Cue-P3, P3 amplitude in the Cue 
condition of the cued continuous performance test; DSB, digit span backward; DSF, digit span 
forward; ERN, error-related negativity amplitude from the flanker task; IQ, intelligence quotient; 
IncongE, errors in the incongruent condition of the flanker task; MRT, mean reaction time from 
the cued continuous performance test; MRT-baseline, mean reaction time from the baseline 
condition of the Fast task; MRT-cong, mean reaction time from the congruent condition of the 
flanker task; MRT-incong, mean reaction time from the incongruent condition of the flanker task; 
N2, N2 component amplitude from the flanker task; NoGo-P3, P3 amplitude in the NoGo 
condition from the cued continuous performance test; OE, omission errors from the cued 
continuous performance test; P3-baseline, P3 amplitude from the baseline condition on the Fast 
task; Pe, error positivity amplitude from the flanker task; rPh with ADHD, phenotypic correlation 
with ADHD; RTV, reaction time variability from the cued continuous performance test; RTV-
baseline, reaction time variability from the baseline condition of the Fast task; RTV-cong, 
reaction time variability from the congruent condition of the flanker task; RTV-incong, reaction 
time variability from the incongruent condition of the flanker task; Sibling r, correlation between 
siblings on each variable. 
Notes: significant (p<0.05) values are given in bold. Variables included in the multivariate factor 







Table S4.2. Descriptive statistics for cognitive-neurophysiological measures divided by group, with test for statistical difference 















p p p 
IQ 96.30 (15.23) 102.85 (14.19) 109.79 (12.45) <.001 <.001 <.01 <.001 
MRT 626.35 (142.81) 576.46 (125.81) 546.48 (118.90) <.001 <.001 <.001 .009 
RTV 183.16 (129.66) 127.76 (86.52) 102.75 (82.60) <.001 <.001 <.001 <.001 
OE 2.86 (4.15) 1.19 (1.88) 0.75 (1.53) <.001 <.001 .02 <.001 
CongE 9.54 (13.12) 5.14 (5.77) 4.24 (8.27) <.001 <.001 .001 .02 
DSF 9.27 (2.09) 9.82 (2.14) 10.41 (2.11) <.001 <.001 .10 .01 
DSB 6.26 (2.42) 6.79 (2.22) 7.96 (2.62) <.001 <.001 .06 <.001 
ERN 7.96 (3.67) 9.76 (4.42) 10.36 (4.73) <.001 <.001 .008 .24 
NoGo-P3 6.82 (4.50) 7.92 (3.52) 8.93 (3.69) <.001 <.001 .004 .26 
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; CongE, number of errors in the congruent condition of the flanker task; DSB, digit span backward; 
DSF, digit span forward; ERN, error-related negativity amplitude from the flanker task; IQ, intelligence quotient; MRT, mean reaction time from the Fast task; 
NoGo-P3, P3 amplitude in the NoGo condition from the cued continuous performance test; OE, number of omission errors from the cued continuous performance 
test; RTV, reaction time variability from the Fast task.  
Notes: Significant (p<0.05) differences are indicated in bold. Group differences between ADHD and control participants on this sample were reported in previous 
analyses (Cheung et al., 2016, Michelini et al., 2016). 
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Table S4.3. Loadings of extracted familial and non-familial factors from the EFAs 
 
 
Familial factors Non-familial factors 
F1 F2 F3 F1 F2 F3 
% Var  53.19 16.27 12.10 32.01 15.72 11.91 
 Factor loadings Factor loadings 
IQ -0.52 0.33 0.07 -0.09 0.61 0.13 
DSF 0.03 0.99 0.04 .06 0.55 -0.09 
DSB -0.38 0.67 0.03 .02 0.44 -0.08 
ERN -0.16 -0.24 0.85 .07 0.03 -0.64 
NGP3 0.07 0.17 0.38 -.06 -0.01 -0.48 
MRT 0.92 -0.01 -0.05 0.96 -0.04 -0.03 
RTV 0.98 0.06 -0.06 0.82 0.01 0.15 
OE 0.14 -0.17 -0.66 0.12 0.06 0.50 
CongE 0.02 0.06 -0.80 0.05 -0.22 0.42 
 Factor correlations Factor correlations 
F1 1   1   
F2 -0.31 1  -0.22 1  
F3 -0.52 0.32 1 0.45 -0.38 1 
Abbreviations: % Var, percentage of variance explained by each factor; ADHD, attention-
deficit/hyperactivity disorder; CongE, errors in the congruent condition of the flanker task; DSB, 
digit span backward; DSF, digit span forward; ERN, error-related negativity amplitude from the 
flanker task; F1, factor 1; F2, factor 2; F3, factor 3; IQ, intelligence quotient; MRT, mean reaction 
time from the Fast task; NoGo-P3, P3 amplitude in the NoGo condition from the cued continuous 
performance test; OE, omission errors from the cued continuous performance test; RTV, reaction 
time variability from the Fast task. 
Note: the largest factor loadings for each variable are given in bold. 
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Table S4.4. Model comparisons 
Model EP -2LL df AIC BIC m.o.c. χ2 df p  
1. Cholesky 126 8163.76 3438 1287.75  -10284.47 - - - - 
2. 3-Factor 64 8242.29 3500 1242.29 -10538.63 1 78.53 62 .08 
3. 1-Factor 55 8320.92 3509 1302.92 -10508.29 2 78.63  9 <.01 
Abbreviations:AIC, Akaike information criterion; BIC, Bayesian information criterion; EP, number 
of estimated parameters; -2LL, -2 log likelihood statistic; df, degrees of freedom; m.o.c., model 
of comparison; χ2, difference in log likelihood statistic.  




Table S4.5. Proportion of phenotypic correlation between cognitive-ERP variables and ADHD 











IQ -0.33 (-0.44; -0.23) 0.60 (0.35;0.82) 0.40 (0.18;0.65) 
DSF -0.25 (-0.35; -0.15) 0.49 (0.15;0.75) 0.51 (0.25;0.86) 
DSB -0.27 (-0.37; -0.17) 0.49 (0.13;0.75) 0.51 (0.25;0.87) 
ERN -0.26 (-0.33; -0.17) 0.49 (0.22;0.75) 0.51 (0.24;0.78) 
NoGo-P3 -0.22 (-0.30; -0.13) 0.41 (0.08;0.76) 0.59 (0.24;0.78) 
MRT 0.37 (0.27; 0.46) 0.40 (0.20;0.62) 0.60 (0.38;0.80) 
RTV 0.37 (0.26; 0.46) 0.41 (0.20;0.63) 0.59 (0.37;0.80) 
OE 0.35 (0.23; 0.44) 0.65 (0.38;0.86) 0.35 (0.15;0.62) 
CongE 0.30 (0.19; 0.39) 0.42 (0.13;0.75) 0.58 (0.25,0.87) 
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; CongE, errors in the congruent 
condition of the flanker task; DSB, digit span backward; DSF, digit span forward; ERN, error-
related negativity amplitude from the flanker task; IQ, intelligence quotient; MRT, mean reaction 
time from the Fast task; NoGo-P3, P3 amplitude in the NoGo condition from the cued continuous 
performance test; OE, omission errors from the cued continuous performance test; RTV, reaction 
time variability from the Fast task. 








Figure S4.1. Scree plots of Exploratory Factor Analysis for familial (top half) and non-familial 






Figure S4.2. Grand average response-locked ERPs of the ERN at FCz electrode between 0-150 ms 
after an erroneous response on the incongruent trials for individuals with ADHD (in red), 






Figure S4.3. Grand average stimulus-locked ERPs of the NoGo-P3 at Cz electrode between 250-
600 ms for individuals with ADHD (in red), unaffected siblings of ADHD probands (in green) and 
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The average number of segments in each group for the Cue, NoGo and Go conditions is reported 
in Table S5.1. The number of segments was entered into univariate ANOVA to check for group 
differences, with “group” as between-subjects variable (ADHD, BD and control participants). 
Groups did not differ on the number of artefact-free segments for the Cue condition [F(2, 






The majority of previous ERP analyses on CPT-OX in ADHD samples did not apply a baseline 
subtraction (Banaschewski et al. 2004; McLoughlin et al. 2010, 2011; Albrecht et al. 2013; 
Doehnert et al. 2013). In this study, we chose to apply a baseline correction in order to reduce 
the influence of pre-stimulus activity on our ERP measures. However, analyses were also 
repeated without baseline correction in order to allow comparison with previous results.  
 
Cue condition 
A trend-level effect of group emerged for the Cue-P3 [F(2,57)=2.48, p=0.09]. Post-hoc 
comparisons showed a significant difference between the ADHD and the BD group (p=0.03), with 
large effect size (Table S5.2). The control group did not differ from either the ADHD (p=0.59) or 
the BD (0.14) groups.  
 
A significant effect of group emerged for the CNV [F(2,57)=3.68, p=0.03]. Post-hoc comparisons 
showed a significant difference between the ADHD and the control group (p=0.01), with large 
effect size (Table S5.2). The BD group did not differ from either the ADHD (p=0.22) or the control 






A significant effect of group on the NoGo-N2 [F(2,57)=5.12, p=0.01]. Post-hoc analyses revealed 
that BD participants significantly differed from ADHD (p=0.01) and control (p=0.02) participants, 
both with large effect sizes (Table S5.2). The ADHD and the control groups did not differ from 
each other (p=0.68). 
 
A significant effect of group emerged on the NoGo-P3 [F(2,57)=3.35, p=0.04]. Post-hoc analyses 
showed that both ADHD (p=0.05) and BD (p=0.02) participants significantly differed from 









Results of data without baseline correction (Table S5.2) showed a reduced Cue-P3 in participants 
with BD compared to participants with ADHD, which was not observed in data with baseline 
correction. No difference emerged between the BD and control groups in the CNV, which was 
at trend level in results of data with baseline correction. Group differences in ERPs from the 
NoGo and Go conditions remained the same.  
 
Of note, an ADHD-control difference in the Cue-P3 was not found when analysing data with or 
without baseline correction. Although this difference has been reported in previous studies 
using this task when a baseline subtraction was not applied (Banaschewski et al. 2004; 
McLoughlin et al. 2010, 2011; Albrecht et al. 2013; Doehnert et al. 2013), this discrepancy is 
likely not due to the use of baseline correction. Possible explanations for the lack of ADHD-





Table S5.1. Mean (SD) number of artefact-free segments in each ERP average by group and 
condition during the CPT-OX 






Cue 58.35 (11.65) 60.10 (10.28) 60.80 (9.05) 
NoGo 30.75 (3.78) 30.05 (4.73) 30.30 (3.85) 
Go 29.22 (5.99) 29.20 (5.29) 30.65 (4.87) 
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; BD, bipolar disorder. 
*Only 18 ADHD participants were included in the average of the Go condition, as two subjects 















ADHD vs. BD  
effect size (d) 
ADHD vs. Controls 
effect size (d) 
BD vs. Controls 
effect size (d) 
Cue-P3 at Pz 1.73 (1.37) 0.72 (1.41) 1.47 (1.67) 0.75* 0.18 0.50 
CNV at Cz -2.33 (1.02) -2.79 (1.29) -3.50 (1.74) 0.41 0.85* 0.48 
NoGo-N2 at Fz -0.45 (0.96) 0.90 (1.94) -0.64 (1.88) 0.90* 0.13 0.83* 
NoGo-P3 at Cz 3.33 (1.92) 2.93 (2.34) 4.50 (1.69) 0.19 0.67* 0.79* 
Go-P3 at CPz 2.77 (2.76) 3.20 (2.85) 3.63 (2.11) 0.17 0.41 0.18 
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; BD, bipolar disorder; CNV, contingent negative variation. 
Notes: mean and SD were calculated on raw data. Large effect sizes are given in bold, medium effect sizes are given in italics; *p<0.05, †p<0.10; results changing 
compared to analysis of data with baseline correction are underlined. 
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The two conditions were not matched on task length, but were matched on the number of trials. 
The fore-period in the baseline condition (8 s) was longer than in the fast-incentive condition (1 
s). This difference was specifically designed to probe sustained attention and vigilance in 
attention-deficit/hyperactivity disorder (ADHD) samples in the baseline condition, and test 
improvements with shorter fore-periods. To exclude the possibility that differences between 
conditions may be due to differential task length, we analysed reaction time variability (RTV) 
performance on both the full baseline condition (presented in the main text) and separately on 
the length-matched segment, consistent with our previous studies on this task (Andreou et al., 
2007, Cheung et al., 2017, Kuntsi et al., 2013). Data from 30 trials of the baseline condition were 
used, to provide a match on length of time on task with the fast-incentive condition. The second 
set of 30 trials are used for this analysis, as this segment of the baseline condition was 
considered more reliable than the first set of 30 trials, which is likely a reflection of an initial 
learning phase during the first part of the task (Andreou et al., 2007). Since the fast-incentive 
condition was always administered after the baseline condition, it did not involve a similar 
learning phase. 
 
A significant main effect of group (p=0.004) and condition (p<0.001), but no group-by-condition 
interaction (p=0.69) emerged, with both the ADHD and the bipolar disorder (BD) groups showing 
increased RTV compared to the control group, but no differences between clinical groups, in the 
length-matched baseline condition (ADHD vs BD: d=0.44, 95% CIs=-0.19–1.07, p=0.17; ADHD vs 
Control: d=1.04, 95%, CIs=0.35–1.71, p=0.003; BD vs Control: d=0.61, 95% CIs=-0.04–1.26, 
p=0.067). All three groups showed significant within-group differences between conditions (all 
p<0.003), but no group differences in the degree of change between conditions (ADHD vs BD: 
d=0.22, 95% CIs=-0.41–0.84, p=0.50; ADHD vs Control: d=0.29, 95% CIs=-0.35–0.62, p=0.37; BD 
vs Control: d=0.17, 95% CIs=-0.47–0.81, p=0.595). 
 
These additional analyses show that comparable results to those in the full baseline were 
obtained for RTV using the length-matched segment of the baseline condition (Andreou et al., 





In time-frequency analyses, the modulations of EEG frequency components in response to a 
stimulus are normalised with respect to spectral power in a pre-defined pre-stimulus period. 
Specifically, the post-stimulus power at each time-frequency point is divided by the mean 
spectral power in the pre-stimulus period (typically reflecting spontaneous EEG) at the same 
frequency (Herrmann et al., 2014, Grandchamp and Delorme, 2011). The normalised post-
stimulus signal is scaled in decibel (dB), a logarithmic unit that represents the ratio of two signals. 
When comparing the ERSPs in two conditions, it is necessary to match the pre-stimulus period 
used to normalise the post-stimulus ERSPs (Herrmann et al., 2014). In the present study, to 
compare the ERSPs in the baseline and fast-incentive conditions, we matched the timing of the 
pre-stimulus window across the two conditions (-2 to -1 s) with respect to the appearance of the 
target stimulus (Figure S6.1). This window represents the -1 to 0 s period before the warning 
stimulus appearing 1 s before the target in the fast-incentive condition, reflecting a window of 
spontaneous EEG activity before warning and target onsets. The same corresponding -2 to -1 s 
window in the baseline condition similarly represents a period of spontaneous EEG activity 
during the long fore-period between the appearance of the warning and of the target. This 
window in the baseline condition was chosen instead of the corresponding pre-warning window 
in the baseline condition (-9 to -8 ms) because segmenting the data around the target from the 
pre-warning window in the baseline condition to the post-target period (-9 to 1 s after the target) 





Since a difference between groups emerged in target-related theta ITC in the fast-incentive 
condition, we carried out an additional analysis to examine whether these differences could be 
attributed to differences in the phase of theta prior to target onset. Theta ITC data were 
calculated as described in the main text, and examined in the -500-0 ms window before 
appearance of target stimuli. We investigated pre-target theta ITC and post-target theta ITC 
(measured as described in the main text) in a random intercept linear model, testing for main 
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effects of group (ADHD vs BD vs control), time window (pre-target vs post-target) and group-by-
window interactions. 
 
A significant effect of time window (p<0.001) and group-by-window interaction (p<0.001), but 
not main effect of group (p=0.38), emerged for theta ITC. Post-hoc tests showed that groups did 
not differ in the pre-target time window (overall group effect: p=0.17), but the control group 
had significantly greater ITC than the ADHD and BD groups in the post-target time window, as 
reported in the main text. All three groups showed a significant increase in theta ITC from the 
pre-target to the post-target time window (all p<0.001), but the control group showed a greater 
degree of change between time windows than the ADHD (d=1.05, p=0.003) and BD (d=1.10, 
p=0.002) groups. The ADHD and BD groups did not differ in the change between time windows 
(d=0.08, p=0.81). 
 
These further analyses indicate that greater phase consistency following target stimuli in the 
control group, compared to the clinical groups, cannot be attributed to differences in the pre-
target window; in the pre-target window, all groups show lower theta ITC values than in the 
post-target window, as expected (Mazaheri and Picton, 2005, Makeig et al., 2004b), but no 
group differences. Greater phase consistency upon target presentation in the control group, 
relative to the clinical groups, may therefore suggest that controls consistently showed a reset 
and alignment in phase of theta oscillations (as indicated by the within-group increase in phase 
consistency from pre-target to post-target windows) over trials. This mechanism of phase-
resetting has been previously associated with optimal behavioural performance (Biau et al., 
2015, Palaniyappan et al., 2012, Lakatos et al., 2009). This process may be less consistent across 
trials in both disorders, as suggested by a lower degree of change from pre-target to post-target 
and lower phase consistency in theta oscillations in ADHD and BD groups than controls. These 
differences point to suboptimal regulation of this neural process in women with ADHD and 







Table S6.1. Descriptive statistics on study variables divided by group 
  Baseline condition Fast-incentive condition 
  
ADHD BD Ctrl ADHD BD Ctrl 
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
RTV 374.44 288.19 289.28 175.80 232.35 240.20 176.87 145.83 132.75 68.83 114.78 79.13 
CNV  -0.35 0.51 -0.35 0.63 -0.33 0.54 -0.79 0.64 -1.29 0.98 -1.84 0.91 
P3  531.58 459.56 501.53 359.17 531.72 496.91 465.10 307.51 427.19 310.80 618.51 388.27 
Theta ERSP (0-500 ms, CP) 1.22 0.69 1.41 0.83 1.54 0.92 0.74 0.76 1.02 0.80 1.31 0.98 
Alpha ERSP (0-500 ms) -0.77 1.05 -0.93 1.26 -1.12 1.58 -0.64 0.82 -0.63 0.81 -0.83 1.42 
Alpha ERSP (500-1000 ms) -1.69 1.38 -1.99 1.78 -2.13 1.99 -0.74 0.95 -0.77 1.34 -1.73 1.86 
Beta ERSP (0-500 ms) -0.98 0.55 -0.76 0.59 -1.03 0.69 -1.13 0.68 -0.77 0.45 -1.23 0.70 
Beta ERSP (500-1000 ms) -1.27 0.71 -0.94 1.41 -0.94 0.92 -0.59 0.71 -0.52 1.13 -0.58 1.02 
Theta ITC (0-500 ms) 0.25 0.06 0.26 0.05 0.28 0.06 0.28 0.07 0.29 0.06 0.33 0.06 
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; BD, bipolar disorder; CNV, contingent negative variation; CP, centro-parietal region; Ctrl, control 





Figure S6.1. A schematic illustration of the temporal sequence of events in the (A) baseline and 
(B) fast‐incentive conditions of the Fast task.  
Notes: In both conditions, the target remained on the screen up to 10 s until a response (response 
time [RT]). The double-headed dashed window corresponds to the pre-stimulus window used to 




Figure S6.2. P3 amplitude measured at Pz in the 300–500 ms window in the ADHD (in red), BD 
(in green) and control (in black) groups across the baseline and fast incentive conditions of the 
Fast task. (A) Grand average in the baseline condition; (B) Grand average in the fast-incentive 






Figure S6.3. Theta event-related spectral perturbation (ERSP) at parietal regions by group across 
the baseline and fast incentive conditions of the Fast task. (A) ERSP in the baseline (top) and fast-
incentive (bottom) conditions; (B) Topographic maps by group in the 0-500 ms window in each 
condition; (C) Condition effects in the 0-500 ms window in the ADHD (in red), BD (in green) and 
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